_MEMBER_data_imp_1 - 94.0-96.0,_MEMBER_data_imp_1 - 96.0-98.0,_MEMBER_data_imp_1 - 98.0-100.0,_LogP_data_imp_1 - 94.0-96.0,_LogP_data_imp_1 - 96.0-98.0,_LogP_data_imp_1 - 98.0-100.0,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,1,1,-4.6,-1.6,-1.6,GO:0030335,positive regulation of cell migration,M111,3,0
1,1,1,-0.91,-0.52,-1.4,GO:0030888,regulation of B cell proliferation,M111,3,0
1,1,1,-0.59,-0.59,-1.4,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,M111,3,0
1,1,1,-3.8,-0.75,-1.8,GO:0045580,regulation of T cell differentiation,M111,3,0
1,1,1,-2.9,-1,-0.6,GO:0034109,homotypic cell-cell adhesion,M111,3,0
1,1,1,-2.7,-2.7,-1.6,GO:0072091,regulation of stem cell proliferation,M111,3,0
1,1,1,-0.91,-0.9,-1.6,GO:1903522,regulation of blood circulation,M111,3,0
1,1,1,-2.4,-0.91,-0.57,hsa04915,Estrogen signaling pathway,M111,3,0
1,1,1,-1.1,-1.1,-1.1,R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,M111,3,0
1,1,1,-2.8,-0.98,-1,GO:0032944,regulation of mononuclear cell proliferation,M111,3,0
1,1,1,-0.72,-1.1,-1.1,GO:0071322,cellular response to carbohydrate stimulus,M111,3,0
1,1,1,-1.8,-0.65,-1.9,GO:0070661,leukocyte proliferation,M111,3,0
1,1,1,-1.2,-0.77,-1.7,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",M111,3,0
1,1,1,-2.2,-1,-2.2,GO:0042098,T cell proliferation,M111,3,0
1,1,1,-2.5,-0.59,-1.9,GO:0032943,mononuclear cell proliferation,M111,3,0
1,1,1,-1.3,-1.9,-0.88,R-HSA-9725370,Signaling by ALK fusions and activated point mutants,M111,3,0
1,1,1,-1.8,-1.2,-0.73,M53,PID INTEGRIN3 PATHWAY,M111,3,0
1,1,1,-2,-2,-2.1,GO:2000630,positive regulation of miRNA metabolic process,M111,3,0
1,1,1,-1.2,-0.73,-0.73,GO:0060443,mammary gland morphogenesis,M111,3,0
1,1,1,-3.9,-1.1,-2,GO:0030036,actin cytoskeleton organization,M111,3,0
1,1,1,-0.78,-0.77,-1.2,GO:0001101,response to acid chemical,M111,3,0
1,1,1,-1.6,-1.1,-2.1,WP474,Endochondral ossification,M111,3,0
1,1,1,-0.88,-0.5,-0.5,WP5293,Acute myeloid leukemia,M111,3,0
1,1,1,-0.73,-2.5,-1.2,GO:0043255,regulation of carbohydrate biosynthetic process,M111,3,0
1,1,1,-2.5,-1.3,-0.5,GO:0043536,positive regulation of blood vessel endothelial cell migration,M111,3,0
1,1,1,-1.6,-0.95,-0.97,R-HSA-9006925,Intracellular signaling by second messengers,M111,3,0
1,1,1,-1.3,-1.2,-1.8,GO:0051148,negative regulation of muscle cell differentiation,M111,3,0
1,1,1,-1.5,-2,-1.5,GO:0002088,lens development in camera-type eye,M111,3,0
1,1,1,-2.5,-0.59,-1.9,GO:0046651,lymphocyte proliferation,M111,3,0
1,1,1,-0.57,-0.57,-1.5,WP69,T cell receptor signaling pathway,M111,3,0
1,1,1,-0.57,-0.57,-0.58,R-HSA-1296071,Potassium Channels,M111,3,0
1,1,1,-2.6,-2.2,-2.3,GO:0007167,enzyme-linked receptor protein signaling pathway,M111,3,0
1,1,1,-1.4,-1.4,-1.7,GO:0150063,visual system development,M111,3,0
1,1,1,-1.1,-0.7,-0.7,GO:0016485,protein processing,M111,3,0
1,1,1,-2.9,-0.98,-2.9,GO:0090068,positive regulation of cell cycle process,M111,3,0
1,1,1,-2.2,-3.1,-3.1,GO:0045596,negative regulation of cell differentiation,M111,3,0
1,1,1,-1.7,-1.4,-1.4,GO:0007517,muscle organ development,M111,3,0
1,1,1,-1.6,-1.1,-1.1,WP5236,Markers of kidney cell lineage,M111,3,0
1,1,1,-3.1,-1,-3.1,GO:0045787,positive regulation of cell cycle,M111,3,0
1,1,1,-3.1,-0.72,-2.5,GO:0045582,positive regulation of T cell differentiation,M111,3,0
1,1,1,-0.73,-0.73,-0.73,GO:0045599,negative regulation of fat cell differentiation,M111,3,0
1,1,1,-1.1,-1.1,-1.4,GO:0022408,negative regulation of cell-cell adhesion,M111,3,0
1,1,1,-0.95,-0.95,-0.96,WP2324,AGE RAGE pathway,M111,3,0
1,1,1,-3.4,-1.7,-1.1,hsa05166,Human T-cell leukemia virus 1 infection,M111,3,0
1,1,1,-2.1,-2.1,-1.6,WP5087,Pleural mesothelioma,M111,3,0
1,1,1,-0.57,-0.57,-1.5,GO:0022029,telencephalon cell migration,M111,3,0
1,1,1,-2.8,-0.77,-1.8,GO:0007264,small GTPase-mediated signal transduction,M111,3,0
1,1,1,-2.5,-3.4,-2.8,GO:0060322,head development,M111,3,0
1,1,1,-1.6,-0.9,-2,GO:0048839,inner ear development,M111,3,0
1,1,1,-0.9,-1.6,-1.3,GO:0032675,regulation of interleukin-6 production,M111,3,0
1,1,1,-2.2,-1,-1,GO:0002707,negative regulation of lymphocyte mediated immunity,M111,3,0
1,1,1,-2.7,-1.4,-0.55,WP2261,Glioblastoma signaling pathways,M111,3,0
1,1,1,-0.98,-1.9,-2.7,GO:0043434,response to peptide hormone,M111,3,0
1,1,1,-1.9,-3.5,-4.2,GO:1902893,regulation of miRNA transcription,M111,3,0
1,1,1,-1.6,-1.3,-2.6,GO:0050804,modulation of chemical synaptic transmission,M111,3,0
1,1,1,-1.9,-0.94,-0.95,GO:0097306,cellular response to alcohol,M111,3,0
1,1,1,-0.55,-0.95,-0.96,WP4321,Thermogenesis,M111,3,0
1,1,1,-2,-2,-2,WP437,EGF EGFR signaling pathway,M111,3,0
1,1,1,-0.75,-0.74,-2.1,GO:0021987,cerebral cortex development,M111,3,0
1,1,1,-0.8,-1.5,-0.81,GO:0035051,cardiocyte differentiation,M111,3,0
1,1,1,-4,-1.1,-0.82,hsa05206,MicroRNAs in cancer,M111,3,0
1,1,1,-2,-1.2,-2,R-HSA-6794362,Protein-protein interactions at synapses,M111,3,0
1,1,1,-0.96,-0.63,-4.1,GO:0007605,sensory perception of sound,M111,3,0
1,1,1,-3.3,-2.2,-1.3,GO:0045859,regulation of protein kinase activity,M111,3,0
1,1,1,-0.75,-0.74,-1.2,GO:0048332,mesoderm morphogenesis,M111,3,0
1,1,1,-2.5,-2.9,-4.1,GO:0098609,cell-cell adhesion,M111,3,0
1,1,1,-1.3,-1.9,-0.88,R-HSA-9700206,Signaling by ALK in cancer,M111,3,0
1,1,1,-1.8,-3.1,-3.1,WP3527,Pre implantation embryo,M111,3,0
1,1,1,-7.2,-1.3,-0.97,hsa04218,Cellular senescence,M111,3,0
1,1,1,-2.8,-0.77,-3.3,hsa04810,Regulation of actin cytoskeleton,M111,3,0
1,1,1,-0.52,-0.52,-2,GO:0021885,forebrain cell migration,M111,3,0
1,1,1,-3.5,-2.4,-3.9,GO:1901699,cellular response to nitrogen compound,M111,3,0
1,1,1,-1.6,-1.9,-3.4,GO:1901652,response to peptide,M111,3,0
1,1,1,-2.1,-0.69,-1.6,R-HSA-2219528,PI3K/AKT Signaling in Cancer,M111,3,0
1,1,1,-2.6,-1.6,-1.7,GO:0071396,cellular response to lipid,M111,3,0
1,1,1,-0.6,-1,-0.6,R-HSA-9679191,Potential therapeutics for SARS,M111,3,0
1,1,1,-1.1,-1.7,-4.5,GO:0007268,chemical synaptic transmission,M111,3,0
1,1,1,-2.1,-1.1,-1.1,GO:0014910,regulation of smooth muscle cell migration,M111,3,0
1,1,1,-3.3,-0.77,-1.1,GO:0042129,regulation of T cell proliferation,M111,3,0
1,1,1,-1.8,-1.8,-1.3,GO:0043401,steroid hormone mediated signaling pathway,M111,3,0
1,1,1,-1.3,-1.6,-2.1,WP236,Adipogenesis,M111,3,0
1,1,1,-1.3,-0.9,-1.3,GO:1903038,negative regulation of leukocyte cell-cell adhesion,M111,3,0
1,1,1,-2.7,-1.4,-0.55,hsa01521,EGFR tyrosine kinase inhibitor resistance,M111,3,0
1,1,1,-0.91,-1.4,-0.52,hsa04910,Insulin signaling pathway,M111,3,0
1,1,1,-1.2,-0.82,-0.83,hsa04390,Hippo signaling pathway,M111,3,0
1,1,1,-1.1,-0.81,-1.1,GO:0021543,pallium development,M111,3,0
1,1,1,-2.9,-0.96,-1.4,GO:0050851,antigen receptor-mediated signaling pathway,M111,3,0
1,1,1,-1.6,-1.1,-0.63,M10,PID BCR 5PATHWAY,M111,3,0
1,1,1,-1.4,-3.2,-3.7,GO:0070848,response to growth factor,M111,3,0
1,1,1,-3.8,-0.81,-0.81,GO:0031032,actomyosin structure organization,M111,3,0
1,1,1,-2.9,-1.8,-3.3,GO:0001701,in utero embryonic development,M111,3,0
1,1,1,-0.95,-0.95,-0.55,WP399,Wnt signaling pathway and pluripotency,M111,3,0
1,1,1,-3.2,-0.69,-0.7,GO:0007405,neuroblast proliferation,M111,3,0
1,1,1,-2.5,-1.1,-1.1,GO:0050866,negative regulation of cell activation,M111,3,0
1,1,1,-2.4,-0.99,-1,M8626,SIG BCR SIGNALING PATHWAY,M111,3,0
1,1,1,-1.8,-1.2,-3.1,GO:0050871,positive regulation of B cell activation,M111,3,0
1,1,1,-1.4,-1.4,-1.4,GO:0071353,cellular response to interleukin-4,M111,3,0
1,1,1,-2.1,-1.3,-1.3,GO:0070670,response to interleukin-4,M111,3,0
1,1,1,-1.4,-3.5,-1.1,GO:0048667,cell morphogenesis involved in neuron differentiation,M111,3,0
1,1,1,-1.9,-0.94,-1.9,hsa04658,Th1 and Th2 cell differentiation,M111,3,0
1,1,1,-1.3,-0.9,-1.3,GO:0036294,cellular response to decreased oxygen levels,M111,3,0
1,1,1,-0.81,-0.8,-2,GO:0021795,cerebral cortex cell migration,M111,3,0
1,1,1,-1.3,-1.2,-1.3,hsa05017,Spinocerebellar ataxia,M111,3,0
1,1,1,-1.6,-0.6,-0.6,GO:0046638,positive regulation of alpha-beta T cell differentiation,M111,3,0
1,1,1,-3.1,-1.2,-2.1,GO:0009611,response to wounding,M111,3,0
1,1,1,-2.4,-4,-2.7,GO:0007420,brain development,M111,3,0
1,1,1,-1.2,-0.74,-1.7,R-HSA-199418,Negative regulation of the PI3K/AKT network,M111,3,0
1,1,1,-1.2,-2.7,-1.9,GO:0043254,regulation of protein-containing complex assembly,M111,3,0
1,1,1,-0.63,-1.1,-2.3,GO:1901989,positive regulation of cell cycle phase transition,M111,3,0
1,1,1,-0.55,-0.95,-0.96,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,M111,3,0
1,1,1,-0.66,-0.66,-0.66,GO:0051224,negative regulation of protein transport,M111,3,0
1,1,1,-0.57,-0.99,-0.58,GO:0003143,embryonic heart tube morphogenesis,M111,3,0
1,1,1,-1.3,-3,-0.92,WP23,B cell receptor signaling pathway,M111,3,0
1,1,1,-1.3,-1.3,-1.9,GO:0007162,negative regulation of cell adhesion,M111,3,0
1,1,1,-1.4,-1.1,-1.1,GO:0008016,regulation of heart contraction,M111,3,0
1,1,1,-0.96,-0.96,-2.9,GO:0030326,embryonic limb morphogenesis,M111,3,0
1,1,1,-0.77,-3.9,-3.3,hsa04550,Signaling pathways regulating pluripotency of stem cells,M111,3,0
1,1,1,-1.5,-1.2,-1.2,GO:0043010,camera-type eye development,M111,3,0
1,1,1,-1.1,-1.1,-1.6,GO:0071453,cellular response to oxygen levels,M111,3,0
1,1,1,-2.5,-1,-1,GO:0050670,regulation of lymphocyte proliferation,M111,3,0
1,1,1,-1.3,-1.2,-1.8,GO:0051153,regulation of striated muscle cell differentiation,M111,3,0
1,1,1,-3.2,-0.61,-1.4,GO:0061351,neural precursor cell proliferation,M111,3,0
1,1,1,-1.3,-1.3,-0.86,hsa04144,Endocytosis,M111,3,0
1,1,1,-1.2,-0.74,-2.3,GO:0072132,mesenchyme morphogenesis,M111,3,0
1,1,1,-1.2,-1.2,-1.2,GO:0022612,gland morphogenesis,M111,3,0
1,1,1,-0.6,-1,-0.6,WP1591,Heart development,M111,3,0
1,1,1,-1.9,-1.3,-2.6,GO:2000648,positive regulation of stem cell proliferation,M111,3,0
1,1,1,-0.95,-0.95,-0.96,R-HSA-9013423,RAC3 GTPase cycle,M111,3,0
1,1,1,-2.8,-1.9,-0.87,WP306,Focal adhesion,M111,3,0
1,1,1,-0.5,-1.3,-1.9,WP2849,Hematopoietic stem cell differentiation,M111,3,0
1,1,1,-1.6,-2,-0.83,GO:0030879,mammary gland development,M111,3,0
1,1,1,-1.8,-2.9,-3.7,GO:0007423,sensory organ development,M111,3,0
1,1,1,-1.8,-1.8,-0.85,GO:1905314,semi-lunar valve development,M111,3,0
1,1,1,-1.8,-0.91,-0.92,GO:0046637,regulation of alpha-beta T cell differentiation,M111,3,0
1,1,1,-1.9,-0.5,-1.4,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",M111,3,0
1,1,1,-3.4,-0.69,-1.1,GO:0031341,regulation of cell killing,M111,3,0
1,1,1,-1.3,-0.85,-1.3,GO:0048661,positive regulation of smooth muscle cell proliferation,M111,3,0
1,1,1,-2.3,-3.4,-4,GO:0140747,regulation of ncRNA transcription,M111,3,0
1,1,1,-1.8,-3.9,-3.9,GO:2000628,regulation of miRNA metabolic process,M111,3,0
1,1,1,-0.77,-1.6,-0.78,GO:0051346,negative regulation of hydrolase activity,M111,3,0
1,1,1,-1.4,-1.4,-5.5,GO:0099536,synaptic signaling,M111,3,0
1,1,1,-0.57,-1.8,-0.57,GO:0021510,spinal cord development,M111,3,0
1,1,1,-0.66,-1.1,-1.1,GO:0071229,cellular response to acid chemical,M111,3,0
1,1,1,-2.5,-1.7,-4,GO:1901653,cellular response to peptide,M111,3,0
1,1,1,-0.69,-1.2,-0.7,GO:0061371,determination of heart left/right asymmetry,M111,3,0
1,1,1,-1.7,-0.92,-2.1,GO:0002700,regulation of production of molecular mediator of immune response,M111,3,0
1,1,1,-1.2,-0.69,-0.7,WP2406,Cardiac progenitor differentiation,M111,3,0
1,1,1,-1.9,-0.87,-0.5,GO:0032663,regulation of interleukin-2 production,M111,3,0
1,1,1,-1.3,-1.3,-0.5,hsa05212,Pancreatic cancer,M111,3,0
1,1,1,-1.1,-1.8,-1.1,WP4241,Type 2 papillary renal cell carcinoma,M111,3,0
1,1,1,-0.84,-1.8,-0.85,GO:0072089,stem cell proliferation,M111,3,0
1,1,1,-1.4,-1.4,-2.7,GO:0071375,cellular response to peptide hormone stimulus,M111,3,0
1,1,1,-1.7,-0.85,-0.86,GO:0001656,metanephros development,M111,3,0
1,1,1,-1.1,-1.9,-2.4,R-HSA-112315,Transmission across Chemical Synapses,M111,3,0
1,1,1,-1.2,-0.74,-0.75,M279,PID RB 1PATHWAY,M111,3,0
1,1,1,-1.4,-1.9,-0.99,GO:0055007,cardiac muscle cell differentiation,M111,3,0
1,1,1,-2.4,-1.6,-2.9,GO:0097305,response to alcohol,M111,3,0
1,1,1,-3.7,-1,-1.6,WP5098,T cell activation SARS CoV 2,M111,3,0
1,1,1,-2,-1.2,-1.2,hsa04914,Progesterone-mediated oocyte maturation,M111,3,0
1,1,1,-0.78,-0.78,-0.79,GO:0033673,negative regulation of kinase activity,M111,3,0
1,1,1,-2.3,-1.7,-2.3,GO:1902895,positive regulation of miRNA transcription,M111,3,0
1,1,1,-1.8,-3.1,-2.4,GO:0032870,cellular response to hormone stimulus,M111,3,0
1,1,1,-0.85,-1.2,-1.2,GO:0031334,positive regulation of protein-containing complex assembly,M111,3,0
1,1,1,-1.8,-1.3,-1.3,GO:0071902,positive regulation of protein serine/threonine kinase activity,M111,3,0
1,1,1,-1.3,-1.7,-1.3,GO:0003170,heart valve development,M111,3,0
1,1,1,-0.94,-0.94,-0.94,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,M111,3,0
1,1,1,-0.77,-2.1,-0.78,WP2884,NRF2 pathway,M111,3,0
1,1,1,-1,-1,-0.64,GO:0002286,T cell activation involved in immune response,M111,3,0
1,1,1,-0.73,-1.2,-0.73,GO:0001947,heart looping,M111,3,0
1,1,1,-2,-0.54,-0.96,WP4685,Melanoma,M111,3,0
1,1,1,-1.6,-0.6,-1.6,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,M111,3,0
1,1,1,-1.6,-1.1,-2.1,WP4808,Endochondral ossification with skeletal dysplasias,M111,3,0
1,1,1,-1.4,-0.65,-0.66,GO:0050868,negative regulation of T cell activation,M111,3,0
1,1,1,-0.73,-0.73,-4.2,M60,PID NFAT TFPATHWAY,M111,3,0
1,1,1,-1.6,-0.93,-2.4,GO:0043583,ear development,M111,3,0
1,1,1,-1.2,-0.69,-0.7,GO:0032720,negative regulation of tumor necrosis factor production,M111,3,0
1,1,1,-0.63,-0.63,-1.4,GO:0043405,regulation of MAP kinase activity,M111,3,0
1,1,1,-2.6,-1,-1,GO:0044770,cell cycle phase transition,M111,3,0
1,1,1,-0.77,-1.3,-2.6,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,M111,3,0
1,1,1,-1.4,-2.3,-0.64,GO:0006109,regulation of carbohydrate metabolic process,M111,3,0
1,1,1,-0.76,-0.75,-0.76,GO:0048639,positive regulation of developmental growth,M111,3,0
1,1,1,-1.3,-1.1,-2.3,GO:0045165,cell fate commitment,M111,3,0
1,1,1,-2,-0.64,-1.5,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",M111,3,0
1,1,1,-0.89,-0.89,-1.5,M34,PID TCR PATHWAY,M111,3,0
1,1,1,-0.69,-0.69,-0.7,hsa04750,Inflammatory mediator regulation of TRP channels,M111,3,0
1,1,1,-3.8,-2.1,-1.1,GO:0051347,positive regulation of transferase activity,M111,3,0
1,1,1,-1.3,-1,-1,GO:0048545,response to steroid hormone,M111,3,0
1,1,1,-3.2,-2.2,-0.81,hsa04510,Focal adhesion,M111,3,0
1,1,1,-0.78,-0.77,-1.7,hsa05321,Inflammatory bowel disease,M111,3,0
1,1,1,-0.81,-1.2,-0.81,GO:0032945,negative regulation of mononuclear cell proliferation,M111,3,0
1,1,1,-1.6,-3.7,-1,WP4674,Head and neck squamous cell carcinoma,M111,3,0
1,1,1,-0.91,-0.91,-1.4,GO:0043406,positive regulation of MAP kinase activity,M111,3,0
1,1,1,-2.1,-1.6,-1.2,WP4666,Hepatitis B infection,M111,3,0
1,1,1,-0.91,-2,-0.92,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,M111,3,0
1,1,1,-1.7,-1.7,-1.7,R-HSA-6794361,Neurexins and neuroligins,M111,3,0
1,1,1,-1.1,-0.66,-0.66,hsa04211,Longevity regulating pathway,M111,3,0
1,1,1,-1.1,-3.5,-1.1,GO:0007411,axon guidance,M111,3,0
1,1,1,-1.6,-1.6,-2.5,WP53,ID signaling pathway,M111,3,0
1,1,1,-1.3,-0.87,-1.4,GO:0051591,response to cAMP,M111,3,0
1,1,1,-1.6,-1.1,-1.1,WP3998,Prader Willi and Angelman syndrome,M111,3,0
1,1,1,-1.1,-1.1,-1.7,hsa04660,T cell receptor signaling pathway,M111,3,0
1,1,1,-0.72,-1.5,-0.73,WP536,Calcium regulation in cardiac cells,M111,3,0
1,1,1,-1.7,-0.85,-2.9,M167,PID AP1 PATHWAY,M111,3,0
1,1,1,-1.2,-1.2,-2.9,GO:0002639,positive regulation of immunoglobulin production,M111,3,0
1,1,1,-1.5,-1.5,-1.5,GO:0071383,cellular response to steroid hormone stimulus,M111,3,0
1,1,1,-4.2,-1.6,-1.6,GO:0040017,positive regulation of locomotion,M111,3,0
1,1,1,-1.1,-1.7,-4.5,GO:0098916,anterograde trans-synaptic signaling,M111,3,0
1,1,1,-1.2,-3.2,-1.5,GO:0050679,positive regulation of epithelial cell proliferation,M111,3,0
1,1,1,-0.52,-0.91,-0.52,GO:0071333,cellular response to glucose stimulus,M111,3,0
1,1,1,-1.4,-1.8,-1.8,GO:0060173,limb development,M111,3,0
1,1,1,-2,-2,-0.92,GO:0003176,aortic valve development,M111,3,0
1,1,1,-1.1,-1.1,-3.4,WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,M111,3,0
1,1,1,-0.59,-0.94,-2.5,M195,PID CMYB PATHWAY,M111,3,0
1,1,1,-2.2,-1.7,-2.7,WP5083,Neuroinflammation and glutamatergic signaling,M111,3,0
1,1,1,-0.8,-0.8,-0.81,GO:0006469,negative regulation of protein kinase activity,M111,3,0
1,1,1,-2.6,-1.1,-1.4,GO:0007015,actin filament organization,M111,3,0
1,1,1,-1.4,-0.59,-0.95,GO:0001837,epithelial to mesenchymal transition,M111,3,0
1,1,1,-1.3,-1.3,-0.81,GO:1904892,regulation of receptor signaling pathway via STAT,M111,3,0
1,1,1,-1.1,-0.84,-1.2,GO:0002695,negative regulation of leukocyte activation,M111,3,0
1,1,1,-0.69,-0.69,-0.7,R-HSA-9013149,RAC1 GTPase cycle,M111,3,0
1,1,1,-3.1,-1.6,-2.6,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M111,3,0
1,1,1,-2.4,-1,-1.3,GO:0070663,regulation of leukocyte proliferation,M111,3,0
1,1,1,-0.64,-2,-2,GO:1901655,cellular response to ketone,M111,3,0
1,1,1,-2.3,-1.1,-0.63,GO:0050853,B cell receptor signaling pathway,M111,3,0
1,1,1,-1.8,-1.1,-1.8,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M111,3,0
1,1,1,-2.2,-2.9,-2.6,GO:0071407,cellular response to organic cyclic compound,M111,3,0
1,1,1,-0.57,-0.91,-1.3,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,M111,3,0
1,1,1,-0.64,-1,-1,GO:0070664,negative regulation of leukocyte proliferation,M111,3,0
1,1,1,-1.2,-1.2,-0.75,R-HSA-3000171,Non-integrin membrane-ECM interactions,M111,3,0
1,1,1,-1.4,-1.4,-1.7,GO:0048880,sensory system development,M111,3,0
1,1,1,-1.8,-1.2,-2.8,GO:0044057,regulation of system process,M111,3,0
1,1,1,-0.96,-0.96,-2.9,GO:0035113,embryonic appendage morphogenesis,M111,3,0
1,1,1,-0.96,-0.63,-0.97,GO:0002718,regulation of cytokine production involved in immune response,M111,3,0
1,1,1,-1.9,-0.76,-1.3,M65,PID FRA PATHWAY,M111,3,0
1,1,1,-2.7,-1.7,-3.5,GO:0071417,cellular response to organonitrogen compound,M111,3,0
1,1,1,-1.4,-2.8,-1.4,GO:0051147,regulation of muscle cell differentiation,M111,3,0
1,1,1,-1.1,-0.63,-1.1,WP117,GPCRs other,M111,3,0
1,1,1,-0.59,-1.4,-1.9,R-HSA-187037,Signaling by NTRK1 (TRKA),M111,3,0
1,1,1,-1.2,-1.5,-4.7,GO:0099537,trans-synaptic signaling,M111,3,0
1,1,1,-2.4,-3.1,-2.8,GO:0061061,muscle structure development,M111,3,0
1,1,1,-1.2,-2.6,-1.2,hsa04380,Osteoclast differentiation,M111,3,0
1,1,1,-1.2,-1.5,-3,GO:0042110,T cell activation,M111,3,0
1,1,1,-1.6,-0.77,-1.6,GO:0002702,positive regulation of production of molecular mediator of immune response,M111,3,0
1,1,1,-1.7,-2.3,-0.66,WP673,ErbB signaling pathway,M111,3,0
1,1,1,-3,-1.3,-1.8,GO:0060021,roof of mouth development,M111,3,0
1,1,1,-1.6,-1.3,-2.6,GO:0099177,regulation of trans-synaptic signaling,M111,3,0
1,1,1,-1.5,-0.78,-1.1,GO:0003279,cardiac septum development,M111,3,0
1,1,1,-1.1,-1.5,-1.5,WP5130,Th17 cell differentiation pathway,M111,3,0
1,1,1,-1,-0.6,-2.9,GO:0003203,endocardial cushion morphogenesis,M111,3,0
1,1,1,-0.96,-1.3,-2,GO:0045664,regulation of neuron differentiation,M111,3,0
1,1,1,-1.5,-1.5,-1.3,GO:0001654,eye development,M111,3,0
1,1,1,-1.2,-1.2,-0.73,WP2034,Leptin signaling pathway,M111,3,0
1,1,1,-1.2,-1.9,-1.9,GO:0090596,sensory organ morphogenesis,M111,3,0
1,1,1,-1.1,-2.3,-1.6,WP2882,Nuclear receptors meta pathway,M111,3,0
1,1,1,-1.9,-1.6,-1.9,GO:0042692,muscle cell differentiation,M111,3,0
1,1,1,-1.1,-0.66,-0.66,GO:0042130,negative regulation of T cell proliferation,M111,3,0
1,1,1,-4,-0.5,-0.5,GO:0001910,regulation of leukocyte mediated cytotoxicity,M111,3,0
1,1,1,-4,-2.3,-1,hsa05207,Chemical carcinogenesis - receptor activation,M111,3,0
1,1,1,-4.2,-1.2,-3.3,M28,PID IL4 2PATHWAY,M111,3,0
1,1,1,-1.1,-2,-2.1,M124,PID CXCR4 PATHWAY,M111,3,0
1,1,1,-1.6,-1.1,-1.2,WP51,Regulation of actin cytoskeleton,M111,3,0
1,1,1,-2.2,-1.2,-0.75,GO:0044772,mitotic cell cycle phase transition,M111,3,0
1,1,1,-0.92,-0.57,-1.8,GO:0030832,regulation of actin filament length,M111,3,0
1,1,1,-2.3,-0.77,-1.2,GO:0002704,negative regulation of leukocyte mediated immunity,M111,3,0
1,1,1,-1.5,-1.1,-1.5,GO:0060411,cardiac septum morphogenesis,M111,3,0
1,1,1,-1.6,-1.6,-0.63,GO:0060412,ventricular septum morphogenesis,M111,3,0
1,1,1,-0.55,-0.95,-0.96,GO:0060761,negative regulation of response to cytokine stimulus,M111,3,0
1,1,1,-0.64,-1,-0.64,hsa05414,Dilated cardiomyopathy,M111,3,0
1,1,1,-0.63,-1.6,-0.63,WP4823,Genes controlling nephrogenesis,M111,3,0
1,1,1,-1.2,-1.2,-0.73,WP395,IL 4 signaling pathway,M111,3,0
1,1,1,-0.94,-0.94,-3.1,GO:0002637,regulation of immunoglobulin production,M111,3,0
1,1,1,-1.6,-1.1,-0.78,hsa04072,Phospholipase D signaling pathway,M111,3,0
1,1,1,-1.7,-2.5,-1.1,GO:0045936,negative regulation of phosphate metabolic process,M111,3,0
1,1,1,-2.8,-1.7,-0.94,hsa04659,Th17 cell differentiation,M111,3,0
1,1,1,-1.6,-0.9,-0.92,R-HSA-1257604,PIP3 activates AKT signaling,M111,3,0
1,1,1,-0.57,-0.57,-0.58,GO:0001960,negative regulation of cytokine-mediated signaling pathway,M111,3,0
1,1,1,-1.5,-1,-0.67,GO:0003179,heart valve morphogenesis,M111,3,0
1,1,1,-1,-1.3,-2.4,GO:0030099,myeloid cell differentiation,M111,3,0
1,1,1,-4.2,-2.1,-1.4,GO:0045860,positive regulation of protein kinase activity,M111,3,0
1,1,1,-0.91,-0.52,-0.52,hsa05221,Acute myeloid leukemia,M111,3,0
1,1,1,-1.3,-0.93,-1.3,GO:0071456,cellular response to hypoxia,M111,3,0
1,1,1,-1.3,-0.8,-0.81,GO:0030890,positive regulation of B cell proliferation,M111,3,0
1,1,1,-0.55,-0.95,-0.55,GO:1904950,negative regulation of establishment of protein localization,M111,3,0
1,1,1,-0.94,-2.3,-0.94,GO:0045913,positive regulation of carbohydrate metabolic process,M111,3,0
1,1,1,-3,-1.9,-1.7,GO:0030029,actin filament-based process,M111,3,0
1,1,1,-1.6,-2,-2,GO:0051146,striated muscle cell differentiation,M111,3,0
1,1,1,-1.4,-0.59,-0.59,GO:1905330,regulation of morphogenesis of an epithelium,M111,3,0
1,1,1,-0.81,-1.2,-0.81,GO:0050672,negative regulation of lymphocyte proliferation,M111,3,0
1,1,1,-1.9,-2.4,-5.3,GO:0008283,cell population proliferation,M111,3,0
1,1,1,-2.3,-1.6,-0.63,GO:0003180,aortic valve morphogenesis,M111,3,0
1,1,1,-1,-1,-1.7,GO:0032715,negative regulation of interleukin-6 production,M111,3,0
1,1,1,-1.7,-2.5,-1.1,GO:0010563,negative regulation of phosphorus metabolic process,M111,3,0
1,1,1,-2.9,-2.1,-3.4,WP3932,Focal adhesion PI3K Akt mTOR signaling pathway,M111,3,0
1,1,1,-1.6,-3.7,-1,WP4149,White fat cell differentiation,M111,3,0
1,1,1,-1.1,-3.5,-1.1,GO:0097485,neuron projection guidance,M111,3,0
1,1,1,-1.4,-2.6,-3.7,GO:0071363,cellular response to growth factor stimulus,M111,3,0
1,1,1,-1.3,-0.91,-0.92,GO:0001892,embryonic placenta development,M111,3,0
1,1,1,-0.95,-0.59,-1.9,GO:0008064,regulation of actin polymerization or depolymerization,M111,3,0
1,1,1,-1.1,-0.63,-0.63,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,M111,3,0
1,1,1,-2.2,-2.7,-1.9,GO:0009725,response to hormone,M111,3,0
1,1,1,-4.1,-1.8,-1.2,GO:0033674,positive regulation of kinase activity,M111,3,0
1,1,1,-1.3,-3.5,-0.81,hsa05211,Renal cell carcinoma,M111,3,0
1,1,1,-1.6,-2.8,-0.72,WP3931,Embryonic stem cell pluripotency pathways,M111,3,0
1,1,1,-2.4,-2.8,-3.3,R-HSA-112316,Neuronal System,M111,3,0
1,1,1,-1.4,-1.8,-1.8,GO:0048736,appendage development,M111,3,0
1,1,1,-1.5,-2,-0.55,hsa04650,Natural killer cell mediated cytotoxicity,M111,3,0
1,1,1,-1.1,-1.6,-1.6,GO:0045665,negative regulation of neuron differentiation,M111,3,0
1,1,1,-0.64,-2,-3.3,GO:0032869,cellular response to insulin stimulus,M111,3,0
1,1,1,-1.1,-0.79,-1.1,GO:0048660,regulation of smooth muscle cell proliferation,M111,3,0
1,1,1,-1.6,-2.2,-1,GO:0061180,mammary gland epithelium development,M111,3,0
1,1,1,-3.3,-1.8,-1.4,hsa05161,Hepatitis B,M111,3,0
1,1,1,-1.2,-1.9,-1.2,GO:0021537,telencephalon development,M111,3,0
1,1,1,-0.73,-0.73,-1.2,R-HSA-948021,Transport to the Golgi and subsequent modification,M111,3,0
1,1,1,-2.2,-0.6,-1.6,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,M111,3,0
1,1,1,-0.89,-0.89,-3,GO:1901992,positive regulation of mitotic cell cycle phase transition,M111,3,0
1,1,1,-2.3,-0.66,-1.1,hsa04540,Gap junction,M111,3,0
1,1,1,-1.7,-0.74,-1.2,GO:0050852,T cell receptor signaling pathway,M111,3,0
1,0,1,-0.63,0,-1.1,GO:0035264,multicellular organism growth,M101,2,0
1,1,0,-1.7,-1,0,R-HSA-2871809,FCERI mediated Ca+2 mobilization,M110,2,0
1,0,1,-1.6,0,-1.3,GO:0002683,negative regulation of immune system process,M101,2,0
1,1,0,-0.65,-0.65,0,GO:0072163,mesonephric epithelium development,M110,2,0
0,1,1,0,-0.59,-0.95,GO:0048864,stem cell development,M011,2,0
0,1,1,0,-1.3,-0.96,GO:0050680,negative regulation of epithelial cell proliferation,M011,2,0
1,0,1,-1.1,0,-1.8,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,M101,2,0
1,1,0,-1.9,-2.9,0,GO:0072224,metanephric glomerulus development,M110,2,0
0,1,1,0,-1.2,-1.2,GO:1903531,negative regulation of secretion by cell,M011,2,0
1,0,1,-0.94,0,-1.5,GO:0089718,amino acid import across plasma membrane,M101,2,0
1,1,0,-0.68,-0.67,0,hsa04062,Chemokine signaling pathway,M110,2,0
1,1,0,-2,-2,0,hsa04933,AGE-RAGE signaling pathway in diabetic complications,M110,2,0
0,1,1,0,-4.3,-1.9,GO:2000629,negative regulation of miRNA metabolic process,M011,2,0
1,1,0,-2,-1.3,0,GO:0032147,activation of protein kinase activity,M110,2,0
1,0,1,-0.66,0,-0.66,GO:0033628,regulation of cell adhesion mediated by integrin,M101,2,0
1,0,1,-0.85,0,-2.8,GO:0010518,positive regulation of phospholipase activity,M101,2,0
0,1,1,0,-1.5,-0.94,GO:0043299,leukocyte degranulation,M011,2,0
1,1,0,-0.6,-1,0,GO:0032653,regulation of interleukin-10 production,M110,2,0
0,1,1,0,-1.5,-0.7,GO:0016525,negative regulation of angiogenesis,M011,2,0
1,1,0,-2.5,-1.1,0,hsa05222,Small cell lung cancer,M110,2,0
1,0,1,-1.1,0,-1.7,GO:0051783,regulation of nuclear division,M101,2,0
1,0,1,-1.8,0,-2.4,GO:0042471,ear morphogenesis,M101,2,0
0,1,1,0,-0.69,-1.8,GO:0060078,regulation of postsynaptic membrane potential,M011,2,0
0,1,1,0,-0.73,-2.5,GO:0045661,regulation of myoblast differentiation,M011,2,0
1,1,0,-1.2,-1.5,0,GO:0016055,Wnt signaling pathway,M110,2,0
1,1,0,-2.9,-1.9,0,GO:0051338,regulation of transferase activity,M110,2,0
0,1,1,0,-1.4,-2.3,GO:0034330,cell junction organization,M011,2,0
1,0,1,-2.6,0,-1.8,R-HSA-1433557,Signaling by SCF-KIT,M101,2,0
0,1,1,0,-0.89,-0.9,GO:0048024,"regulation of mRNA splicing, via spliceosome",M011,2,0
1,0,1,-1.7,0,-1.7,GO:1902751,positive regulation of cell cycle G2/M phase transition,M101,2,0
1,1,0,-1.1,-0.7,0,hsa05170,Human immunodeficiency virus 1 infection,M110,2,0
1,1,0,-0.63,-3,0,WP4331,Neovascularization processes,M110,2,0
1,1,0,-2.4,-3,0,M186,PID PDGFRB PATHWAY,M110,2,0
0,1,1,0,-0.8,-1.2,GO:0000302,response to reactive oxygen species,M011,2,0
1,1,0,-0.6,-1,0,M105,PID TELOMERASE PATHWAY,M110,2,0
0,1,1,0,-0.91,-0.92,GO:0008277,regulation of G protein-coupled receptor signaling pathway,M011,2,0
1,0,1,-2.1,0,-1.5,M115,PID REG GR PATHWAY,M101,2,0
1,0,1,-0.77,0,-0.77,GO:0032273,positive regulation of protein polymerization,M101,2,0
0,1,1,0,-0.94,-1.5,GO:0038093,Fc receptor signaling pathway,M011,2,0
0,1,1,0,-1.2,-1.9,R-HSA-9844594,Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,M011,2,0
1,0,1,-2.8,0,-0.85,WP304,Kit receptor signaling pathway,M101,2,0
1,0,1,-2.6,0,-2.2,WP4172,PI3K Akt signaling pathway,M101,2,0
1,1,0,-0.64,-1.5,0,GO:0050714,positive regulation of protein secretion,M110,2,0
0,1,1,0,-1.3,-2.3,GO:0001764,neuron migration,M011,2,0
1,1,0,-1.1,-1.1,0,hsa04213,Longevity regulating pathway - multiple species,M110,2,0
1,1,0,-0.94,-0.94,0,GO:0071320,cellular response to cAMP,M110,2,0
1,1,0,-1.5,-1.1,0,GO:0010959,regulation of metal ion transport,M110,2,0
0,1,1,0,-0.99,-4.2,GO:0051965,positive regulation of synapse assembly,M011,2,0
1,0,1,-1.8,0,-0.73,GO:0033077,T cell differentiation in thymus,M101,2,0
1,1,0,-0.99,-1.5,0,hsa04662,B cell receptor signaling pathway,M110,2,0
1,1,0,-0.94,-1.5,0,M286,PID TGFBR PATHWAY,M110,2,0
1,1,0,-1.3,-1.8,0,WP710,DNA damage response only ATM dependent,M110,2,0
1,1,0,-0.94,-0.94,0,R-HSA-8943724,Regulation of PTEN gene transcription,M110,2,0
1,1,0,-3.3,-1.9,0,GO:0043549,regulation of kinase activity,M110,2,0
0,1,1,0,-2.2,-0.96,WP2853,Endoderm differentiation,M011,2,0
1,0,1,-0.85,0,-0.85,WP1971,Integrated cancer pathway,M101,2,0
0,1,1,0,-1.6,-1.1,GO:0008015,blood circulation,M011,2,0
0,1,1,0,-0.59,-1.9,GO:0048663,neuron fate commitment,M011,2,0
0,1,1,0,-1.5,-0.94,WP410,Exercise induced circadian regulation,M011,2,0
0,1,1,0,-1.2,-2.7,R-HSA-9012999,RHO GTPase cycle,M011,2,0
0,1,1,0,-2.6,-2.7,GO:0051216,cartilage development,M011,2,0
1,0,1,-1,0,-1,GO:0009314,response to radiation,M101,2,0
1,0,1,-2.4,0,-2,GO:0090257,regulation of muscle system process,M101,2,0
0,1,1,0,-1.1,-2.1,GO:0010976,positive regulation of neuron projection development,M011,2,0
1,0,1,-0.73,0,-1.2,GO:1902475,L-alpha-amino acid transmembrane transport,M101,2,0
1,0,1,-1.6,0,-1.6,GO:0007346,regulation of mitotic cell cycle,M101,2,0
1,0,1,-1.9,0,-2.9,GO:0045579,positive regulation of B cell differentiation,M101,2,0
1,0,1,-0.66,0,-2.4,GO:0060193,positive regulation of lipase activity,M101,2,0
1,1,0,-1.3,-0.87,0,hsa05210,Colorectal cancer,M110,2,0
1,1,0,-1.8,-1,0,GO:0048754,branching morphogenesis of an epithelial tube,M110,2,0
0,1,1,0,-0.79,-2.3,GO:1901888,regulation of cell junction assembly,M011,2,0
1,0,1,-3.6,0,-1.2,GO:0050863,regulation of T cell activation,M101,2,0
1,0,1,-0.96,0,-0.64,R-HSA-202733,Cell surface interactions at the vascular wall,M101,2,0
1,1,0,-0.85,-0.85,0,GO:0061008,hepaticobiliary system development,M110,2,0
1,1,0,-1.2,-0.69,0,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,M110,2,0
1,0,1,-0.66,0,-1.1,GO:0045058,T cell selection,M101,2,0
1,1,0,-1.9,-1.2,0,hsa04010,MAPK signaling pathway,M110,2,0
0,1,1,0,-1.2,-1.2,GO:0040007,growth,M011,2,0
1,1,0,-0.98,-0.61,0,hsa05410,Hypertrophic cardiomyopathy,M110,2,0
1,0,1,-0.99,0,-1,GO:0007416,synapse assembly,M101,2,0
1,0,1,-0.68,0,-1.4,GO:0051495,positive regulation of cytoskeleton organization,M101,2,0
0,1,1,0,-1.5,-1.5,GO:0035265,organ growth,M011,2,0
1,0,1,-1.3,0,-1.8,GO:0043502,regulation of muscle adaptation,M101,2,0
1,1,0,-1.3,-0.95,0,GO:0050921,positive regulation of chemotaxis,M110,2,0
1,1,0,-1.2,-1.2,0,GO:0002250,adaptive immune response,M110,2,0
1,0,1,-0.94,0,-0.94,GO:0006664,glycolipid metabolic process,M101,2,0
1,0,1,-2.3,0,-0.86,WP5090,Complement system in neuronal development and plasticity,M101,2,0
0,1,1,0,-1.7,-3,GO:0051962,positive regulation of nervous system development,M011,2,0
1,1,0,-1,-1,0,M255,PID HIF1 TFPATHWAY,M110,2,0
1,0,1,-2.4,0,-1.4,hsa04151,PI3K-Akt signaling pathway,M101,2,0
1,0,1,-1.2,0,-1.7,GO:0030833,regulation of actin filament polymerization,M101,2,0
1,0,1,-1.7,0,-1.1,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",M101,2,0
1,1,0,-1.1,-2,0,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,M110,2,0
1,1,0,-1.3,-0.81,0,GO:0002040,sprouting angiogenesis,M110,2,0
1,0,1,-3.4,0,-3.4,GO:0045588,positive regulation of gamma-delta T cell differentiation,M101,2,0
1,1,0,-1.4,-0.84,0,GO:0043124,negative regulation of canonical NF-kappaB signal transduction,M110,2,0
1,0,1,-2,0,-2,GO:0048598,embryonic morphogenesis,M101,2,0
0,1,1,0,-1.2,-1.2,WP585,Interferon type I signaling pathways,M011,2,0
0,1,1,0,-1.1,-1.8,GO:0007632,visual behavior,M011,2,0
1,0,1,-1.6,0,-1.6,GO:0051966,"regulation of synaptic transmission, glutamatergic",M101,2,0
0,1,1,0,-0.75,-1.5,GO:0050953,sensory perception of light stimulus,M011,2,0
1,1,0,-5.2,-3.9,0,WP5434,Pathways in cancer,M110,2,0
1,0,1,-0.52,0,-0.52,GO:1903036,positive regulation of response to wounding,M101,2,0
1,1,0,-3.5,-1.6,0,hsa01522,Endocrine resistance,M110,2,0
0,1,1,0,-1,-1,GO:0071900,regulation of protein serine/threonine kinase activity,M011,2,0
0,1,1,0,-1.9,-1.9,GO:0120161,regulation of cold-induced thermogenesis,M011,2,0
1,0,1,-0.74,0,-0.74,GO:0001959,regulation of cytokine-mediated signaling pathway,M101,2,0
1,1,0,-0.89,-0.89,0,GO:0050918,positive chemotaxis,M110,2,0
0,1,1,0,-0.52,-1.4,GO:0097009,energy homeostasis,M011,2,0
0,1,1,0,-0.57,-0.92,GO:0046777,protein autophosphorylation,M011,2,0
0,1,1,0,-1,-2.9,R-HSA-9031628,NGF-stimulated transcription,M011,2,0
1,1,0,-1.5,-1.5,0,GO:0007219,Notch signaling pathway,M110,2,0
0,1,1,0,-1.4,-1.4,GO:0030032,lamellipodium assembly,M011,2,0
1,0,1,-1.3,0,-0.81,R-HSA-388841,Costimulation by the CD28 family,M101,2,0
1,1,0,-2,-2,0,GO:0072210,metanephric nephron development,M110,2,0
0,1,1,0,-0.94,-0.59,GO:0071805,potassium ion transmembrane transport,M011,2,0
0,1,1,0,-1.4,-0.55,WP4341,Non genomic actions of 1 25 dihydroxyvitamin D3,M011,2,0
0,1,1,0,-1.5,-0.89,GO:0002263,cell activation involved in immune response,M011,2,0
1,1,0,-2.2,-1.5,0,GO:0048645,animal organ formation,M110,2,0
1,1,0,-0.94,-0.94,0,GO:0030225,macrophage differentiation,M110,2,0
1,1,0,-3.4,-1.7,0,R-HSA-383280,Nuclear Receptor transcription pathway,M110,2,0
1,1,0,-1.4,-0.84,0,hsa04150,mTOR signaling pathway,M110,2,0
1,0,1,-1.1,0,-0.66,GO:0007265,Ras protein signal transduction,M101,2,0
0,1,1,0,-2.7,-1.1,GO:0001894,tissue homeostasis,M011,2,0
0,1,1,0,-1,-1.3,GO:0003018,vascular process in circulatory system,M011,2,0
1,0,1,-1.2,0,-1.2,GO:0043242,negative regulation of protein-containing complex disassembly,M101,2,0
0,1,1,0,-1,-1,hsa03320,PPAR signaling pathway,M011,2,0
1,0,1,-0.73,0,-0.73,hsa05230,Central carbon metabolism in cancer,M101,2,0
1,0,1,-1.3,0,-1.3,WP3640,Imatinib and chronic myeloid leukemia,M101,2,0
1,0,1,-0.85,0,-0.85,GO:0002701,negative regulation of production of molecular mediator of immune response,M101,2,0
1,0,1,-1.5,0,-1.5,GO:0045639,positive regulation of myeloid cell differentiation,M101,2,0
1,0,1,-3.7,0,-1.6,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M101,2,0
1,0,1,-1.8,0,-1.5,GO:0051054,positive regulation of DNA metabolic process,M101,2,0
1,1,0,-3,-2.9,0,GO:0032989,cellular anatomical entity morphogenesis,M110,2,0
1,1,0,-1.3,-1.3,0,GO:0048384,retinoic acid receptor signaling pathway,M110,2,0
0,1,1,0,-1.3,-0.96,GO:0031331,positive regulation of cellular catabolic process,M011,2,0
1,0,1,-2.8,0,-0.87,GO:0002819,regulation of adaptive immune response,M101,2,0
0,1,1,0,-1.6,-0.94,GO:0071559,response to transforming growth factor beta,M011,2,0
0,1,1,0,-0.94,-0.94,GO:1902930,regulation of alcohol biosynthetic process,M011,2,0
0,1,1,0,-0.7,-0.7,GO:0048771,tissue remodeling,M011,2,0
1,1,0,-2.5,-0.61,0,GO:0030168,platelet activation,M110,2,0
1,1,0,-3.1,-4.1,0,GO:0045766,positive regulation of angiogenesis,M110,2,0
1,0,1,-3,0,-1.9,GO:0051251,positive regulation of lymphocyte activation,M101,2,0
1,0,1,-0.59,0,-0.95,GO:0051494,negative regulation of cytoskeleton organization,M101,2,0
1,0,1,-1.2,0,-1.9,GO:0050808,synapse organization,M101,2,0
1,1,0,-0.78,-2,0,WP2431,Spinal cord injury,M110,2,0
1,1,0,-0.6,-2.2,0,GO:0051149,positive regulation of muscle cell differentiation,M110,2,0
1,0,1,-1.6,0,-0.63,GO:0010660,regulation of muscle cell apoptotic process,M101,2,0
1,1,0,-1.3,-1.9,0,WP1544,MicroRNAs in cardiomyocyte hypertrophy,M110,2,0
1,1,0,-0.95,-0.54,0,GO:1902692,regulation of neuroblast proliferation,M110,2,0
1,0,1,-3.9,0,-2.5,GO:0022407,regulation of cell-cell adhesion,M101,2,0
1,0,1,-0.66,0,-1.1,WP5055,Burn wound healing,M101,2,0
1,1,0,-0.64,-2.6,0,GO:0016049,cell growth,M110,2,0
0,1,1,0,-0.6,-1,R-HSA-3906995,Diseases associated with O-glycosylation of proteins,M011,2,0
1,1,0,-4.8,-1.1,0,hsa05214,Glioma,M110,2,0
0,1,1,0,-0.59,-1.4,GO:0007612,learning,M011,2,0
1,0,1,-1.6,0,-1.6,GO:0007259,receptor signaling pathway via JAK-STAT,M101,2,0
1,0,1,-2.2,0,-2.2,GO:0046629,gamma-delta T cell activation,M101,2,0
0,1,1,0,-1.3,-1.3,GO:0032940,secretion by cell,M011,2,0
0,1,1,0,-2.7,-0.81,GO:0002444,myeloid leukocyte mediated immunity,M011,2,0
1,0,1,-1.6,0,-1.6,WP4842,Mammalian disorder of sexual development,M101,2,0
0,1,1,0,-2.6,-2.3,GO:0001568,blood vessel development,M011,2,0
1,1,0,-1.5,-0.74,0,R-HSA-114608,Platelet degranulation,M110,2,0
1,1,0,-3.7,-1.2,0,GO:0031342,negative regulation of cell killing,M110,2,0
0,1,1,0,-1.2,-0.83,GO:0043632,modification-dependent macromolecule catabolic process,M011,2,0
1,0,1,-2,0,-2,GO:0045471,response to ethanol,M101,2,0
1,0,1,-1.1,0,-2.5,GO:0050864,regulation of B cell activation,M101,2,0
0,1,1,0,-0.77,-2.3,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),M011,2,0
1,0,1,-2.2,0,-1.4,GO:0010921,regulation of phosphatase activity,M101,2,0
1,1,0,-2.4,-0.99,0,WP314,Fas ligand pathway and stress induction of heat shock proteins,M110,2,0
1,0,1,-1.5,0,-0.73,GO:0002705,positive regulation of leukocyte mediated immunity,M101,2,0
1,1,0,-1.2,-0.74,0,WP4746,Thyroid hormones production and peripheral downstream signaling effects,M110,2,0
1,1,0,-1.3,-1.3,0,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,M110,2,0
1,1,0,-1,-0.67,0,GO:0010811,positive regulation of cell-substrate adhesion,M110,2,0
0,1,1,0,-1.8,-1.5,GO:0030856,regulation of epithelial cell differentiation,M011,2,0
1,1,0,-3,-1.3,0,WP127,IL 5 signaling pathway,M110,2,0
1,0,1,-1.2,0,-0.7,hsa04927,Cortisol synthesis and secretion,M101,2,0
1,1,0,-2,-0.98,0,GO:0061138,morphogenesis of a branching epithelium,M110,2,0
0,1,1,0,-1.2,-0.83,GO:0019941,modification-dependent protein catabolic process,M011,2,0
1,1,0,-2.3,-0.84,0,hsa05169,Epstein-Barr virus infection,M110,2,0
1,1,0,-0.77,-2.6,0,WP4313,Ferroptosis,M110,2,0
1,0,1,-4.4,0,-3.1,GO:0046645,positive regulation of gamma-delta T cell activation,M101,2,0
1,1,0,-1.9,-1.9,0,R-HSA-199992,trans-Golgi Network Vesicle Budding,M110,2,0
0,1,1,0,-1.8,-1.1,GO:1990849,vacuolar localization,M011,2,0
1,1,0,-2.2,-0.85,0,GO:0001763,morphogenesis of a branching structure,M110,2,0
1,0,1,-0.52,0,-3.4,GO:0060191,regulation of lipase activity,M101,2,0
1,0,1,-1.5,0,-1.1,hsa05160,Hepatitis C,M101,2,0
0,1,1,0,-0.8,-1.2,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,M011,2,0
0,1,1,0,-1.5,-2,GO:0048469,cell maturation,M011,2,0
1,0,1,-1.2,0,-1.2,R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,M101,2,0
0,1,1,0,-1.8,-1.1,GO:0032418,lysosome localization,M011,2,0
1,0,1,-0.8,0,-1.6,GO:0007623,circadian rhythm,M101,2,0
1,0,1,-0.95,0,-0.55,WP4657,22q11 2 copy number variation syndrome,M101,2,0
1,1,0,-4.5,-1.7,0,GO:0042327,positive regulation of phosphorylation,M110,2,0
1,0,1,-1,0,-1.1,GO:0002719,negative regulation of cytokine production involved in immune response,M101,2,0
1,1,0,-0.55,-0.54,0,GO:0009566,fertilization,M110,2,0
1,0,1,-0.63,0,-0.63,GO:0060760,positive regulation of response to cytokine stimulus,M101,2,0
0,1,1,0,-1.7,-1.1,M272,PID CD8 TCR DOWNSTREAM PATHWAY,M011,2,0
1,0,1,-2.9,0,-1.1,GO:0042060,wound healing,M101,2,0
1,1,0,-0.59,-0.59,0,GO:0033157,regulation of intracellular protein transport,M110,2,0
0,1,1,0,-0.6,-1,GO:0042093,T-helper cell differentiation,M011,2,0
0,1,1,0,-1.5,-2.4,WP3971,OSX and miRNAs in tooth development,M011,2,0
1,1,0,-2.3,-0.77,0,hsa04722,Neurotrophin signaling pathway,M110,2,0
1,1,0,-1.1,-1.1,0,GO:0021587,cerebellum morphogenesis,M110,2,0
1,1,0,-1,-1,0,R-HSA-76002,"Platelet activation, signaling and aggregation",M110,2,0
1,1,0,-1.6,-0.99,0,GO:0009593,detection of chemical stimulus,M110,2,0
1,1,0,-0.99,-0.99,0,GO:0001945,lymph vessel development,M110,2,0
1,0,1,-1.5,0,-1,GO:0006836,neurotransmitter transport,M101,2,0
1,1,0,-2.2,-0.89,0,GO:0002715,regulation of natural killer cell mediated immunity,M110,2,0
0,1,1,0,-4.3,-1.9,GO:1902894,negative regulation of miRNA transcription,M011,2,0
1,1,0,-2.2,-0.71,0,hsa04066,HIF-1 signaling pathway,M110,2,0
1,1,0,-5.8,-1.6,0,GO:0010595,positive regulation of endothelial cell migration,M110,2,0
1,0,1,-1.8,0,-0.7,GO:0048146,positive regulation of fibroblast proliferation,M101,2,0
1,1,0,-0.59,-0.94,0,GO:0050806,positive regulation of synaptic transmission,M110,2,0
1,1,0,-2.4,-2.4,0,GO:0072239,metanephric glomerulus vasculature development,M110,2,0
1,0,1,-0.72,0,-0.72,GO:0006986,response to unfolded protein,M101,2,0
0,1,1,0,-0.57,-2.1,hsa04666,Fc gamma R-mediated phagocytosis,M011,2,0
1,1,0,-5.1,-1.8,0,GO:0010634,positive regulation of epithelial cell migration,M110,2,0
0,1,1,0,-1,-2.4,GO:0048706,embryonic skeletal system development,M011,2,0
0,1,1,0,-0.84,-0.85,M183,PID IL6 7 PATHWAY,M011,2,0
1,1,0,-2.4,-1.5,0,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,M110,2,0
1,0,1,-1.4,0,-0.99,GO:0006937,regulation of muscle contraction,M101,2,0
1,1,0,-2.1,-1,0,GO:0003281,ventricular septum development,M110,2,0
1,1,0,-1.3,-0.93,0,GO:2000177,regulation of neural precursor cell proliferation,M110,2,0
1,1,0,-1.5,-0.94,0,M48,PID MET PATHWAY,M110,2,0
1,1,0,-3.2,-1.2,0,WP4262,Breast cancer pathway,M110,2,0
1,1,0,-1.9,-1,0,GO:0009267,cellular response to starvation,M110,2,0
1,1,0,-1.2,-1.2,0,WP2526,PDGF pathway,M110,2,0
1,0,1,-1.7,0,-1.7,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,M101,2,0
1,1,0,-0.89,-0.89,0,GO:0006024,glycosaminoglycan biosynthetic process,M110,2,0
1,1,0,-1.2,-1.2,0,WP4538,Regulatory circuits of the STAT3 signaling pathway,M110,2,0
0,1,1,0,-1.3,-0.97,GO:0006511,ubiquitin-dependent protein catabolic process,M011,2,0
1,1,0,-0.77,-0.76,0,M236,PID DELTA NP63 PATHWAY,M110,2,0
1,0,1,-3.2,0,-2,GO:0002694,regulation of leukocyte activation,M101,2,0
1,0,1,-2.7,0,-3.7,GO:0001775,cell activation,M101,2,0
1,0,1,-1.6,0,-0.81,hsa04514,Cell adhesion molecules,M101,2,0
1,0,1,-1.3,0,-1.3,GO:0030010,establishment of cell polarity,M101,2,0
1,0,1,-1.8,0,-1.2,GO:0002757,immune response-activating signaling pathway,M101,2,0
1,1,0,-2,-0.95,0,GO:0003073,regulation of systemic arterial blood pressure,M110,2,0
1,0,1,-1.7,0,-3,hsa04724,Glutamatergic synapse,M101,2,0
1,1,0,-1.7,-3.4,0,GO:0048812,neuron projection morphogenesis,M110,2,0
0,1,1,0,-1.2,-1.2,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,M011,2,0
1,1,0,-2.5,-1.2,0,GO:0050878,regulation of body fluid levels,M110,2,0
0,1,1,0,-1.5,-1.5,GO:0030513,positive regulation of BMP signaling pathway,M011,2,0
1,0,1,-0.84,0,-3.2,GO:0045931,positive regulation of mitotic cell cycle,M101,2,0
1,1,0,-0.66,-1.5,0,GO:0097529,myeloid leukocyte migration,M110,2,0
0,1,1,0,-1,-1.1,GO:0042551,neuron maturation,M011,2,0
1,0,1,-1.2,0,-1.8,GO:0010389,regulation of G2/M transition of mitotic cell cycle,M101,2,0
1,0,1,-0.89,0,-2.2,GO:1900274,regulation of phospholipase C activity,M101,2,0
1,1,0,-0.64,-0.64,0,GO:0045833,negative regulation of lipid metabolic process,M110,2,0
0,1,1,0,-0.89,-1.9,GO:0031346,positive regulation of cell projection organization,M011,2,0
1,1,0,-1.2,-1.7,0,WP2355,Corticotropin releasing hormone signaling pathway,M110,2,0
0,1,1,0,-0.64,-1,GO:0003015,heart process,M011,2,0
0,1,1,0,-1.4,-2.3,GO:0032868,response to insulin,M011,2,0
1,1,0,-2.8,-0.71,0,hsa05220,Chronic myeloid leukemia,M110,2,0
0,1,1,0,-0.5,-0.5,GO:1900182,positive regulation of protein localization to nucleus,M011,2,0
0,1,1,0,-0.61,-0.62,GO:0007492,endoderm development,M011,2,0
1,1,0,-1.2,-1.2,0,WP2374,Oncostatin M signaling pathway,M110,2,0
1,1,0,-2.4,-1,0,hsa05226,Gastric cancer,M110,2,0
0,1,1,0,-1.3,-1.3,hsa05032,Morphine addiction,M011,2,0
1,0,1,-1.2,0,-0.89,GO:0071356,cellular response to tumor necrosis factor,M101,2,0
1,0,1,-0.65,0,-1.4,GO:0030183,B cell differentiation,M101,2,0
1,0,1,-2.8,0,-3.2,GO:0030097,hemopoiesis,M101,2,0
1,1,0,-2.4,-0.99,0,GO:0042269,regulation of natural killer cell mediated cytotoxicity,M110,2,0
0,1,1,0,-0.93,-0.95,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M011,2,0
0,1,1,0,-0.74,-1.7,GO:0030509,BMP signaling pathway,M011,2,0
0,1,1,0,-1.2,-1.2,GO:0035162,embryonic hemopoiesis,M011,2,0
1,1,0,-1.1,-0.66,0,GO:0035924,cellular response to vascular endothelial growth factor stimulus,M110,2,0
1,0,1,-5.3,0,-0.75,hsa05215,Prostate cancer,M101,2,0
0,1,1,0,-0.76,-1.3,GO:0032890,regulation of organic acid transport,M011,2,0
1,1,0,-0.88,-0.5,0,GO:0060688,regulation of morphogenesis of a branching structure,M110,2,0
0,1,1,0,-1.9,-0.84,GO:0048593,camera-type eye morphogenesis,M011,2,0
1,1,0,-2,-0.8,0,R-HSA-1912422,Pre-NOTCH Expression and Processing,M110,2,0
1,0,1,-1.8,0,-1.8,GO:0044706,multi-multicellular organism process,M101,2,0
1,1,0,-1.2,-1.2,0,WP4205,MET in type 1 papillary renal cell carcinoma,M110,2,0
1,1,0,-0.92,-0.57,0,GO:0032651,regulation of interleukin-1 beta production,M110,2,0
1,0,1,-1.3,0,-2.1,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",M101,2,0
1,1,0,-0.69,-0.69,0,M151,PID AR TF PATHWAY,M110,2,0
1,0,1,-1.3,0,-1.3,GO:1901880,negative regulation of protein depolymerization,M101,2,0
1,1,0,-1.3,-1.3,0,GO:0002573,myeloid leukocyte differentiation,M110,2,0
1,0,1,-3.1,0,-1.5,GO:0051249,regulation of lymphocyte activation,M101,2,0
1,1,0,-0.85,-2.8,0,M285,PID HNF3A PATHWAY,M110,2,0
1,1,0,-1.4,-1.4,0,R-HSA-2980736,Peptide hormone metabolism,M110,2,0
1,1,0,-1.5,-1.5,0,GO:0051402,neuron apoptotic process,M110,2,0
1,0,1,-0.94,0,-0.94,GO:0003171,atrioventricular valve development,M101,2,0
1,1,0,-0.57,-0.91,0,GO:0009799,specification of symmetry,M110,2,0
1,1,0,-1.3,-1.9,0,GO:0030518,intracellular steroid hormone receptor signaling pathway,M110,2,0
1,1,0,-3.4,-1.7,0,M91,PID TCPTP PATHWAY,M110,2,0
1,0,1,-1,0,-1.1,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,M101,2,0
1,0,1,-0.77,0,-0.77,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,M101,2,0
0,1,1,0,-0.84,-0.85,GO:0071326,cellular response to monosaccharide stimulus,M011,2,0
1,0,1,-3.2,0,-3.2,GO:0045621,positive regulation of lymphocyte differentiation,M101,2,0
1,0,1,-2.9,0,-2.5,GO:0045619,regulation of lymphocyte differentiation,M101,2,0
1,1,0,-0.59,-0.94,0,GO:0008037,cell recognition,M110,2,0
1,1,0,-1.3,-1.2,0,WP4263,Pancreatic adenocarcinoma pathway,M110,2,0
1,1,0,-2.2,-1.4,0,GO:0002716,negative regulation of natural killer cell mediated immunity,M110,2,0
1,0,1,-1.7,0,-1.3,hsa05162,Measles,M101,2,0
1,1,0,-3.4,-1.7,0,R-HSA-1280215,Cytokine Signaling in Immune system,M110,2,0
0,1,1,0,-0.71,-0.72,hsa04670,Leukocyte transendothelial migration,M011,2,0
1,1,0,-0.85,-0.84,0,WP3286,Copper homeostasis,M110,2,0
1,0,1,-1.4,0,-0.62,GO:0048145,regulation of fibroblast proliferation,M101,2,0
1,1,0,-0.5,-0.5,0,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,M110,2,0
1,0,1,-2,0,-1.2,GO:0051785,positive regulation of nuclear division,M101,2,0
1,1,0,-0.88,-0.87,0,GO:0001889,liver development,M110,2,0
1,0,1,-1.7,0,-1.1,R-HSA-2559585,Oncogene Induced Senescence,M101,2,0
1,0,1,-0.81,0,-1.3,GO:0007266,Rho protein signal transduction,M101,2,0
1,1,0,-2.4,-1.6,0,GO:0072012,glomerulus vasculature development,M110,2,0
0,1,1,0,-1.1,-2.5,GO:0042476,odontogenesis,M011,2,0
1,1,0,-1.2,-0.88,0,WP289,Myometrial relaxation and contraction pathways,M110,2,0
1,1,0,-3.4,-1,0,M100,PID SHP2 PATHWAY,M110,2,0
1,0,1,-2.3,0,-1.1,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M101,2,0
0,1,1,0,-0.73,-0.73,GO:0030282,bone mineralization,M011,2,0
1,1,0,-1.5,-1.1,0,GO:0042594,response to starvation,M110,2,0
0,1,1,0,-0.54,-0.96,GO:0050773,regulation of dendrite development,M011,2,0
1,1,0,-0.84,-1.3,0,WP428,Wnt signaling,M110,2,0
1,0,1,-0.63,0,-0.63,GO:0090303,positive regulation of wound healing,M101,2,0
1,0,1,-0.66,0,-0.66,R-HSA-9012852,Signaling by NOTCH3,M101,2,0
0,1,1,0,-0.89,-0.9,GO:0045445,myoblast differentiation,M011,2,0
1,1,0,-2.4,-1,0,WP4658,Small cell lung cancer,M110,2,0
1,0,1,-1.3,0,-0.81,GO:0035303,regulation of dephosphorylation,M101,2,0
1,0,1,-1.1,0,-3.5,GO:0050954,sensory perception of mechanical stimulus,M101,2,0
1,1,0,-2.8,-0.57,0,GO:0061045,negative regulation of wound healing,M110,2,0
1,0,1,-0.85,0,-2.8,GO:0045577,regulation of B cell differentiation,M101,2,0
0,1,1,0,-1.5,-1.2,GO:0002252,immune effector process,M011,2,0
0,1,1,0,-0.54,-0.96,GO:0002292,T cell differentiation involved in immune response,M011,2,0
1,0,1,-4.2,0,-1.7,GO:0045785,positive regulation of cell adhesion,M101,2,0
1,0,1,-0.81,0,-1.3,hsa04610,Complement and coagulation cascades,M101,2,0
1,0,1,-1,0,-1.4,GO:0007369,gastrulation,M101,2,0
0,1,1,0,-0.99,-2.4,M44,PID HIF2PATHWAY,M011,2,0
1,0,1,-2.3,0,-3,GO:0048568,embryonic organ development,M101,2,0
1,0,1,-1.9,0,-1.3,GO:0045622,regulation of T-helper cell differentiation,M101,2,0
1,1,0,-1.2,-1.2,0,GO:0007044,cell-substrate junction assembly,M110,2,0
0,1,1,0,-1.8,-1.1,GO:0050769,positive regulation of neurogenesis,M011,2,0
1,1,0,-0.89,-0.89,0,WP3680,Physico chemical features and toxicity associated pathways,M110,2,0
1,0,1,-1.6,0,-1.2,GO:0062013,positive regulation of small molecule metabolic process,M101,2,0
0,1,1,0,-0.76,-1.3,GO:0090398,cellular senescence,M011,2,0
1,1,0,-3.9,-2.6,0,hsa04630,JAK-STAT signaling pathway,M110,2,0
1,1,0,-1.3,-0.81,0,GO:0021549,cerebellum development,M110,2,0
1,1,0,-2.8,-1.6,0,WP170,Nuclear receptors,M110,2,0
1,0,1,-3,0,-2.3,GO:1903706,regulation of hemopoiesis,M101,2,0
1,1,0,-0.88,-1.3,0,GO:0031333,negative regulation of protein-containing complex assembly,M110,2,0
0,1,1,0,-1.2,-0.78,GO:0006486,protein glycosylation,M011,2,0
1,0,1,-0.98,0,-1.3,hsa04014,Ras signaling pathway,M101,2,0
1,0,1,-2,0,-1.2,GO:0030866,cortical actin cytoskeleton organization,M101,2,0
1,0,1,-2.3,0,-2.7,GO:1903708,positive regulation of hemopoiesis,M101,2,0
1,1,0,-1.8,-1.8,0,WP3915,Angiopoietin like protein 8 regulatory pathway,M110,2,0
1,0,1,-1.9,0,-1.9,GO:0046633,alpha-beta T cell proliferation,M101,2,0
0,1,1,0,-0.54,-0.96,WP75,Toll like receptor signaling pathway,M011,2,0
1,0,1,-0.69,0,-1.2,R-HSA-9013106,RHOC GTPase cycle,M101,2,0
1,1,0,-1.7,-1.2,0,GO:0046660,female sex differentiation,M110,2,0
1,0,1,-0.99,0,-1,R-HSA-1226099,Signaling by FGFR in disease,M101,2,0
1,0,1,-1.4,0,-1.9,WP3945,TYROBP causal network in microglia,M101,2,0
1,1,0,-1.7,-1,0,M141,PID PI3KCI PATHWAY,M110,2,0
1,1,0,-1.1,-0.71,0,R-HSA-2559583,Cellular Senescence,M110,2,0
1,0,1,-1.6,0,-0.6,GO:2000107,negative regulation of leukocyte apoptotic process,M101,2,0
0,1,1,0,-1.6,-1.6,GO:0003206,cardiac chamber morphogenesis,M011,2,0
0,1,1,0,-1.1,-1.1,GO:0010837,regulation of keratinocyte proliferation,M011,2,0
1,1,0,-1.2,-0.85,0,GO:0051250,negative regulation of lymphocyte activation,M110,2,0
0,1,1,0,-0.84,-0.85,GO:0009880,embryonic pattern specification,M011,2,0
1,1,0,-2.1,-2.1,0,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,M110,2,0
1,0,1,-1.3,0,-2.5,GO:0003197,endocardial cushion development,M101,2,0
0,1,1,0,-1.8,-1.2,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M011,2,0
1,1,0,-5.5,-1.9,0,GO:0045937,positive regulation of phosphate metabolic process,M110,2,0
1,1,0,-1.2,-1.2,0,GO:0051155,positive regulation of striated muscle cell differentiation,M110,2,0
0,1,1,0,-0.73,-1.2,GO:0031641,regulation of myelination,M011,2,0
1,0,1,-1.8,0,-2.2,hsa04020,Calcium signaling pathway,M101,2,0
1,1,0,-1.2,-1.2,0,WP524,G13 signaling pathway,M110,2,0
1,0,1,-1.1,0,-1.6,GO:0002520,immune system development,M101,2,0
1,0,1,-0.98,0,-2.2,GO:0035108,limb morphogenesis,M101,2,0
1,1,0,-0.95,-0.59,0,GO:0034767,positive regulation of monoatomic ion transmembrane transport,M110,2,0
1,0,1,-2.2,0,-3.5,GO:0043009,chordate embryonic development,M101,2,0
0,1,1,0,-1.7,-1.1,GO:0099175,regulation of postsynapse organization,M011,2,0
1,0,1,-0.66,0,-1.1,GO:0032330,regulation of chondrocyte differentiation,M101,2,0
1,0,1,-2.9,0,-0.82,GO:0070665,positive regulation of leukocyte proliferation,M101,2,0
1,1,0,-0.86,-2.9,0,WP481,Insulin signaling,M110,2,0
1,0,1,-0.89,0,-0.9,GO:0051588,regulation of neurotransmitter transport,M101,2,0
0,1,1,0,-0.77,-3,GO:1901890,positive regulation of cell junction assembly,M011,2,0
1,0,1,-0.86,0,-0.86,GO:0060993,kidney morphogenesis,M101,2,0
0,1,1,0,-2.5,-0.5,GO:0009165,nucleotide biosynthetic process,M011,2,0
0,1,1,0,-0.99,-1.5,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,M011,2,0
0,1,1,0,-0.5,-0.5,R-HSA-9614085,FOXO-mediated transcription,M011,2,0
0,1,1,0,-2.2,-1.8,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,M011,2,0
1,0,1,-0.63,0,-0.64,R-HSA-9709957,Sensory Perception,M101,2,0
1,0,1,-1.1,0,-1.1,hsa05165,Human papillomavirus infection,M101,2,0
0,1,1,0,-1.8,-1.2,GO:0090287,regulation of cellular response to growth factor stimulus,M011,2,0
1,1,0,-0.89,-0.89,0,GO:0006023,aminoglycan biosynthetic process,M110,2,0
1,1,0,-0.63,-0.96,0,GO:0051592,response to calcium ion,M110,2,0
0,1,1,0,-0.96,-0.98,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M011,2,0
1,1,0,-0.94,-0.94,0,GO:0099173,postsynapse organization,M110,2,0
1,0,1,-0.73,0,-0.73,GO:0060135,maternal process involved in female pregnancy,M101,2,0
1,1,0,-0.69,-0.69,0,GO:0043627,response to estrogen,M110,2,0
1,1,0,-1,-2.5,0,GO:0014896,muscle hypertrophy,M110,2,0
0,1,1,0,-0.87,-0.5,GO:0030901,midbrain development,M011,2,0
1,1,0,-0.9,-1.5,0,GO:0051047,positive regulation of secretion,M110,2,0
0,1,1,0,-3.4,-1.4,GO:0030900,forebrain development,M011,2,0
1,1,0,-2.1,-1.5,0,GO:0055006,cardiac cell development,M110,2,0
1,1,0,-2,-2.7,0,hsa05231,Choline metabolism in cancer,M110,2,0
1,0,1,-1.1,0,-1.4,GO:0034329,cell junction assembly,M101,2,0
1,1,0,-0.75,-1.7,0,GO:0060070,canonical Wnt signaling pathway,M110,2,0
0,1,1,0,-2.1,-5.2,WP2064,Neural crest differentiation,M011,2,0
1,0,1,-1,0,-1,GO:0010639,negative regulation of organelle organization,M101,2,0
1,0,1,-0.84,0,-0.85,GO:0015748,organophosphate ester transport,M101,2,0
1,1,0,-1.2,-0.69,0,GO:0048546,digestive tract morphogenesis,M110,2,0
1,0,1,-1.4,0,-1.8,GO:0010638,positive regulation of organelle organization,M101,2,0
1,0,1,-0.92,0,-1.2,WP5420,ADHD and autism ASD linked metabolic pathways and SNP,M101,2,0
1,1,0,-0.55,-0.54,0,WP2572,Primary focal segmental glomerulosclerosis FSGS,M110,2,0
0,1,1,0,-0.84,-0.85,GO:0035272,exocrine system development,M011,2,0
1,1,0,-1.3,-0.76,0,GO:0050850,positive regulation of calcium-mediated signaling,M110,2,0
0,1,1,0,-0.95,-0.55,R-HSA-9664433,Leishmania parasite growth and survival,M011,2,0
1,1,0,-0.99,-0.99,0,WP3614,Photodynamic therapy induced HIF 1 survival signaling,M110,2,0
1,0,1,-0.71,0,-1,GO:0001704,formation of primary germ layer,M101,2,0
1,1,0,-2.7,-1.4,0,GO:2000379,positive regulation of reactive oxygen species metabolic process,M110,2,0
1,1,0,-1.2,-1.5,0,GO:0198738,cell-cell signaling by wnt,M110,2,0
1,1,0,-0.81,-1.8,0,GO:0048592,eye morphogenesis,M110,2,0
1,1,0,-0.98,-2.6,0,WP706,Sudden infant death syndrome SIDS susceptibility pathways,M110,2,0
1,0,1,-2.2,0,-0.75,GO:0002709,regulation of T cell mediated immunity,M101,2,0
0,1,1,0,-0.73,-1.4,R-HSA-9758941,Gastrulation,M011,2,0
1,1,0,-0.64,-2.6,0,GO:0048588,developmental cell growth,M110,2,0
1,1,0,-0.77,-1.6,0,GO:0001938,positive regulation of endothelial cell proliferation,M110,2,0
1,1,0,-1.7,-0.82,0,hsa05418,Fluid shear stress and atherosclerosis,M110,2,0
1,0,1,-1.3,0,-1.3,GO:0002710,negative regulation of T cell mediated immunity,M101,2,0
1,0,1,-0.91,0,-0.92,GO:0043200,response to amino acid,M101,2,0
0,1,1,0,-1.2,-1.3,GO:0003205,cardiac chamber development,M011,2,0
1,1,0,-1.5,-0.57,0,GO:0035914,skeletal muscle cell differentiation,M110,2,0
1,0,1,-1.5,0,-1.5,WP4539,Synaptic signaling pathways associated with autism spectrum disorder,M101,2,0
1,1,0,-1.3,-0.76,0,WP2037,Prolactin signaling pathway,M110,2,0
1,0,1,-0.69,0,-0.7,GO:2001236,regulation of extrinsic apoptotic signaling pathway,M101,2,0
1,1,0,-1.6,-1.3,0,GO:0048732,gland development,M110,2,0
1,0,1,-0.98,0,-1.3,GO:0001890,placenta development,M101,2,0
1,0,1,-1.6,0,-0.69,GO:0048534,hematopoietic or lymphoid organ development,M101,2,0
1,1,0,-0.73,-0.73,0,R-HSA-9824439,Bacterial Infection Pathways,M110,2,0
0,1,1,0,-1.2,-3.3,GO:0044089,positive regulation of cellular component biogenesis,M011,2,0
1,1,0,-2.8,-0.84,0,M162,PID RXR VDR PATHWAY,M110,2,0
1,1,0,-0.91,-0.52,0,GO:0072171,mesonephric tubule morphogenesis,M110,2,0
0,1,1,0,-1.2,-0.78,GO:0043413,macromolecule glycosylation,M011,2,0
1,1,0,-1.2,-1.6,0,GO:0034764,positive regulation of transmembrane transport,M110,2,0
1,0,1,-3,0,-3,GO:0050867,positive regulation of cell activation,M101,2,0
0,1,1,0,-0.52,-0.92,GO:0051101,regulation of DNA binding,M011,2,0
1,0,1,-2.4,0,-0.74,GO:0002706,regulation of lymphocyte mediated immunity,M101,2,0
1,0,1,-1.7,0,-1.2,WP4630,Measles virus infection,M101,2,0
1,0,1,-2.9,0,-2.2,GO:0002696,positive regulation of leukocyte activation,M101,2,0
1,1,0,-0.95,-0.95,0,WP4018,Clear cell renal cell carcinoma pathways,M110,2,0
1,1,0,-1.5,-0.72,0,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,M110,2,0
1,1,0,-1.5,-0.89,0,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M110,2,0
1,0,1,-0.98,0,-1.7,GO:0030217,T cell differentiation,M101,2,0
0,1,1,0,-1.3,-1.7,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M011,2,0
1,1,0,-0.6,-1,0,GO:0007589,body fluid secretion,M110,2,0
1,1,0,-3,-0.89,0,GO:0070527,platelet aggregation,M110,2,0
1,1,0,-0.52,-0.91,0,GO:0030203,glycosaminoglycan metabolic process,M110,2,0
1,1,0,-2.4,-1.8,0,hsa04921,Oxytocin signaling pathway,M110,2,0
1,0,1,-0.63,0,-0.63,GO:1900024,regulation of substrate adhesion-dependent cell spreading,M101,2,0
1,1,0,-3.1,-1.2,0,GO:0055001,muscle cell development,M110,2,0
1,1,0,-1.5,-1.5,0,M7955,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,M110,2,0
0,1,1,0,-1.6,-4.5,WP5417,Cell lineage map for neuronal differentiation,M011,2,0
0,1,1,0,-1.5,-0.89,GO:0002366,leukocyte activation involved in immune response,M011,2,0
1,1,0,-1.8,-1.1,0,GO:0031669,cellular response to nutrient levels,M110,2,0
1,1,0,-0.72,-0.71,0,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,M110,2,0
1,1,0,-2.3,-0.88,0,hsa04068,FoxO signaling pathway,M110,2,0
0,1,1,0,-2.6,-2,GO:0044092,negative regulation of molecular function,M011,2,0
1,1,0,-1.3,-2.3,0,hsa04919,Thyroid hormone signaling pathway,M110,2,0
0,1,1,0,-1.2,-0.78,hsa04725,Cholinergic synapse,M011,2,0
0,1,1,0,-1.2,-1.9,R-HSA-9843743,Transcriptional regulation of brown and beige adipocyte differentiation,M011,2,0
1,0,1,-0.94,0,-1.5,GO:1901879,regulation of protein depolymerization,M101,2,0
0,1,1,0,-0.57,-0.58,GO:0060350,endochondral bone morphogenesis,M011,2,0
1,0,1,-3.8,0,-3.8,GO:0046643,regulation of gamma-delta T cell activation,M101,2,0
0,1,1,0,-0.87,-0.88,GO:0002285,lymphocyte activation involved in immune response,M011,2,0
1,1,0,-0.83,-1.6,0,R-HSA-9824443,Parasitic Infection Pathways,M110,2,0
0,1,1,0,-1.2,-1.2,GO:0060795,cell fate commitment involved in formation of primary germ layer,M011,2,0
1,1,0,-1.2,-1.2,0,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,M110,2,0
0,1,1,0,-1.3,-1.3,M290,PID IL12 STAT4 PATHWAY,M011,2,0
1,0,1,-1,0,-1.6,GO:0051493,regulation of cytoskeleton organization,M101,2,0
1,1,0,-1.2,-1.7,0,GO:0009755,hormone-mediated signaling pathway,M110,2,0
1,0,1,-2.5,0,-1.4,GO:0002244,hematopoietic progenitor cell differentiation,M101,2,0
1,0,1,-2.8,0,-1.5,GO:0010564,regulation of cell cycle process,M101,2,0
0,1,1,0,-1.2,-0.8,GO:0070167,regulation of biomineral tissue development,M011,2,0
1,0,1,-0.75,0,-2.6,WP4540,Hippo signaling regulation pathways,M101,2,0
1,0,1,-1.4,0,-1.4,GO:0050728,negative regulation of inflammatory response,M101,2,0
1,0,1,-2.5,0,-1.2,GO:0046634,regulation of alpha-beta T cell activation,M101,2,0
1,0,1,-0.77,0,-0.77,GO:0071230,cellular response to amino acid stimulus,M101,2,0
1,1,0,-4.5,-2.5,0,GO:0010594,regulation of endothelial cell migration,M110,2,0
1,1,0,-1.6,-1.6,0,WP5353,Macrophage stimulating protein MSP signaling network map,M110,2,0
1,0,1,-0.93,0,-0.94,GO:0014074,response to purine-containing compound,M101,2,0
0,1,1,0,-1.5,-1.5,GO:0019080,viral gene expression,M011,2,0
0,1,1,0,-3.5,-2.9,GO:0002062,chondrocyte differentiation,M011,2,0
1,0,1,-3.5,0,-3.5,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M101,2,0
1,0,1,-2.9,0,-4.1,GO:0045586,regulation of gamma-delta T cell differentiation,M101,2,0
1,1,0,-0.98,-1.9,0,GO:0032526,response to retinoic acid,M110,2,0
0,1,1,0,-4.2,-1.3,R-HSA-9843745,Adipogenesis,M011,2,0
1,1,0,-0.96,-0.63,0,GO:0034976,response to endoplasmic reticulum stress,M110,2,0
0,1,1,0,-1.1,-0.63,hsa04920,Adipocytokine signaling pathway,M011,2,0
0,1,1,0,-1.9,-7.5,GO:0001501,skeletal system development,M011,2,0
0,1,1,0,-0.74,-1.1,GO:0030510,regulation of BMP signaling pathway,M011,2,0
1,0,1,-1.1,0,-1.5,R-HSA-8980692,RHOA GTPase cycle,M101,2,0
0,1,1,0,-2.7,-1.1,GO:0060249,anatomical structure homeostasis,M011,2,0
1,0,1,-2.7,0,-0.81,M92,PID ANGIOPOIETIN RECEPTOR PATHWAY,M101,2,0
0,1,1,0,-1.7,-1.2,GO:1904888,cranial skeletal system development,M011,2,0
0,1,1,0,-0.69,-1.8,GO:0045598,regulation of fat cell differentiation,M011,2,0
0,1,1,0,-2.4,-1.2,GO:0030857,negative regulation of epithelial cell differentiation,M011,2,0
1,1,0,-2.1,-2.1,0,WP1539,Angiogenesis,M110,2,0
1,1,0,-3.2,-1.6,0,GO:0031401,positive regulation of protein modification process,M110,2,0
0,1,1,0,-2,-2,GO:0060537,muscle tissue development,M011,2,0
1,1,0,-2,-1.2,0,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,M110,2,0
1,1,0,-1.4,-5,0,GO:1901342,regulation of vasculature development,M110,2,0
1,1,0,-1.2,-1.4,0,GO:0060627,regulation of vesicle-mediated transport,M110,2,0
1,0,1,-0.89,0,-1.8,R-HSA-9018519,Estrogen-dependent gene expression,M101,2,0
0,1,1,0,-1.5,-1.5,GO:1901654,response to ketone,M011,2,0
0,1,1,0,-1.1,-1.6,hsa04928,"Parathyroid hormone synthesis, secretion and action",M011,2,0
1,0,1,-1.6,0,-0.63,GO:0018108,peptidyl-tyrosine phosphorylation,M101,2,0
0,1,1,0,-1.7,-1.1,R-HSA-9694635,Translation of Structural Proteins,M011,2,0
1,1,0,-1.1,-2,0,GO:0043086,negative regulation of catalytic activity,M110,2,0
0,1,1,0,-1.9,-1.9,GO:0035115,embryonic forelimb morphogenesis,M011,2,0
1,1,0,-5,-3.7,0,hsa05200,Pathways in cancer,M110,2,0
1,0,1,-0.57,0,-0.92,GO:0048844,artery morphogenesis,M101,2,0
1,1,0,-1.3,-1.6,0,GO:0060541,respiratory system development,M110,2,0
1,0,1,-0.94,0,-2.3,GO:0010863,positive regulation of phospholipase C activity,M101,2,0
1,0,1,-1.2,0,-1.2,R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,M101,2,0
1,1,0,-1.4,-2.4,0,GO:0031400,negative regulation of protein modification process,M110,2,0
1,1,0,-1.5,-1.5,0,WP4304,Oligodendrocyte specification and differentiation leading to myelin components for CNS,M110,2,0
1,1,0,-1.6,-2.5,0,R-HSA-9006335,Signaling by Erythropoietin,M110,2,0
0,1,1,0,-1.4,-1.1,GO:0140352,export from cell,M011,2,0
0,1,1,0,-0.63,-2.3,GO:0006887,exocytosis,M011,2,0
0,1,1,0,-2.4,-2.8,GO:0007507,heart development,M011,2,0
1,0,1,-3.9,0,-1,GO:0050870,positive regulation of T cell activation,M101,2,0
1,1,0,-0.69,-1.1,0,R-HSA-400253,Circadian Clock,M110,2,0
1,0,1,-3.5,0,-1.3,GO:0050777,negative regulation of immune response,M101,2,0
1,0,1,-0.57,0,-0.58,hsa05150,Staphylococcus aureus infection,M101,2,0
0,1,1,0,-1.7,-3,GO:0014706,striated muscle tissue development,M011,2,0
1,1,0,-0.81,-1.1,0,GO:1904062,regulation of monoatomic cation transmembrane transport,M110,2,0
1,0,1,-0.69,0,-0.7,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,M101,2,0
1,0,1,-0.88,0,-0.88,GO:0061035,regulation of cartilage development,M101,2,0
0,1,1,0,-0.89,-1.5,WP4222,Phosphodiesterases in neuronal function,M011,2,0
1,1,0,-0.57,-0.57,0,R-HSA-373755,Semaphorin interactions,M110,2,0
1,1,0,-2,-2,0,GO:0030323,respiratory tube development,M110,2,0
1,0,1,-1.8,0,-1.8,GO:0044703,multi-organism reproductive process,M101,2,0
1,0,1,-0.89,0,-0.9,GO:1903509,liposaccharide metabolic process,M101,2,0
1,1,0,-0.81,-1.3,0,M239,PID A6B1 A6B4 INTEGRIN PATHWAY,M110,2,0
1,1,0,-1.5,-1.5,0,WP286,IL 3 signaling pathway,M110,2,0
1,0,1,-1.6,0,-2.6,WP4541,Hippo Merlin signaling dysregulation,M101,2,0
0,1,1,0,-1.2,-1.2,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",M011,2,0
0,1,1,0,-1.7,-1.7,WP2880,Glucocorticoid receptor pathway,M011,2,0
1,1,0,-0.94,-0.94,0,WP5078,T cell modulation in pancreatic cancer,M110,2,0
1,0,1,-0.93,0,-1.8,GO:1902905,positive regulation of supramolecular fiber organization,M101,2,0
1,0,1,-4.3,0,-1.7,GO:2000147,positive regulation of cell motility,M101,2,0
1,0,1,-1.6,0,-1.6,GO:0097696,receptor signaling pathway via STAT,M101,2,0
0,1,1,0,-0.66,-0.66,GO:0019935,cyclic-nucleotide-mediated signaling,M011,2,0
1,0,1,-2.1,0,-1.4,GO:0031668,cellular response to extracellular stimulus,M101,2,0
0,1,1,0,-1.9,-2.3,GO:0051960,regulation of nervous system development,M011,2,0
1,0,1,-1.8,0,-1.1,GO:0002699,positive regulation of immune effector process,M101,2,0
1,0,1,-0.84,0,-1.2,GO:0010948,negative regulation of cell cycle process,M101,2,0
1,1,0,-0.69,-0.69,0,GO:0000209,protein polyubiquitination,M110,2,0
0,1,1,0,-0.52,-0.52,GO:0009798,axis specification,M011,2,0
1,0,1,-0.73,0,-4.2,GO:0010517,regulation of phospholipase activity,M101,2,0
1,0,1,-0.6,0,-0.6,R-HSA-373760,L1CAM interactions,M101,2,0
1,0,1,-1.3,0,-1,GO:0097190,apoptotic signaling pathway,M101,2,0
1,1,0,-1.2,-0.77,0,GO:1904064,positive regulation of cation transmembrane transport,M110,2,0
1,0,1,-0.69,0,-0.7,GO:0001961,positive regulation of cytokine-mediated signaling pathway,M101,2,0
0,1,1,0,-1.2,-1.5,GO:0002443,leukocyte mediated immunity,M011,2,0
0,1,1,0,-0.76,-1.3,GO:0051651,maintenance of location in cell,M011,2,0
0,1,1,0,-1.2,-1.2,GO:0048701,embryonic cranial skeleton morphogenesis,M011,2,0
0,1,1,0,-2.6,-1.1,M33,PID GLYPICAN 1PATHWAY,M011,2,0
1,1,0,-3.9,-1.2,0,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,M110,2,0
1,0,1,-2.1,0,-0.85,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",M101,2,0
0,1,1,0,-1.2,-2.5,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,M011,2,0
1,1,0,-1.7,-1.1,0,GO:0032655,regulation of interleukin-12 production,M110,2,0
1,1,0,-0.66,-0.66,0,M256,PID TAP63 PATHWAY,M110,2,0
1,1,0,-1.8,-0.57,0,GO:2000106,regulation of leukocyte apoptotic process,M110,2,0
1,0,1,-0.98,0,-2.2,GO:0035107,appendage morphogenesis,M101,2,0
0,1,1,0,-0.54,-0.55,WP5144,NRP1 triggered signaling pathways in pancreatic cancer,M011,2,0
1,1,0,-2.1,-0.97,0,hsa05163,Human cytomegalovirus infection,M110,2,0
0,1,1,0,-0.99,-0.58,R-HSA-6806834,Signaling by MET,M011,2,0
0,1,1,0,-3.5,-2.7,GO:0050678,regulation of epithelial cell proliferation,M011,2,0
1,1,0,-2,-1.2,0,GO:0002703,regulation of leukocyte mediated immunity,M110,2,0
0,1,1,0,-1.2,-1.2,GO:0071675,regulation of mononuclear cell migration,M011,2,0
1,0,1,-0.77,0,-0.77,GO:0046636,negative regulation of alpha-beta T cell activation,M101,2,0
0,1,1,0,-0.89,-1.9,GO:0048863,stem cell differentiation,M011,2,0
0,1,1,0,-2.8,-0.58,GO:0072522,purine-containing compound biosynthetic process,M011,2,0
1,0,1,-3,0,-1.1,GO:0002820,negative regulation of adaptive immune response,M101,2,0
1,1,0,-1.7,-1.7,0,GO:0030324,lung development,M110,2,0
1,1,0,-1.3,-1.7,0,R-HSA-199991,Membrane Trafficking,M110,2,0
1,0,1,-0.68,0,-0.68,hsa05014,Amyotrophic lateral sclerosis,M101,2,0
1,1,0,-0.65,-0.65,0,GO:0001657,ureteric bud development,M110,2,0
0,1,1,0,-1.1,-2.7,GO:0045055,regulated exocytosis,M011,2,0
1,0,1,-0.66,0,-1.1,R-HSA-446203,Asparagine N-linked glycosylation,M101,2,0
1,0,1,-2.8,0,-0.85,GO:2000573,positive regulation of DNA biosynthetic process,M101,2,0
0,1,1,0,-0.73,-1.8,GO:0042733,embryonic digit morphogenesis,M011,2,0
1,0,1,-0.57,0,-0.57,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,M101,2,0
1,0,1,-1.1,0,-2,GO:0046631,alpha-beta T cell activation,M101,2,0
1,1,0,-1.1,-1.1,0,GO:0032743,positive regulation of interleukin-2 production,M110,2,0
1,0,1,-1.8,0,-1.2,GO:0002253,activation of immune response,M101,2,0
0,1,1,0,-0.57,-0.58,R-HSA-9830369,Kidney development,M011,2,0
1,1,0,-4,-2.6,0,GO:0010632,regulation of epithelial cell migration,M110,2,0
1,0,1,-0.73,0,-1.2,GO:0051258,protein polymerization,M101,2,0
1,0,1,-2.7,0,-2.7,R-HSA-210500,Glutamate Neurotransmitter Release Cycle,M101,2,0
1,0,1,-1.9,0,-1.6,GO:0009410,response to xenobiotic stimulus,M101,2,0
1,1,0,-1.7,-1.2,0,WP2263,Androgen receptor network in prostate cancer,M110,2,0
1,0,1,-1.8,0,-2.1,GO:0002521,leukocyte differentiation,M101,2,0
1,1,0,-3.3,-1.2,0,hsa05224,Breast cancer,M110,2,0
1,0,1,-1.5,0,-1.5,GO:1902749,regulation of cell cycle G2/M phase transition,M101,2,0
1,0,1,-1.3,0,-1.3,GO:0051052,regulation of DNA metabolic process,M101,2,0
1,1,0,-0.52,-0.52,0,GO:0043467,regulation of generation of precursor metabolites and energy,M110,2,0
1,0,1,-2.1,0,-1.4,M231,PID KIT PATHWAY,M101,2,0
1,0,1,-1.4,0,-0.74,hsa05203,Viral carcinogenesis,M101,2,0
0,1,1,0,-0.84,-0.85,GO:0071331,cellular response to hexose stimulus,M011,2,0
0,1,1,0,-2.4,-2.9,GO:0050803,regulation of synapse structure or activity,M011,2,0
0,1,1,0,-1.6,-1.1,hsa04625,C-type lectin receptor signaling pathway,M011,2,0
1,0,1,-1.1,0,-0.73,GO:0045444,fat cell differentiation,M101,2,0
1,1,0,-0.57,-0.57,0,hsa04071,Sphingolipid signaling pathway,M110,2,0
1,0,1,-1.4,0,-0.62,WP5381,Smith Magenis and Potocki Lupski syndrome copy number variation,M101,2,0
1,1,0,-4,-1.6,0,GO:0001934,positive regulation of protein phosphorylation,M110,2,0
1,1,0,-1.2,-2.3,0,GO:0001933,negative regulation of protein phosphorylation,M110,2,0
1,0,1,-1.1,0,-2.5,hsa05202,Transcriptional misregulation in cancer,M101,2,0
0,1,1,0,-1.3,-0.57,hsa04611,Platelet activation,M011,2,0
0,1,1,0,-2,-2,GO:0019082,viral protein processing,M011,2,0
1,1,0,-4,-1.2,0,GO:0032102,negative regulation of response to external stimulus,M110,2,0
0,1,1,0,-1.1,-1.1,GO:0051145,smooth muscle cell differentiation,M011,2,0
0,1,1,0,-1.1,-2.8,GO:0031214,biomineral tissue development,M011,2,0
0,1,1,0,-1.3,-0.97,GO:0062197,cellular response to chemical stress,M011,2,0
1,1,0,-0.84,-1.3,0,hsa05323,Rheumatoid arthritis,M110,2,0
0,1,1,0,-1.3,-2.7,WP5198,Inflammatory bowel disease signaling,M011,2,0
1,0,1,-1.2,0,-2.7,GO:0015800,acidic amino acid transport,M101,2,0
0,1,1,0,-0.81,-0.81,GO:0045669,positive regulation of osteoblast differentiation,M011,2,0
1,1,0,-1.9,-1.5,0,GO:0043535,regulation of blood vessel endothelial cell migration,M110,2,0
0,1,1,0,-1.3,-1.3,GO:0007389,pattern specification process,M011,2,0
1,1,0,-0.57,-0.99,0,GO:0009914,hormone transport,M110,2,0
1,1,0,-1.7,-1,0,hsa04137,Mitophagy - animal,M110,2,0
0,1,1,0,-1.8,-1.8,GO:0035137,hindlimb morphogenesis,M011,2,0
1,0,1,-1.6,0,-1.1,GO:0019221,cytokine-mediated signaling pathway,M101,2,0
1,0,1,-2,0,-2,GO:0030101,natural killer cell activation,M101,2,0
1,0,1,-1.7,0,-0.66,GO:2000242,negative regulation of reproductive process,M101,2,0
0,1,1,0,-1.2,-1.2,WP5094,Orexin receptor pathway,M011,2,0
1,0,1,-3.9,0,-1.5,GO:0022409,positive regulation of cell-cell adhesion,M101,2,0
1,1,0,-1.2,-1.2,0,GO:0150115,cell-substrate junction organization,M110,2,0
1,1,0,-0.61,-0.98,0,WP4396,Nonalcoholic fatty liver disease,M110,2,0
1,0,1,-2.7,0,-1.3,GO:0002698,negative regulation of immune effector process,M101,2,0
1,0,1,-1.1,0,-0.75,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,M101,2,0
1,1,0,-1.5,-1.5,0,WP254,Apoptosis,M110,2,0
1,1,0,-1.8,-1.3,0,GO:2000377,regulation of reactive oxygen species metabolic process,M110,2,0
0,1,1,0,-1.4,-1.4,M12,PID RHOA PATHWAY,M011,2,0
1,1,0,-4.7,-1.3,0,hsa05223,Non-small cell lung cancer,M110,2,0
1,1,0,-2.1,-1.7,0,GO:0072006,nephron development,M110,2,0
1,1,0,-1.3,-0.76,0,GO:1904019,epithelial cell apoptotic process,M110,2,0
1,0,1,-3,0,-1.5,GO:1902105,regulation of leukocyte differentiation,M101,2,0
1,1,0,-0.89,-2.2,0,WP2848,Pluripotent stem cell differentiation pathway,M110,2,0
1,1,0,-1.6,-3.4,0,GO:0120039,plasma membrane bounded cell projection morphogenesis,M110,2,0
1,1,0,-2.4,-1.8,0,GO:0055013,cardiac muscle cell development,M110,2,0
1,0,1,-1,0,-1.1,M276,PID FGF PATHWAY,M101,2,0
0,1,1,0,-1.5,-0.7,GO:1901343,negative regulation of vasculature development,M011,2,0
1,1,0,-1.6,-1.6,0,hsa05225,Hepatocellular carcinoma,M110,2,0
1,1,0,-0.63,-0.63,0,GO:0001655,urogenital system development,M110,2,0
1,1,0,-1.5,-4.7,0,GO:0045765,regulation of angiogenesis,M110,2,0
1,1,0,-2,-0.83,0,hsa05205,Proteoglycans in cancer,M110,2,0
1,1,0,-0.86,-0.85,0,M145,PID P53 DOWNSTREAM PATHWAY,M110,2,0
0,1,1,0,-2.9,-2.5,GO:0061448,connective tissue development,M011,2,0
0,1,1,0,-1.6,-2.1,GO:0048704,embryonic skeletal system morphogenesis,M011,2,0
0,1,1,0,-0.89,-1.5,GO:2000401,regulation of lymphocyte migration,M011,2,0
1,0,1,-0.72,0,-0.72,R-HSA-5576891,Cardiac conduction,M101,2,0
1,0,1,-2.8,0,-1.7,GO:0002697,regulation of immune effector process,M101,2,0
1,1,0,-1.4,-0.84,0,GO:0048806,genitalia development,M110,2,0
0,1,1,0,-0.95,-0.55,GO:0008306,associative learning,M011,2,0
1,1,0,-0.9,-1.6,0,GO:0003231,cardiac ventricle development,M110,2,0
1,0,1,-0.66,0,-1.1,WP5053,Development of ureteric collection system,M101,2,0
1,1,0,-0.89,-0.89,0,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,M110,2,0
0,1,1,0,-0.75,-0.76,GO:0045667,regulation of osteoblast differentiation,M011,2,0
0,1,1,0,-1.4,-0.95,GO:0045666,positive regulation of neuron differentiation,M011,2,0
0,1,1,0,-1.2,-0.75,GO:0070085,glycosylation,M011,2,0
1,0,1,-5.3,0,-2.4,GO:0050865,regulation of cell activation,M101,2,0
0,1,1,0,-0.71,-1.1,GO:0030500,regulation of bone mineralization,M011,2,0
1,1,0,-0.72,-1.5,0,GO:0032642,regulation of chemokine production,M110,2,0
0,1,1,0,-1.6,-0.63,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,M011,2,0
1,0,1,-2.2,0,-0.72,GO:0046635,positive regulation of alpha-beta T cell activation,M101,2,0
1,1,0,-0.85,-2.1,0,hsa04012,ErbB signaling pathway,M110,2,0
1,1,0,-1.2,-0.85,0,GO:2000116,regulation of cysteine-type endopeptidase activity,M110,2,0
1,1,0,-3.2,-1.3,0,WP4806,EGFR tyrosine kinase inhibitor resistance,M110,2,0
1,1,0,-2.5,-1.4,0,GO:0030522,intracellular receptor signaling pathway,M110,2,0
1,0,1,-2.7,0,-0.74,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M101,2,0
0,1,1,0,-2.4,-2.2,GO:0001944,vasculature development,M011,2,0
0,1,1,0,-0.73,-1.2,GO:0001709,cell fate determination,M011,2,0
0,1,1,0,-1.3,-1.3,WP3942,PPAR signaling pathway,M011,2,0
1,1,0,-1.6,-3.4,0,GO:0048858,cell projection morphogenesis,M110,2,0
1,1,0,-1.3,-2.1,0,GO:0050886,endocrine process,M110,2,0
1,1,0,-0.69,-1.2,0,GO:0061572,actin filament bundle organization,M110,2,0
1,1,0,-0.94,-0.94,0,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,M110,2,0
1,0,1,-3.4,0,-2,GO:0097435,supramolecular fiber organization,M101,2,0
0,1,1,0,-0.69,-1.8,GO:0032088,negative regulation of NF-kappaB transcription factor activity,M011,2,0
1,0,1,-0.65,0,-0.66,GO:0010565,regulation of cellular ketone metabolic process,M101,2,0
1,0,1,-2.6,0,-0.77,GO:0014911,positive regulation of smooth muscle cell migration,M101,2,0
1,0,1,-0.94,0,-0.94,GO:0048048,embryonic eye morphogenesis,M101,2,0
0,1,1,0,-0.6,-1,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",M011,2,0
0,1,1,0,-1.9,-1.9,GO:0098926,postsynaptic signal transduction,M011,2,0
1,0,1,-1.1,0,-1.1,GO:0046683,response to organophosphorus,M101,2,0
0,1,1,0,-0.69,-1.2,GO:0070301,cellular response to hydrogen peroxide,M011,2,0
1,1,0,-1.6,-1.8,0,GO:0048514,blood vessel morphogenesis,M110,2,0
0,1,1,0,-2.2,-2.7,WP2857,Mesodermal commitment pathway,M011,2,0
1,1,0,-2.9,-4.5,0,GO:1904018,positive regulation of vasculature development,M110,2,0
1,0,1,-1.8,0,-1.1,GO:0030865,cortical cytoskeleton organization,M101,2,0
1,0,1,-1,0,-1.7,R-HSA-9664407,Parasite infection,M101,2,0
0,1,1,0,-0.75,-0.76,GO:0009100,glycoprotein metabolic process,M011,2,0
0,1,1,0,-1.3,-1.3,GO:0035633,maintenance of blood-brain barrier,M011,2,0
1,0,1,-2.3,0,-2.7,GO:1902107,positive regulation of leukocyte differentiation,M101,2,0
1,0,1,-0.99,0,-1,M54,PID IL12 2PATHWAY,M101,2,0
1,1,0,-1.3,-3.4,0,GO:0061564,axon development,M110,2,0
1,1,0,-0.85,-0.84,0,M58,PID AR PATHWAY,M110,2,0
1,1,0,-0.99,-0.99,0,GO:0021575,hindbrain morphogenesis,M110,2,0
0,1,1,0,-1.4,-1.9,GO:0051048,negative regulation of secretion,M011,2,0
0,1,1,0,-2.2,-1.2,GO:0002067,glandular epithelial cell differentiation,M011,2,0
1,1,0,-0.69,-1.2,0,GO:1905332,positive regulation of morphogenesis of an epithelium,M110,2,0
0,1,1,0,-0.77,-0.78,hsa04714,Thermogenesis,M011,2,0
1,0,1,-1.7,0,-0.96,R-HSA-8939211,ESR-mediated signaling,M101,2,0
0,1,1,0,-0.66,-0.66,GO:0045687,positive regulation of glial cell differentiation,M011,2,0
1,1,0,-1.1,-1.1,0,GO:2000647,negative regulation of stem cell proliferation,M110,2,0
1,1,0,-1.6,-1.5,0,WP382,MAPK signaling pathway,M110,2,0
1,0,1,-0.94,0,-0.94,GO:0007088,regulation of mitotic nuclear division,M101,2,0
0,1,1,0,-1.5,-1.5,WP453,Inflammatory response pathway,M011,2,0
0,1,1,0,-1.5,-0.7,GO:2000181,negative regulation of blood vessel morphogenesis,M011,2,0
0,1,1,0,-1.4,-1.7,GO:0051640,organelle localization,M011,2,0
0,1,1,0,-1.2,-0.88,GO:0098727,maintenance of cell number,M011,2,0
1,0,1,-1.5,0,-1.5,GO:0045637,regulation of myeloid cell differentiation,M101,2,0
1,1,0,-2.4,-0.69,0,WP3611,Photodynamic therapy induced AP 1 survival signaling,M110,2,0
0,1,1,0,-0.81,-0.81,GO:0003229,ventricular cardiac muscle tissue development,M011,2,0
1,0,1,-1,0,-1.7,R-HSA-9664417,Leishmania phagocytosis,M101,2,0
1,1,0,-1.3,-0.81,0,WP5205,Clock controlled autophagy in bone metabolism,M110,2,0
1,0,1,-0.8,0,-0.8,WP2840,Hair follicle development cytodifferentiation part 3 of 3,M101,2,0
0,1,1,0,-1.5,-1.5,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M011,2,0
0,1,1,0,-0.77,-3,GO:0051963,regulation of synapse assembly,M011,2,0
0,1,1,0,-0.77,-1.7,M288,PID HES HEY PATHWAY,M011,2,0
1,0,1,-0.69,0,-1.2,GO:0008347,glial cell migration,M101,2,0
0,1,1,0,-0.88,-2.3,GO:0071772,response to BMP,M011,2,0
1,0,1,-1.4,0,-1.1,GO:0050727,regulation of inflammatory response,M101,2,0
1,0,1,-0.93,0,-2.7,GO:1902903,regulation of supramolecular fiber organization,M101,2,0
0,1,1,0,-0.8,-1.2,WP2858,Ectoderm differentiation,M011,2,0
1,1,0,-1.6,-3.5,0,GO:0007409,axonogenesis,M110,2,0
1,0,1,-1.3,0,-2.1,R-HSA-112310,Neurotransmitter release cycle,M101,2,0
0,1,1,0,-0.88,-2.3,GO:0071773,cellular response to BMP stimulus,M011,2,0
0,1,1,0,-0.91,-1.8,M18,PID INTEGRIN1 PATHWAY,M011,2,0
1,1,0,-0.69,-1.2,0,GO:0051017,actin filament bundle assembly,M110,2,0
0,1,1,0,-2.4,-2.9,GO:0050807,regulation of synapse organization,M011,2,0
0,1,1,0,-1.1,-1.6,GO:0031644,regulation of nervous system process,M011,2,0
1,0,1,-0.6,0,-0.6,R-HSA-9013404,RAC2 GTPase cycle,M101,2,0
0,1,1,0,-1.1,-1.6,R-HSA-166520,Signaling by NTRKs,M011,2,0
1,0,1,-2.4,0,-1.5,GO:0001779,natural killer cell differentiation,M101,2,0
1,1,0,-1.5,-1,0,GO:0022037,metencephalon development,M110,2,0
1,1,0,-2.1,-2.4,0,GO:0001525,angiogenesis,M110,2,0
0,1,1,0,-0.91,-0.92,GO:0034614,cellular response to reactive oxygen species,M011,2,0
1,1,0,-0.63,-1.1,0,WP231,TNF alpha signaling pathway,M110,2,0
0,1,1,0,-0.84,-0.85,R-HSA-8875878,MET promotes cell motility,M011,2,0
1,0,1,-2.3,0,-1.7,GO:0042472,inner ear morphogenesis,M101,2,0
1,0,1,-4.1,0,-2.4,GO:1903037,regulation of leukocyte cell-cell adhesion,M101,2,0
1,0,1,-1.8,0,-1.5,GO:0002764,immune response-regulating signaling pathway,M101,2,0
1,1,0,-3.3,-2.5,0,R-HSA-449147,Signaling by Interleukins,M110,2,0
0,1,1,0,-1.2,-2,GO:1904752,regulation of vascular associated smooth muscle cell migration,M011,2,0
1,0,1,-0.6,0,-1,GO:0050854,regulation of antigen receptor-mediated signaling pathway,M101,2,0
0,1,1,0,-0.84,-1.9,GO:0022604,regulation of cell morphogenesis,M011,2,0
0,1,1,0,-1.9,-0.77,GO:0060419,heart growth,M011,2,0
1,0,1,-1.2,0,-1.9,M88,PID CD8 TCR PATHWAY,M101,2,0
0,1,1,0,-1.1,-2.5,GO:0003007,heart morphogenesis,M011,2,0
0,1,1,0,-2.1,-1.7,GO:0002065,columnar/cuboidal epithelial cell differentiation,M011,2,0
1,1,0,-0.57,-0.99,0,WP185,Integrin mediated cell adhesion,M110,2,0
1,1,0,-1.1,-0.66,0,GO:0010906,regulation of glucose metabolic process,M110,2,0
1,0,1,-1.6,0,-0.63,GO:0018212,peptidyl-tyrosine modification,M101,2,0
1,0,1,-1.7,0,-1.4,GO:0002429,immune response-activating cell surface receptor signaling pathway,M101,2,0
1,0,1,-0.61,0,-0.62,GO:0045638,negative regulation of myeloid cell differentiation,M101,2,0
0,1,1,0,-1.1,-1.8,GO:0035883,enteroendocrine cell differentiation,M011,2,0
1,1,0,-4.6,-1.2,0,WP4255,Non small cell lung cancer,M110,2,0
1,1,0,-1.6,-0.6,0,M200,PID ERA GENOMIC PATHWAY,M110,2,0
1,0,1,-1.2,0,-1.9,GO:0007215,glutamate receptor signaling pathway,M101,2,0
1,0,1,-0.81,0,-0.81,R-HSA-202403,TCR signaling,M101,2,0
1,1,0,-2.3,-1.5,0,GO:0061437,renal system vasculature development,M110,2,0
0,1,1,0,-0.79,-1.5,GO:0051656,establishment of organelle localization,M011,2,0
0,1,1,0,-1.8,-2.4,GO:0048871,multicellular organismal-level homeostasis,M011,2,0
1,1,0,-1.1,-2.1,0,GO:0042326,negative regulation of phosphorylation,M110,2,0
1,0,1,-0.77,0,-0.77,WP1541,Energy metabolism,M101,2,0
0,1,1,0,-2.1,-0.85,R-HSA-9772573,Late SARS-CoV-2 Infection Events,M011,2,0
1,1,0,-0.65,-0.65,0,GO:0072164,mesonephric tubule development,M110,2,0
1,1,0,-5.5,-1.9,0,GO:0010562,positive regulation of phosphorus metabolic process,M110,2,0
0,1,1,0,-3,-0.63,GO:0006164,purine nucleotide biosynthetic process,M011,2,0
1,1,0,-2.6,-1.5,0,R-HSA-5653656,Vesicle-mediated transport,M110,2,0
1,1,0,-2.3,-2.3,0,GO:0035239,tube morphogenesis,M110,2,0
1,1,0,-0.64,-0.64,0,GO:0060972,left/right pattern formation,M110,2,0
1,0,1,-1,0,-1.1,R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,M101,2,0
0,1,1,0,-1.4,-0.55,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,M011,2,0
1,1,0,-0.5,-0.87,0,GO:0006022,aminoglycan metabolic process,M110,2,0
1,0,1,-1.1,0,-1.1,R-HSA-9659379,Sensory processing of sound,M101,2,0
0,1,1,0,-1.2,-1.2,GO:0048589,developmental growth,M011,2,0
1,0,1,-2,0,-1.2,GO:0007163,establishment or maintenance of cell polarity,M101,2,0
1,1,0,-2.3,-1.5,0,GO:0061440,kidney vasculature development,M110,2,0
1,0,1,-0.99,0,-1,R-HSA-452723,Transcriptional regulation of pluripotent stem cells,M101,2,0
0,1,1,0,-1.4,-0.55,GO:0051100,negative regulation of binding,M011,2,0
0,1,1,0,-0.99,-0.58,WP4932,7q11 23 copy number variation syndrome,M011,2,0
1,1,0,-0.83,-1.6,0,R-HSA-9658195,Leishmania infection,M110,2,0
0,1,1,0,-0.91,-0.52,WP2118,Arrhythmogenic right ventricular cardiomyopathy,M011,2,0
1,0,1,-1.8,0,-1.3,GO:0007565,female pregnancy,M101,2,0
0,1,1,0,-0.89,-2.2,GO:0003161,cardiac conduction system development,M011,2,0
0,1,1,0,-1.3,-1.3,GO:0097581,lamellipodium organization,M011,2,0
1,0,1,-1.5,0,-0.94,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,M101,2,0
1,0,1,-1.2,0,-2.4,GO:0045646,regulation of erythrocyte differentiation,M101,2,0
1,0,1,-0.78,0,-0.78,GO:0001707,mesoderm formation,M101,2,0
0,1,1,0,-1.9,-1.1,GO:0007498,mesoderm development,M011,2,0
1,0,1,-1.5,0,-0.7,R-HSA-877300,Interferon gamma signaling,M101,2,0
1,1,0,-1.8,-1.3,0,R-HSA-8856828,Clathrin-mediated endocytosis,M110,2,0
1,0,1,-1.4,0,-2.8,GO:1903131,mononuclear cell differentiation,M101,2,0
1,0,1,-1.5,0,-1.2,GO:1901987,regulation of cell cycle phase transition,M101,2,0
1,0,1,-1.5,0,-1.5,GO:1901990,regulation of mitotic cell cycle phase transition,M101,2,0
1,1,0,-0.57,-0.91,0,GO:0009855,determination of bilateral symmetry,M110,2,0
0,1,1,0,-0.57,-1,GO:0002293,alpha-beta T cell differentiation involved in immune response,M011,2,0
1,1,0,-0.66,-1.1,0,WP3646,Hepatitis C and hepatocellular carcinoma,M110,2,0
1,0,1,-1.1,0,-1.1,GO:0043030,regulation of macrophage activation,M101,2,0
1,0,1,-0.63,0,-1.1,GO:0015807,L-amino acid transport,M101,2,0
0,1,1,0,-1.5,-2.3,GO:0048738,cardiac muscle tissue development,M011,2,0
0,1,1,0,-0.63,-0.63,GO:0055010,ventricular cardiac muscle tissue morphogenesis,M011,2,0
1,1,0,-0.78,-1.2,0,GO:0010508,positive regulation of autophagy,M110,2,0
1,0,1,-0.94,0,-0.94,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,M101,2,0
1,0,1,-1.1,0,-1.1,GO:1901796,regulation of signal transduction by p53 class mediator,M101,2,0
1,1,0,-1.7,-1.3,0,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M110,2,0
1,1,0,-0.66,-0.66,0,GO:1903510,mucopolysaccharide metabolic process,M110,2,0
0,1,1,0,-1.3,-1.3,hsa04015,Rap1 signaling pathway,M011,2,0
0,1,1,0,-0.64,-0.64,R-HSA-418555,G alpha (s) signalling events,M011,2,0
0,1,1,0,-0.67,-0.68,R-HSA-196854,Metabolism of vitamins and cofactors,M011,2,0
1,0,1,-2.1,0,-0.67,GO:0007229,integrin-mediated signaling pathway,M101,2,0
1,1,0,-2,-1.1,0,WP4239,Epithelial to mesenchymal transition in colorectal cancer,M110,2,0
0,1,1,0,-1.8,-0.78,GO:0034599,cellular response to oxidative stress,M011,2,0
1,0,1,-0.69,0,-0.7,GO:0050766,positive regulation of phagocytosis,M101,2,0
1,0,1,-1.1,0,-1.9,GO:0030031,cell projection assembly,M101,2,0
1,0,1,-0.66,0,-0.67,GO:0035966,response to topologically incorrect protein,M101,2,0
1,1,0,-0.77,-1.1,0,GO:0045861,negative regulation of proteolysis,M110,2,0
1,0,1,-1.8,0,-2,GO:0008285,negative regulation of cell population proliferation,M101,2,0
1,1,0,-2.2,-0.89,0,WP2571,Polycystic kidney disease pathway,M110,2,0
0,1,1,0,-1.5,-1,GO:0120162,positive regulation of cold-induced thermogenesis,M011,2,0
0,1,1,0,-0.84,-1.4,GO:0120163,negative regulation of cold-induced thermogenesis,M011,2,0
1,0,1,-1.7,0,-1.4,GO:0032970,regulation of actin filament-based process,M101,2,0
1,1,0,-1.2,-1.2,0,WP4906,3q29 copy number variation syndrome,M110,2,0
1,1,0,-1.2,-0.73,0,GO:0002028,regulation of sodium ion transport,M110,2,0
1,0,1,-1.5,0,-0.55,R-HSA-194138,Signaling by VEGF,M101,2,0
1,0,1,-0.72,0,-0.73,GO:1901991,negative regulation of mitotic cell cycle phase transition,M101,2,0
1,0,1,-0.87,0,-0.87,R-HSA-9694516,SARS-CoV-2 Infection,M101,2,0
1,0,1,-1.1,0,-1.4,GO:0032956,regulation of actin cytoskeleton organization,M101,2,0
1,0,1,-1.2,0,-0.73,GO:0015914,phospholipid transport,M101,2,0
0,1,1,0,-2.4,-2,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,M011,2,0
1,1,0,-1.9,-1.2,0,GO:0043122,regulation of canonical NF-kappaB signal transduction,M110,2,0
0,1,1,0,-1.1,-1.1,GO:0003151,outflow tract morphogenesis,M011,2,0
0,1,1,0,-1.2,-1.2,GO:0008542,visual learning,M011,2,0
1,1,0,-2.4,-2.4,0,GO:0032835,glomerulus development,M110,2,0
1,0,1,-0.73,0,-1.2,GO:0043244,regulation of protein-containing complex disassembly,M101,2,0
0,1,1,0,-1.3,-2.1,GO:0051602,response to electrical stimulus,M011,2,0
1,0,1,-1.1,0,-1.5,GO:0032271,regulation of protein polymerization,M101,2,0
0,1,1,0,-1.2,-5,GO:0061515,myeloid cell development,M011,2,0
1,1,0,-0.73,-0.73,0,GO:0140014,mitotic nuclear division,M110,2,0
1,0,1,-1,0,-1.7,R-HSA-9664422,FCGR3A-mediated phagocytosis,M101,2,0
0,1,1,0,-0.57,-1,GO:0002287,alpha-beta T cell activation involved in immune response,M011,2,0
0,1,1,0,-0.95,-0.55,R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,M011,2,0
1,0,1,-1.1,0,-2.1,GO:0048562,embryonic organ morphogenesis,M101,2,0
0,1,1,0,-1.9,-1.9,GO:0035116,embryonic hindlimb morphogenesis,M011,2,0
0,1,1,0,-0.96,-0.97,GO:0019827,stem cell population maintenance,M011,2,0
0,1,1,0,-0.97,-2.6,GO:0071695,anatomical structure maturation,M011,2,0
1,0,1,-1.8,0,-1.8,GO:0045648,positive regulation of erythrocyte differentiation,M101,2,0
1,0,1,-0.78,0,-0.79,GO:1901988,negative regulation of cell cycle phase transition,M101,2,0
1,0,1,-1.1,0,-1.1,GO:0046928,regulation of neurotransmitter secretion,M101,2,0
0,1,1,0,-1.6,-3.3,GO:0010720,positive regulation of cell development,M011,2,0
0,1,1,0,-1.7,-1.7,GO:0035136,forelimb morphogenesis,M011,2,0
0,1,1,0,-0.66,-1.1,GO:0050684,regulation of mRNA processing,M011,2,0
1,0,1,-2.4,0,-3.4,GO:0009792,embryo development ending in birth or egg hatching,M101,2,0
1,0,1,-1.1,0,-0.85,M5883,NABA SECRETED FACTORS,M101,2,0
1,1,0,-0.91,-0.52,0,WP4216,Chromosomal and microsatellite instability in colorectal cancer,M110,2,0
1,1,0,-1.6,-1.1,0,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,M110,2,0
0,1,1,0,-1,-2.2,WP5373,Osteoarthritic chondrocyte hypertrophy,M011,2,0
0,1,1,0,-0.73,-0.73,WP3995,Prion disease pathway,M011,2,0
1,0,1,-1.2,0,-0.84,M3468,NABA ECM REGULATORS,M101,2,0
0,1,1,0,-2,-0.81,GO:0055017,cardiac muscle tissue growth,M011,2,0
1,1,0,-0.71,-1.4,0,GO:0030902,hindbrain development,M110,2,0
1,1,0,-2.1,-1.5,0,GO:0006897,endocytosis,M110,2,0
1,0,0,-0.95,0,0,GO:0009299,mRNA transcription,M100,1,0
0,1,0,0,-3.1,0,R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,M010,1,0
1,0,0,-1.5,0,0,GO:0048729,tissue morphogenesis,M100,1,0
1,0,0,-0.75,0,0,GO:0015980,energy derivation by oxidation of organic compounds,M100,1,0
1,0,0,-0.63,0,0,GO:0021761,limbic system development,M100,1,0
1,0,0,-2.9,0,0,R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,M100,1,0
0,1,0,0,-1,0,R-HSA-5688426,Deubiquitination,M010,1,0
0,0,1,0,0,-1.4,GO:0048762,mesenchymal cell differentiation,M001,1,0
1,0,0,-1.5,0,0,GO:1902807,negative regulation of cell cycle G1/S phase transition,M100,1,0
0,0,1,0,0,-2.2,GO:0070486,leukocyte aggregation,M001,1,0
1,0,0,-1,0,0,WP4844,Influence of laminopathies on Wnt signaling,M100,1,0
0,0,1,0,0,-1.5,GO:0042113,B cell activation,M001,1,0
0,0,1,0,0,-2.2,GO:0060485,mesenchyme development,M001,1,0
0,0,1,0,0,-1.7,GO:0042391,regulation of membrane potential,M001,1,0
0,1,0,0,-2.4,0,GO:0003298,physiological muscle hypertrophy,M010,1,0
0,1,0,0,-1.9,0,M12705,SIG CD40PATHWAYMAP,M010,1,0
0,1,0,0,-1.5,0,GO:2001046,positive regulation of integrin-mediated signaling pathway,M010,1,0
0,1,0,0,-0.77,0,GO:0035050,embryonic heart tube development,M010,1,0
0,0,1,0,0,-1,GO:0032963,collagen metabolic process,M001,1,0
0,0,1,0,0,-0.9,GO:0031076,embryonic camera-type eye development,M001,1,0
1,0,0,-1.5,0,0,M295,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,M100,1,0
0,1,0,0,-1.9,0,GO:0070099,regulation of chemokine-mediated signaling pathway,M010,1,0
1,0,0,-0.84,0,0,GO:0055092,sterol homeostasis,M100,1,0
0,0,1,0,0,-1.9,WP5174,Ulcerative colitis signaling,M001,1,0
1,0,0,-1.9,0,0,GO:0032703,negative regulation of interleukin-2 production,M100,1,0
0,0,1,0,0,-2,GO:0035988,chondrocyte proliferation,M001,1,0
0,0,1,0,0,-1.3,GO:0000725,recombinational repair,M001,1,0
1,0,0,-2.7,0,0,WP322,Osteoblast signaling,M100,1,0
0,0,1,0,0,-1.6,GO:0048278,vesicle docking,M001,1,0
1,0,0,-1.9,0,0,GO:0010922,positive regulation of phosphatase activity,M100,1,0
1,0,0,-2.1,0,0,WP366,TGF beta signaling pathway,M100,1,0
1,0,0,-0.63,0,0,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,M100,1,0
1,0,0,-2,0,0,hsa04115,p53 signaling pathway,M100,1,0
0,1,0,0,-1.6,0,GO:2000146,negative regulation of cell motility,M010,1,0
0,1,0,0,-1.1,0,GO:1903532,positive regulation of secretion by cell,M010,1,0
0,0,1,0,0,-0.77,GO:1903313,positive regulation of mRNA metabolic process,M001,1,0
0,0,1,0,0,-2.2,GO:0014743,regulation of muscle hypertrophy,M001,1,0
0,1,0,0,-0.94,0,GO:0031670,cellular response to nutrient,M010,1,0
1,0,0,-0.99,0,0,R-HSA-2559580,Oxidative Stress Induced Senescence,M100,1,0
0,1,0,0,-0.91,0,GO:0030595,leukocyte chemotaxis,M010,1,0
1,0,0,-0.73,0,0,GO:0031503,protein-containing complex localization,M100,1,0
1,0,0,-1.8,0,0,GO:0061458,reproductive system development,M100,1,0
1,0,0,-0.79,0,0,hsa04148,Efferocytosis,M100,1,0
0,1,0,0,-0.98,0,GO:0022898,regulation of transmembrane transporter activity,M010,1,0
0,1,0,0,-0.57,0,GO:0090316,positive regulation of intracellular protein transport,M010,1,0
1,0,0,-1.7,0,0,GO:0033033,negative regulation of myeloid cell apoptotic process,M100,1,0
1,0,0,-2.7,0,0,GO:0001915,negative regulation of T cell mediated cytotoxicity,M100,1,0
0,1,0,0,-1.8,0,WP560,TGF beta receptor signaling,M010,1,0
1,0,0,-2.2,0,0,R-HSA-1251985,Nuclear signaling by ERBB4,M100,1,0
1,0,0,-0.89,0,0,GO:0043470,regulation of carbohydrate catabolic process,M100,1,0
0,1,0,0,-2.4,0,R-HSA-197264,Nicotinamide salvaging,M010,1,0
1,0,0,-2,0,0,GO:0032104,regulation of response to extracellular stimulus,M100,1,0
0,0,1,0,0,-0.81,GO:0071385,cellular response to glucocorticoid stimulus,M001,1,0
1,0,0,-1.6,0,0,GO:0002396,MHC protein complex assembly,M100,1,0
0,1,0,0,-1.1,0,GO:0034219,carbohydrate transmembrane transport,M010,1,0
0,0,1,0,0,-0.78,R-HSA-909733,Interferon alpha/beta signaling,M001,1,0
1,0,0,-1.1,0,0,GO:0002833,positive regulation of response to biotic stimulus,M100,1,0
1,0,0,-0.83,0,0,GO:0007160,cell-matrix adhesion,M100,1,0
1,0,0,-0.63,0,0,GO:0045620,negative regulation of lymphocyte differentiation,M100,1,0
0,1,0,0,-0.57,0,GO:0009144,purine nucleoside triphosphate metabolic process,M010,1,0
1,0,0,-1.7,0,0,GO:0060444,branching involved in mammary gland duct morphogenesis,M100,1,0
0,0,1,0,0,-1.6,GO:0002347,response to tumor cell,M001,1,0
0,0,1,0,0,-1.1,GO:0019933,cAMP-mediated signaling,M001,1,0
0,0,1,0,0,-1.5,WP619,Type II interferon signaling,M001,1,0
0,0,1,0,0,-2.6,GO:0014741,negative regulation of muscle hypertrophy,M001,1,0
0,0,1,0,0,-2.4,GO:0061052,negative regulation of cell growth involved in cardiac muscle cell development,M001,1,0
0,1,0,0,-1.7,0,R-HSA-1483255,PI Metabolism,M010,1,0
1,0,0,-0.95,0,0,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,M100,1,0
1,0,0,-1.3,0,0,GO:0006984,ER-nucleus signaling pathway,M100,1,0
1,0,0,-0.89,0,0,GO:0044773,mitotic DNA damage checkpoint signaling,M100,1,0
0,1,0,0,-1.2,0,GO:0043954,cellular component maintenance,M010,1,0
0,0,1,0,0,-2,GO:0140888,interferon-mediated signaling pathway,M001,1,0
0,1,0,0,-2.9,0,GO:0060644,mammary gland epithelial cell differentiation,M010,1,0
0,1,0,0,-2.2,0,M193,PID NEPHRIN NEPH1 PATHWAY,M010,1,0
1,0,0,-2.7,0,0,GO:0002483,antigen processing and presentation of endogenous peptide antigen,M100,1,0
0,1,0,0,-2.1,0,GO:0002279,mast cell activation involved in immune response,M010,1,0
1,0,0,-1.9,0,0,GO:0007006,mitochondrial membrane organization,M100,1,0
0,0,1,0,0,-1.1,GO:0051898,negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M001,1,0
0,1,0,0,-0.84,0,GO:0045995,regulation of embryonic development,M010,1,0
1,0,0,-1.3,0,0,GO:0035335,peptidyl-tyrosine dephosphorylation,M100,1,0
0,0,1,0,0,-2.3,GO:1902532,negative regulation of intracellular signal transduction,M001,1,0
1,0,0,-2.1,0,0,M5885,NABA MATRISOME ASSOCIATED,M100,1,0
1,0,0,-0.63,0,0,GO:0070542,response to fatty acid,M100,1,0
0,1,0,0,-0.85,0,R-HSA-9006936,Signaling by TGFB family members,M010,1,0
1,0,0,-3.2,0,0,WP3657,Hematopoietic stem cell gene regulation by GABP alpha beta complex,M100,1,0
0,0,1,0,0,-1.3,GO:0051090,regulation of DNA-binding transcription factor activity,M001,1,0
0,0,1,0,0,-0.78,hsa05034,Alcoholism,M001,1,0
0,1,0,0,-1.6,0,GO:0030540,female genitalia development,M010,1,0
0,0,1,0,0,-1.5,GO:0008366,axon ensheathment,M001,1,0
0,1,0,0,-1.4,0,WP5088,Prostaglandin signaling,M010,1,0
1,0,0,-1.4,0,0,R-HSA-69236,G1 Phase,M100,1,0
0,0,1,0,0,-0.94,GO:0045732,positive regulation of protein catabolic process,M001,1,0
0,0,1,0,0,-1.1,R-HSA-8940973,RUNX2 regulates osteoblast differentiation,M001,1,0
1,0,0,-1.7,0,0,WP3844,PI3K AKT mTOR signaling pathway and therapeutic opportunities in prostate cancer,M100,1,0
0,1,0,0,-2.5,0,GO:0006979,response to oxidative stress,M010,1,0
1,0,0,-0.78,0,0,GO:0043271,negative regulation of monoatomic ion transport,M100,1,0
0,0,1,0,0,-1.4,hsa05322,Systemic lupus erythematosus,M001,1,0
0,0,1,0,0,-1,GO:1903825,organic acid transmembrane transport,M001,1,0
0,0,1,0,0,-3.1,GO:0003272,endocardial cushion formation,M001,1,0
1,0,0,-0.99,0,0,GO:0010656,negative regulation of muscle cell apoptotic process,M100,1,0
1,0,0,-1.3,0,0,GO:0035306,positive regulation of dephosphorylation,M100,1,0
0,1,0,0,-0.75,0,R-HSA-4839726,Chromatin organization,M010,1,0
0,1,0,0,-0.99,0,R-HSA-163685,Integration of energy metabolism,M010,1,0
1,0,0,-0.75,0,0,GO:0072078,nephron tubule morphogenesis,M100,1,0
0,1,0,0,-1.9,0,GO:0048488,synaptic vesicle endocytosis,M010,1,0
1,0,0,-1.6,0,0,WP1403,AMP activated protein kinase signaling,M100,1,0
1,0,0,-1.1,0,0,GO:0031570,DNA integrity checkpoint signaling,M100,1,0
1,0,0,-1.6,0,0,GO:0044819,mitotic G1/S transition checkpoint signaling,M100,1,0
1,0,0,-1.3,0,0,GO:0051926,negative regulation of calcium ion transport,M100,1,0
1,0,0,-1.2,0,0,GO:0010662,regulation of striated muscle cell apoptotic process,M100,1,0
0,0,1,0,0,-0.57,GO:0098656,monoatomic anion transmembrane transport,M001,1,0
0,0,1,0,0,-1.4,M36,PID IL27 PATHWAY,M001,1,0
0,1,0,0,-1.8,0,GO:0050708,regulation of protein secretion,M010,1,0
0,1,0,0,-2.7,0,GO:0043547,positive regulation of GTPase activity,M010,1,0
1,0,0,-1.2,0,0,GO:0071496,cellular response to external stimulus,M100,1,0
0,0,1,0,0,-1.3,GO:0048596,embryonic camera-type eye morphogenesis,M001,1,0
1,0,0,-0.95,0,0,GO:0016241,regulation of macroautophagy,M100,1,0
1,0,0,-1.9,0,0,GO:0098901,regulation of cardiac muscle cell action potential,M100,1,0
1,0,0,-0.69,0,0,R-HSA-9013026,RHOB GTPase cycle,M100,1,0
1,0,0,-2.7,0,0,GO:0061438,renal system vasculature morphogenesis,M100,1,0
0,0,1,0,0,-0.83,GO:1902904,negative regulation of supramolecular fiber organization,M001,1,0
1,0,0,-2.6,0,0,GO:0009991,response to extracellular stimulus,M100,1,0
0,1,0,0,-2.4,0,GO:0043087,regulation of GTPase activity,M010,1,0
1,0,0,-1.2,0,0,WP4963,p53 transcriptional gene network,M100,1,0
0,0,1,0,0,-1.8,GO:0110053,regulation of actin filament organization,M001,1,0
1,0,0,-2.3,0,0,M66,PID MYC ACTIV PATHWAY,M100,1,0
0,0,1,0,0,-1.2,GO:0050974,detection of mechanical stimulus involved in sensory perception,M001,1,0
1,0,0,-1.2,0,0,WP4534,Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms,M100,1,0
0,0,1,0,0,-1.3,GO:0000724,double-strand break repair via homologous recombination,M001,1,0
1,0,0,-1.3,0,0,GO:0014812,muscle cell migration,M100,1,0
0,1,0,0,-1.9,0,GO:0007628,adult walking behavior,M010,1,0
1,0,0,-0.69,0,0,WP4754,IL 18 signaling pathway,M100,1,0
1,0,0,-1.9,0,0,GO:0006809,nitric oxide biosynthetic process,M100,1,0
0,0,1,0,0,-1.1,GO:0035710,"CD4-positive, alpha-beta T cell activation",M001,1,0
1,0,0,-0.98,0,0,R-HSA-3700989,Transcriptional Regulation by TP53,M100,1,0
1,0,0,-1.6,0,0,R-HSA-5655302,Signaling by FGFR1 in disease,M100,1,0
1,0,0,-1.3,0,0,GO:0051345,positive regulation of hydrolase activity,M100,1,0
1,0,0,-1.2,0,0,GO:0001824,blastocyst development,M100,1,0
0,0,1,0,0,-1.6,GO:0045923,positive regulation of fatty acid metabolic process,M001,1,0
1,0,0,-1.6,0,0,GO:0048599,oocyte development,M100,1,0
0,1,0,0,-0.69,0,GO:0014003,oligodendrocyte development,M010,1,0
1,0,0,-2.2,0,0,R-HSA-9703465,Signaling by FLT3 fusion proteins,M100,1,0
0,1,0,0,-0.99,0,GO:2000036,regulation of stem cell population maintenance,M010,1,0
1,0,0,-1,0,0,WP2817,Mammary gland development pathway Pregnancy and lactation Stage 3 of 4,M100,1,0
1,0,0,-1.1,0,0,GO:2000045,regulation of G1/S transition of mitotic cell cycle,M100,1,0
0,1,0,0,-0.54,0,R-HSA-1980143,Signaling by NOTCH1,M010,1,0
0,1,0,0,-2.4,0,GO:0061049,cell growth involved in cardiac muscle cell development,M010,1,0
0,1,0,0,-2,0,GO:0006661,phosphatidylinositol biosynthetic process,M010,1,0
0,0,1,0,0,-0.81,GO:0010883,regulation of lipid storage,M001,1,0
0,0,1,0,0,-1,R-HSA-166658,Complement cascade,M001,1,0
0,0,1,0,0,-1.9,GO:0097152,mesenchymal cell apoptotic process,M001,1,0
0,0,1,0,0,-0.7,GO:0019229,regulation of vasoconstriction,M001,1,0
1,0,0,-0.75,0,0,GO:0002720,positive regulation of cytokine production involved in immune response,M100,1,0
0,0,1,0,0,-1,R-HSA-8874081,MET activates PTK2 signaling,M001,1,0
1,0,0,-1.5,0,0,GO:0070228,regulation of lymphocyte apoptotic process,M100,1,0
0,1,0,0,-1.5,0,GO:0080164,regulation of nitric oxide metabolic process,M010,1,0
0,0,1,0,0,-1.6,GO:1990806,ligand-gated ion channel signaling pathway,M001,1,0
0,1,0,0,-0.64,0,hsa04640,Hematopoietic cell lineage,M010,1,0
1,0,0,-1.6,0,0,GO:0060041,retina development in camera-type eye,M100,1,0
0,1,0,0,-1.4,0,R-HSA-3214815,HDACs deacetylate histones,M010,1,0
0,1,0,0,-1,0,GO:0032733,positive regulation of interleukin-10 production,M010,1,0
1,0,0,-1.1,0,0,WP707,DNA damage response,M100,1,0
0,1,0,0,-1.7,0,GO:0090659,walking behavior,M010,1,0
1,0,0,-1.1,0,0,GO:0016125,sterol metabolic process,M100,1,0
0,1,0,0,-2,0,hsa04370,VEGF signaling pathway,M010,1,0
0,1,0,0,-1.4,0,GO:0045773,positive regulation of axon extension,M010,1,0
1,0,0,-1.4,0,0,GO:0046902,regulation of mitochondrial membrane permeability,M100,1,0
0,1,0,0,-1.6,0,GO:0002092,positive regulation of receptor internalization,M010,1,0
1,0,0,-0.94,0,0,GO:0034110,regulation of homotypic cell-cell adhesion,M100,1,0
1,0,0,-1.2,0,0,GO:1900544,positive regulation of purine nucleotide metabolic process,M100,1,0
0,0,1,0,0,-0.85,WP5362,TAR syndrome,M001,1,0
1,0,0,-2.1,0,0,GO:0010927,cellular component assembly involved in morphogenesis,M100,1,0
0,0,1,0,0,-2.1,GO:0016444,somatic cell DNA recombination,M001,1,0
0,1,0,0,-0.8,0,GO:0090087,regulation of peptide transport,M010,1,0
1,0,0,-0.52,0,0,GO:0046467,membrane lipid biosynthetic process,M100,1,0
1,0,0,-2.2,0,0,GO:0010659,cardiac muscle cell apoptotic process,M100,1,0
0,1,0,0,-1.7,0,GO:0030859,polarized epithelial cell differentiation,M010,1,0
1,0,0,-1.7,0,0,GO:1904862,inhibitory synapse assembly,M100,1,0
0,1,0,0,-1.2,0,GO:0070252,actin-mediated cell contraction,M010,1,0
0,1,0,0,-0.57,0,GO:0019751,polyol metabolic process,M010,1,0
1,0,0,-1.5,0,0,GO:0060706,cell differentiation involved in embryonic placenta development,M100,1,0
0,0,1,0,0,-0.73,GO:0035987,endodermal cell differentiation,M001,1,0
1,0,0,-2.7,0,0,GO:0061439,kidney vasculature morphogenesis,M100,1,0
0,1,0,0,-1.1,0,GO:0032722,positive regulation of chemokine production,M010,1,0
1,0,0,-0.88,0,0,R-HSA-69275,G2/M Transition,M100,1,0
0,1,0,0,-1.9,0,hsa00910,Nitrogen metabolism,M010,1,0
0,1,0,0,-1.8,0,R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",M010,1,0
1,0,0,-1,0,0,GO:0021695,cerebellar cortex development,M100,1,0
0,0,1,0,0,-1.2,GO:0060325,face morphogenesis,M001,1,0
0,0,1,0,0,-0.91,GO:1905952,regulation of lipid localization,M001,1,0
1,0,0,-2.4,0,0,GO:0010799,regulation of peptidyl-threonine phosphorylation,M100,1,0
0,0,1,0,0,-1.1,GO:0007611,learning or memory,M001,1,0
1,0,0,-2.2,0,0,R-HSA-4090294,SUMOylation of intracellular receptors,M100,1,0
0,1,0,0,-1.7,0,GO:1902459,positive regulation of stem cell population maintenance,M010,1,0
1,0,0,-1,0,0,GO:0007595,lactation,M100,1,0
0,0,1,0,0,-1.1,R-HSA-977606,Regulation of Complement cascade,M001,1,0
1,0,0,-3.1,0,0,GO:0072104,glomerular capillary formation,M100,1,0
0,1,0,0,-1.9,0,GO:2000737,negative regulation of stem cell differentiation,M010,1,0
0,0,1,0,0,-1.9,GO:0006835,dicarboxylic acid transport,M001,1,0
0,0,1,0,0,-0.77,hsa00230,Purine metabolism,M001,1,0
0,0,1,0,0,-0.85,GO:0030199,collagen fibril organization,M001,1,0
0,0,1,0,0,-1.4,GO:0002891,positive regulation of immunoglobulin mediated immune response,M001,1,0
0,0,1,0,0,-1.4,R-HSA-2428928,IRS-related events triggered by IGF1R,M001,1,0
1,0,0,-1.4,0,0,M220,PID CASPASE PATHWAY,M100,1,0
1,0,0,-1.8,0,0,GO:0035304,regulation of protein dephosphorylation,M100,1,0
0,1,0,0,-2,0,WP3630,NAD metabolism sirtuins and aging,M010,1,0
1,0,0,-1.6,0,0,M41,PID ER NONGENOMIC PATHWAY,M100,1,0
0,0,1,0,0,-0.85,GO:0002312,B cell activation involved in immune response,M001,1,0
1,0,0,-2.2,0,0,GO:0061041,regulation of wound healing,M100,1,0
0,0,1,0,0,-2.5,GO:0001503,ossification,M001,1,0
0,1,0,0,-0.5,0,GO:0170039,proteinogenic amino acid metabolic process,M010,1,0
0,1,0,0,-0.89,0,GO:0008643,carbohydrate transport,M010,1,0
0,0,1,0,0,-1.1,GO:0051650,establishment of vesicle localization,M001,1,0
0,0,1,0,0,-0.81,GO:0002685,regulation of leukocyte migration,M001,1,0
1,0,0,-1.5,0,0,GO:0007009,plasma membrane organization,M100,1,0
1,0,0,-1.4,0,0,GO:0032535,regulation of cellular component size,M100,1,0
0,0,1,0,0,-0.83,GO:1904035,regulation of epithelial cell apoptotic process,M001,1,0
0,1,0,0,-1.5,0,GO:0006954,inflammatory response,M010,1,0
1,0,0,-0.92,0,0,WP179,Cell cycle,M100,1,0
1,0,0,-1.5,0,0,GO:0070232,regulation of T cell apoptotic process,M100,1,0
0,0,1,0,0,-0.63,R-HSA-428157,Sphingolipid metabolism,M001,1,0
1,0,0,-0.73,0,0,GO:0048477,oogenesis,M100,1,0
1,0,0,-3.6,0,0,GO:0098581,detection of external biotic stimulus,M100,1,0
0,0,1,0,0,-2.8,GO:0043433,negative regulation of DNA-binding transcription factor activity,M001,1,0
1,0,0,-1.4,0,0,R-HSA-416476,G alpha (q) signalling events,M100,1,0
0,1,0,0,-1.7,0,WP334,GPCRs class B secretin like,M010,1,0
1,0,0,-2.3,0,0,WP4758,Nephrotic syndrome,M100,1,0
1,0,0,-2.7,0,0,GO:0010543,regulation of platelet activation,M100,1,0
0,1,0,0,-1.1,0,GO:0030111,regulation of Wnt signaling pathway,M010,1,0
1,0,0,-0.63,0,0,GO:0072175,epithelial tube formation,M100,1,0
0,0,1,0,0,-0.62,GO:0062014,negative regulation of small molecule metabolic process,M001,1,0
0,0,1,0,0,-2.6,GO:0030098,lymphocyte differentiation,M001,1,0
0,0,1,0,0,-0.7,hsa04512,ECM-receptor interaction,M001,1,0
0,0,1,0,0,-1.4,GO:0050885,neuromuscular process controlling balance,M001,1,0
0,0,1,0,0,-2.1,GO:0034340,response to type I interferon,M001,1,0
1,0,0,-1.3,0,0,GO:0042742,defense response to bacterium,M100,1,0
0,0,1,0,0,-0.77,R-HSA-5083635,Defective B3GALTL causes PpS,M001,1,0
1,0,0,-0.52,0,0,GO:0071482,cellular response to light stimulus,M100,1,0
0,0,1,0,0,-1.1,GO:0007431,salivary gland development,M001,1,0
0,0,1,0,0,-0.81,GO:0002011,morphogenesis of an epithelial sheet,M001,1,0
0,1,0,0,-0.73,0,GO:0032024,positive regulation of insulin secretion,M010,1,0
0,0,1,0,0,-1.3,GO:0120035,regulation of plasma membrane bounded cell projection organization,M001,1,0
0,1,0,0,-1.3,0,GO:0006163,purine nucleotide metabolic process,M010,1,0
0,1,0,0,-1.6,0,GO:0045494,photoreceptor cell maintenance,M010,1,0
0,1,0,0,-1.6,0,GO:0002275,myeloid cell activation involved in immune response,M010,1,0
0,1,0,0,-2.4,0,GO:0034762,regulation of transmembrane transport,M010,1,0
1,0,0,-1.6,0,0,M40,PID E2F PATHWAY,M100,1,0
1,0,0,-1.6,0,0,R-HSA-1839124,FGFR1 mutant receptor activation,M100,1,0
0,0,1,0,0,-1.2,GO:0007435,salivary gland morphogenesis,M001,1,0
0,1,0,0,-1,0,M181,PID BMP PATHWAY,M010,1,0
1,0,0,-1.9,0,0,M1718,SIG IL4RECEPTOR IN B LYPHOCYTES,M100,1,0
1,0,0,-2,0,0,hsa04720,Long-term potentiation,M100,1,0
1,0,0,-1.6,0,0,GO:0045591,positive regulation of regulatory T cell differentiation,M100,1,0
0,1,0,0,-0.69,0,hsa04613,Neutrophil extracellular trap formation,M010,1,0
1,0,0,-2.2,0,0,GO:0070243,regulation of thymocyte apoptotic process,M100,1,0
0,1,0,0,-1.7,0,M175,PID ERBB2 ERBB3 PATHWAY,M010,1,0
0,0,1,0,0,-1.5,GO:0007218,neuropeptide signaling pathway,M001,1,0
0,1,0,0,-0.94,0,GO:0072676,lymphocyte migration,M010,1,0
1,0,0,-2.9,0,0,M122,PID IL2 1PATHWAY,M100,1,0
0,1,0,0,-0.74,0,GO:0010469,regulation of signaling receptor activity,M010,1,0
1,0,0,-1.4,0,0,R-HSA-9006931,Signaling by Nuclear Receptors,M100,1,0
0,1,0,0,-1.6,0,GO:0055086,nucleobase-containing small molecule metabolic process,M010,1,0
0,1,0,0,-1.7,0,WP4816,TGF beta receptor signaling in skeletal dysplasias,M010,1,0
0,1,0,0,-0.89,0,GO:1901379,regulation of potassium ion transmembrane transport,M010,1,0
0,1,0,0,-1.4,0,GO:0001570,vasculogenesis,M010,1,0
0,1,0,0,-0.66,0,GO:0060048,cardiac muscle contraction,M010,1,0
0,1,0,0,-1.9,0,M206,PID PDGFRA PATHWAY,M010,1,0
1,0,0,-2,0,0,GO:0043410,positive regulation of MAPK cascade,M100,1,0
1,0,0,-2.2,0,0,GO:0098543,detection of other organism,M100,1,0
1,0,0,-1.8,0,0,hsa04934,Cushing syndrome,M100,1,0
1,0,0,-1.2,0,0,GO:0033032,regulation of myeloid cell apoptotic process,M100,1,0
1,0,0,-1.9,0,0,GO:0098657,import into cell,M100,1,0
0,0,1,0,0,-0.72,GO:0006397,mRNA processing,M001,1,0
0,0,1,0,0,-0.85,GO:1990869,cellular response to chemokine,M001,1,0
0,1,0,0,-1.3,0,R-HSA-3000157,Laminin interactions,M010,1,0
1,0,0,-1,0,0,GO:0010935,regulation of macrophage cytokine production,M100,1,0
0,1,0,0,-1.5,0,GO:0002526,acute inflammatory response,M010,1,0
1,0,0,-2.4,0,0,GO:0050688,regulation of defense response to virus,M100,1,0
0,1,0,0,-1.6,0,GO:0046474,glycerophospholipid biosynthetic process,M010,1,0
0,1,0,0,-1.2,0,GO:0046879,hormone secretion,M010,1,0
1,0,0,-1.7,0,0,hsa04022,cGMP-PKG signaling pathway,M100,1,0
0,1,0,0,-1.5,0,GO:0061337,cardiac conduction,M010,1,0
0,1,0,0,-0.7,0,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,M010,1,0
0,1,0,0,-1.7,0,GO:0071560,cellular response to transforming growth factor beta stimulus,M010,1,0
0,0,1,0,0,-0.58,GO:0070507,regulation of microtubule cytoskeleton organization,M001,1,0
0,1,0,0,-1.3,0,M3008,NABA ECM GLYCOPROTEINS,M010,1,0
0,0,1,0,0,-0.94,GO:0050856,regulation of T cell receptor signaling pathway,M001,1,0
0,0,1,0,0,-1.9,GO:0002828,regulation of type 2 immune response,M001,1,0
1,0,0,-2.1,0,0,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,M100,1,0
0,0,1,0,0,-2,GO:0003013,circulatory system process,M001,1,0
1,0,0,-3,0,0,GO:2000178,negative regulation of neural precursor cell proliferation,M100,1,0
1,0,0,-1.5,0,0,M281,PID FAK PATHWAY,M100,1,0
0,0,1,0,0,-1.9,GO:0002920,regulation of humoral immune response,M001,1,0
1,0,0,-1.8,0,0,WP3303,RAC1 PAK1 p38 MMP2 pathway,M100,1,0
1,0,0,-1.3,0,0,R-HSA-195258,RHO GTPase Effectors,M100,1,0
0,1,0,0,-1.3,0,R-HSA-1483257,Phospholipid metabolism,M010,1,0
1,0,0,-1.1,0,0,GO:0060562,epithelial tube morphogenesis,M100,1,0
1,0,0,-1.6,0,0,R-HSA-9682385,FLT3 signaling in disease,M100,1,0
1,0,0,-0.64,0,0,GO:0031396,regulation of protein ubiquitination,M100,1,0
0,1,0,0,-1,0,GO:0032735,positive regulation of interleukin-12 production,M010,1,0
1,0,0,-0.63,0,0,GO:0042445,hormone metabolic process,M100,1,0
1,0,0,-2.4,0,0,GO:0071350,cellular response to interleukin-15,M100,1,0
1,0,0,-1.3,0,0,GO:1903318,negative regulation of protein maturation,M100,1,0
0,0,1,0,0,-1.9,GO:2000679,positive regulation of transcription regulatory region DNA binding,M001,1,0
1,0,0,-1.1,0,0,GO:0001952,regulation of cell-matrix adhesion,M100,1,0
0,0,1,0,0,-1.5,GO:0007272,ensheathment of neurons,M001,1,0
0,0,1,0,0,-0.55,R-HSA-1442490,Collagen degradation,M001,1,0
0,0,1,0,0,-1.3,R-HSA-74751,Insulin receptor signalling cascade,M001,1,0
1,0,0,-1.6,0,0,GO:0060416,response to growth hormone,M100,1,0
0,1,0,0,-1.3,0,GO:0046390,ribose phosphate biosynthetic process,M010,1,0
0,1,0,0,-2.2,0,GO:0090183,regulation of kidney development,M010,1,0
1,0,0,-1.3,0,0,GO:0031589,cell-substrate adhesion,M100,1,0
1,0,0,-1.1,0,0,GO:0045807,positive regulation of endocytosis,M100,1,0
1,0,0,-1.6,0,0,hsa04217,Necroptosis,M100,1,0
1,0,0,-1.4,0,0,R-HSA-69231,Cyclin D associated events in G1,M100,1,0
1,0,0,-0.99,0,0,R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,M100,1,0
1,0,0,-1.6,0,0,GO:0097194,execution phase of apoptosis,M100,1,0
0,0,1,0,0,-2.6,GO:0010453,regulation of cell fate commitment,M001,1,0
0,1,0,0,-0.52,0,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,M010,1,0
0,1,0,0,-1.3,0,GO:0035886,vascular associated smooth muscle cell differentiation,M010,1,0
0,1,0,0,-0.72,0,GO:0002688,regulation of leukocyte chemotaxis,M010,1,0
0,1,0,0,-0.57,0,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,M010,1,0
1,0,0,-1.5,0,0,hsa05219,Bladder cancer,M100,1,0
0,1,0,0,-1.6,0,GO:0014009,glial cell proliferation,M010,1,0
0,0,1,0,0,-1.9,GO:0030219,megakaryocyte differentiation,M001,1,0
1,0,0,-0.99,0,0,GO:0071887,leukocyte apoptotic process,M100,1,0
0,0,1,0,0,-1.1,GO:0036075,replacement ossification,M001,1,0
0,1,0,0,-0.65,0,M2,PID SMAD2 3NUCLEAR PATHWAY,M010,1,0
0,0,1,0,0,-1.9,WP4875,Disruption of postsynaptic signaling by CNV,M001,1,0
1,0,0,-1.6,0,0,GO:1903034,regulation of response to wounding,M100,1,0
0,0,1,0,0,-1.1,R-HSA-8878171,Transcriptional regulation by RUNX1,M001,1,0
0,0,1,0,0,-0.86,GO:0150104,transport across blood-brain barrier,M001,1,0
0,0,1,0,0,-0.83,GO:0009952,anterior/posterior pattern specification,M001,1,0
0,1,0,0,-1.6,0,WP712,Estrogen signaling pathway,M010,1,0
1,0,0,-0.5,0,0,GO:0001843,neural tube closure,M100,1,0
0,1,0,0,-1.4,0,GO:0072678,T cell migration,M010,1,0
0,0,1,0,0,-0.58,GO:0017148,negative regulation of translation,M001,1,0
0,1,0,0,-0.73,0,GO:0043266,regulation of potassium ion transport,M010,1,0
1,0,0,-1.6,0,0,GO:0046545,development of primary female sexual characteristics,M100,1,0
0,0,1,0,0,-1.1,GO:0060323,head morphogenesis,M001,1,0
0,0,1,0,0,-1.1,GO:1904645,response to amyloid-beta,M001,1,0
1,0,0,-1.4,0,0,GO:0006694,steroid biosynthetic process,M100,1,0
1,0,0,-3.1,0,0,GO:0070669,response to interleukin-2,M100,1,0
1,0,0,-1.6,0,0,GO:0051151,negative regulation of smooth muscle cell differentiation,M100,1,0
1,0,0,-0.81,0,0,GO:0000075,cell cycle checkpoint signaling,M100,1,0
0,0,1,0,0,-1.2,GO:1905562,regulation of vascular endothelial cell proliferation,M001,1,0
0,1,0,0,-0.84,0,R-HSA-422356,Regulation of insulin secretion,M010,1,0
1,0,0,-0.5,0,0,GO:0043525,positive regulation of neuron apoptotic process,M100,1,0
1,0,0,-1.7,0,0,GO:0009648,photoperiodism,M100,1,0
1,0,0,-1.7,0,0,GO:0062012,regulation of small molecule metabolic process,M100,1,0
0,0,1,0,0,-0.52,GO:0001706,endoderm formation,M001,1,0
1,0,0,-0.69,0,0,WP2586,Aryl hydrocarbon receptor pathway,M100,1,0
0,0,1,0,0,-1.7,R-HSA-194315,Signaling by Rho GTPases,M001,1,0
1,0,0,-2.3,0,0,GO:0002831,regulation of response to biotic stimulus,M100,1,0
0,1,0,0,-1,0,GO:0048675,axon extension,M010,1,0
0,1,0,0,-1.6,0,GO:0021515,cell differentiation in spinal cord,M010,1,0
1,0,0,-0.63,0,0,R-HSA-9820952,Respiratory Syncytial Virus Infection Pathway,M100,1,0
1,0,0,-3.4,0,0,GO:0055003,cardiac myofibril assembly,M100,1,0
0,1,0,0,-1.1,0,GO:1901568,fatty acid derivative metabolic process,M010,1,0
0,0,1,0,0,-3.8,GO:0048821,erythrocyte development,M001,1,0
0,1,0,0,-2.5,0,GO:0043116,negative regulation of vascular permeability,M010,1,0
1,0,0,-0.69,0,0,R-HSA-9730414,MITF-M-regulated melanocyte development,M100,1,0
0,1,0,0,-1.7,0,GO:0002274,myeloid leukocyte activation,M010,1,0
1,0,0,-2,0,0,WP530,Cytokines and inflammatory response,M100,1,0
0,1,0,0,-1.4,0,GO:0001562,response to protozoan,M010,1,0
1,0,0,-2,0,0,GO:0071378,cellular response to growth hormone stimulus,M100,1,0
1,0,0,-1.8,0,0,GO:0016310,phosphorylation,M100,1,0
0,0,1,0,0,-2.4,GO:0002262,myeloid cell homeostasis,M001,1,0
1,0,0,-1.1,0,0,WP45,G1 to S cell cycle control,M100,1,0
0,1,0,0,-0.76,0,GO:0043300,regulation of leukocyte degranulation,M010,1,0
0,1,0,0,-0.94,0,GO:0046470,phosphatidylcholine metabolic process,M010,1,0
0,0,1,0,0,-2.2,GO:0098868,bone growth,M001,1,0
0,1,0,0,-5,0,GO:0030855,epithelial cell differentiation,M010,1,0
1,0,0,-3.1,0,0,R-HSA-9009391,Extra-nuclear estrogen signaling,M100,1,0
1,0,0,-3.1,0,0,R-HSA-9669938,Signaling by KIT in disease,M100,1,0
1,0,0,-1,0,0,GO:0034502,protein localization to chromosome,M100,1,0
1,0,0,-1.7,0,0,GO:0002643,regulation of tolerance induction,M100,1,0
1,0,0,-1.8,0,0,GO:0006942,regulation of striated muscle contraction,M100,1,0
0,1,0,0,-2,0,M158,PID INTEGRIN4 PATHWAY,M010,1,0
0,1,0,0,-1.8,0,WP5352,10q11 21q11 23 copy number variation syndrome,M010,1,0
1,0,0,-1.3,0,0,GO:0008584,male gonad development,M100,1,0
0,0,1,0,0,-0.52,GO:1903052,positive regulation of proteolysis involved in protein catabolic process,M001,1,0
0,0,1,0,0,-1,GO:0034249,negative regulation of amide metabolic process,M001,1,0
0,0,1,0,0,-0.85,R-HSA-8941326,RUNX2 regulates bone development,M001,1,0
1,0,0,-1.3,0,0,GO:1902806,regulation of cell cycle G1/S phase transition,M100,1,0
0,1,0,0,-0.8,0,GO:0032409,regulation of transporter activity,M010,1,0
1,0,0,-2.7,0,0,R-HSA-8985947,Interleukin-9 signaling,M100,1,0
0,1,0,0,-0.88,0,hsa05152,Tuberculosis,M010,1,0
1,0,0,-1.5,0,0,GO:0030539,male genitalia development,M100,1,0
1,0,0,-1.1,0,0,GO:0032760,positive regulation of tumor necrosis factor production,M100,1,0
0,1,0,0,-1.9,0,GO:0046854,phosphatidylinositol phosphate biosynthetic process,M010,1,0
1,0,0,-2.7,0,0,hsa04917,Prolactin signaling pathway,M100,1,0
1,0,0,-1.9,0,0,WP2814,Mammary gland development pathway Puberty Stage 2 of 4,M100,1,0
0,0,1,0,0,-0.96,GO:0050906,detection of stimulus involved in sensory perception,M001,1,0
0,0,1,0,0,-2.6,GO:0035249,"synaptic transmission, glutamatergic",M001,1,0
0,0,1,0,0,-0.92,GO:0070555,response to interleukin-1,M001,1,0
1,0,0,-0.95,0,0,R-HSA-5684996,MAPK1/MAPK3 signaling,M100,1,0
0,1,0,0,-1.6,0,GO:1903672,positive regulation of sprouting angiogenesis,M010,1,0
0,0,1,0,0,-1,GO:1905039,carboxylic acid transmembrane transport,M001,1,0
0,1,0,0,-0.64,0,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,M010,1,0
1,0,0,-0.6,0,0,hsa04925,Aldosterone synthesis and secretion,M100,1,0
0,1,0,0,-0.71,0,GO:0010977,negative regulation of neuron projection development,M010,1,0
1,0,0,-1.6,0,0,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,M100,1,0
0,1,0,0,-0.69,0,GO:0045921,positive regulation of exocytosis,M010,1,0
1,0,0,-1.6,0,0,GO:0031571,mitotic G1 DNA damage checkpoint signaling,M100,1,0
0,0,1,0,0,-1.2,GO:0050779,RNA destabilization,M001,1,0
1,0,0,-0.98,0,0,R-HSA-157118,Signaling by NOTCH,M100,1,0
0,0,1,0,0,-2,GO:0009612,response to mechanical stimulus,M001,1,0
1,0,0,-0.99,0,0,WP4949,16p11 2 proximal deletion syndrome,M100,1,0
0,1,0,0,-1.9,0,WP4481,Resistin as a regulator of inflammation,M010,1,0
1,0,0,-1,0,0,GO:0034612,response to tumor necrosis factor,M100,1,0
0,1,0,0,-1.1,0,GO:0071241,cellular response to inorganic substance,M010,1,0
1,0,0,-0.88,0,0,GO:2001242,regulation of intrinsic apoptotic signaling pathway,M100,1,0
1,0,0,-1.2,0,0,GO:0032729,positive regulation of type II interferon production,M100,1,0
1,0,0,-1.5,0,0,GO:0043534,blood vessel endothelial cell migration,M100,1,0
0,0,1,0,0,-3.5,GO:0021700,developmental maturation,M001,1,0
0,1,0,0,-0.66,0,GO:0002793,positive regulation of peptide secretion,M010,1,0
1,0,0,-1.7,0,0,GO:0140894,endolysosomal toll-like receptor signaling pathway,M100,1,0
0,1,0,0,-1.3,0,GO:0070168,negative regulation of biomineral tissue development,M010,1,0
0,1,0,0,-1.9,0,WP2795,Cardiac hypertrophic response,M010,1,0
1,0,0,-0.89,0,0,WP5300,TROP2 regulatory signaling,M100,1,0
0,0,1,0,0,-4.3,GO:0060348,bone development,M001,1,0
1,0,0,-1.2,0,0,GO:0006493,protein O-linked glycosylation,M100,1,0
0,0,1,0,0,-0.85,GO:0006766,vitamin metabolic process,M001,1,0
0,1,0,0,-1.5,0,R-HSA-2871796,FCERI mediated MAPK activation,M010,1,0
0,0,1,0,0,-0.94,GO:0014855,striated muscle cell proliferation,M001,1,0
0,0,1,0,0,-0.83,GO:0009582,detection of abiotic stimulus,M001,1,0
1,0,0,-1.1,0,0,WP4542,Leukocyte intrinsic Hippo pathway functions,M100,1,0
1,0,0,-0.72,0,0,GO:0061053,somite development,M100,1,0
0,0,1,0,0,-1.1,GO:0150077,regulation of neuroinflammatory response,M001,1,0
0,0,1,0,0,-0.6,R-HSA-381119,Unfolded Protein Response (UPR),M001,1,0
1,0,0,-1,0,0,GO:0010212,response to ionizing radiation,M100,1,0
1,0,0,-2.3,0,0,GO:0033135,regulation of peptidyl-serine phosphorylation,M100,1,0
1,0,0,-1.2,0,0,GO:0010721,negative regulation of cell development,M100,1,0
0,0,1,0,0,-1.7,GO:0017156,calcium-ion regulated exocytosis,M001,1,0
1,0,0,-1.4,0,0,WP4673,Male infertility,M100,1,0
0,0,1,0,0,-0.72,GO:0014020,primary neural tube formation,M001,1,0
1,0,0,-4.8,0,0,R-HSA-8983432,Interleukin-15 signaling,M100,1,0
1,0,0,-0.85,0,0,hsa05131,Shigellosis,M100,1,0
1,0,0,-2.2,0,0,M271,PID PI3K PLC TRK PATHWAY,M100,1,0
0,1,0,0,-1.4,0,GO:0001738,morphogenesis of a polarized epithelium,M010,1,0
0,1,0,0,-2,0,GO:0001936,regulation of endothelial cell proliferation,M010,1,0
1,0,0,-1.5,0,0,GO:0046640,regulation of alpha-beta T cell proliferation,M100,1,0
1,0,0,-2,0,0,GO:0007548,sex differentiation,M100,1,0
1,0,0,-0.94,0,0,GO:0044843,cell cycle G1/S phase transition,M100,1,0
0,0,1,0,0,-1.1,GO:2000772,regulation of cellular senescence,M001,1,0
0,1,0,0,-0.91,0,GO:0046434,organophosphate catabolic process,M010,1,0
1,0,0,-0.81,0,0,GO:2001257,regulation of cation channel activity,M100,1,0
1,0,0,-0.91,0,0,GO:0050810,regulation of steroid biosynthetic process,M100,1,0
0,0,1,0,0,-1.1,GO:0042552,myelination,M001,1,0
0,1,0,0,-1.2,0,GO:1903305,regulation of regulated secretory pathway,M010,1,0
1,0,0,-0.99,0,0,WP2873,Aryl hydrocarbon receptor pathway,M100,1,0
1,0,0,-2.1,0,0,GO:0002708,positive regulation of lymphocyte mediated immunity,M100,1,0
1,0,0,-0.68,0,0,GO:1902106,negative regulation of leukocyte differentiation,M100,1,0
0,0,1,0,0,-0.69,GO:1990823,response to leukemia inhibitory factor,M001,1,0
1,0,0,-1.2,0,0,GO:0045824,negative regulation of innate immune response,M100,1,0
0,1,0,0,-0.57,0,GO:0046887,positive regulation of hormone secretion,M010,1,0
1,0,0,-2.2,0,0,GO:0060707,trophoblast giant cell differentiation,M100,1,0
1,0,0,-0.93,0,0,hsa04371,Apelin signaling pathway,M100,1,0
1,0,0,-1.3,0,0,M87,PID LKB1 PATHWAY,M100,1,0
0,1,0,0,-1.4,0,GO:0086091,regulation of heart rate by cardiac conduction,M010,1,0
1,0,0,-0.98,0,0,GO:2001234,negative regulation of apoptotic signaling pathway,M100,1,0
0,1,0,0,-1.2,0,GO:1903828,negative regulation of protein localization,M010,1,0
0,0,1,0,0,-0.7,R-HSA-3781865,Diseases of glycosylation,M001,1,0
0,1,0,0,-3.7,0,GO:0031175,neuron projection development,M010,1,0
0,0,1,0,0,-3,WP2032,Thyroid stimulating hormone TSH signaling pathway,M001,1,0
1,0,0,-3.9,0,0,M1315,SIG PIP3 SIGNALING IN B LYMPHOCYTES,M100,1,0
0,1,0,0,-1.4,0,WP4211,Transcriptional cascade regulating adipogenesis,M010,1,0
0,0,1,0,0,-0.85,GO:1990868,response to chemokine,M001,1,0
1,0,0,-1,0,0,GO:0090330,regulation of platelet aggregation,M100,1,0
0,1,0,0,-2.7,0,GO:0071679,commissural neuron axon guidance,M010,1,0
0,1,0,0,-0.8,0,GO:0006879,intracellular iron ion homeostasis,M010,1,0
0,1,0,0,-1.3,0,hsa04664,Fc epsilon RI signaling pathway,M010,1,0
1,0,0,-1.4,0,0,hsa04913,Ovarian steroidogenesis,M100,1,0
0,0,1,0,0,-1.7,GO:0016447,somatic recombination of immunoglobulin gene segments,M001,1,0
1,0,0,-0.93,0,0,WP4217,Ebola virus infection in host,M100,1,0
1,0,0,-2.1,0,0,GO:0048511,rhythmic process,M100,1,0
1,0,0,-3,0,0,M50,PID PTP1B PATHWAY,M100,1,0
1,0,0,-1.6,0,0,GO:0050818,regulation of coagulation,M100,1,0
0,0,1,0,0,-0.89,GO:0046620,regulation of organ growth,M001,1,0
1,0,0,-1.2,0,0,GO:0060291,long-term synaptic potentiation,M100,1,0
0,0,1,0,0,-1.1,GO:0001958,endochondral ossification,M001,1,0
0,0,1,0,0,-0.85,M8,PID ENDOTHELIN PATHWAY,M001,1,0
1,0,0,-1.4,0,0,GO:0046209,nitric oxide metabolic process,M100,1,0
1,0,0,-3,0,0,GO:0055002,striated muscle cell development,M100,1,0
1,0,0,-1.7,0,0,GO:0046661,male sex differentiation,M100,1,0
1,0,0,-2,0,0,GO:0010559,regulation of glycoprotein biosynthetic process,M100,1,0
0,0,1,0,0,-1.3,GO:0036293,response to decreased oxygen levels,M001,1,0
1,0,0,-0.64,0,0,GO:1902115,regulation of organelle assembly,M100,1,0
0,1,0,0,-0.69,0,hsa04727,GABAergic synapse,M010,1,0
0,1,0,0,-0.69,0,GO:0007586,digestion,M010,1,0
1,0,0,-0.81,0,0,R-HSA-983705,Signaling by the B Cell Receptor (BCR),M100,1,0
1,0,0,-0.94,0,0,GO:0070229,negative regulation of lymphocyte apoptotic process,M100,1,0
0,1,0,0,-0.69,0,GO:0060976,coronary vasculature development,M010,1,0
0,1,0,0,-1.9,0,WP5036,Angiotensin II receptor type 1 pathway,M010,1,0
0,0,1,0,0,-1.1,GO:0034248,regulation of amide metabolic process,M001,1,0
0,1,0,0,-0.72,0,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,M010,1,0
0,0,1,0,0,-1.9,GO:0061050,regulation of cell growth involved in cardiac muscle cell development,M001,1,0
0,0,1,0,0,-1.6,GO:0008360,regulation of cell shape,M001,1,0
1,0,0,-1.9,0,0,R-HSA-418038,Nucleotide-like (purinergic) receptors,M100,1,0
0,1,0,0,-0.99,0,GO:0061097,regulation of protein tyrosine kinase activity,M010,1,0
1,0,0,-1.2,0,0,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,M100,1,0
1,0,0,-1,0,0,GO:0042462,eye photoreceptor cell development,M100,1,0
0,0,1,0,0,-2.7,GO:0043065,positive regulation of apoptotic process,M001,1,0
0,1,0,0,-0.66,0,GO:0070169,positive regulation of biomineral tissue development,M010,1,0
1,0,0,-1.2,0,0,GO:0002260,lymphocyte homeostasis,M100,1,0
1,0,0,-1.5,0,0,GO:0042770,signal transduction in response to DNA damage,M100,1,0
1,0,0,-0.85,0,0,M17,PID NOTCH PATHWAY,M100,1,0
0,1,0,0,-0.6,0,hsa04713,Circadian entrainment,M010,1,0
0,0,1,0,0,-1.3,GO:0019722,calcium-mediated signaling,M001,1,0
0,1,0,0,-2.4,0,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,M010,1,0
0,1,0,0,-0.85,0,GO:0006813,potassium ion transport,M010,1,0
0,0,1,0,0,-1.5,GO:0002889,regulation of immunoglobulin mediated immune response,M001,1,0
0,1,0,0,-1.4,0,WP3413,NOTCH1 regulation of endothelial cell calcification,M010,1,0
0,1,0,0,-3.4,0,GO:0000902,cell morphogenesis,M010,1,0
0,1,0,0,-0.63,0,GO:0009199,ribonucleoside triphosphate metabolic process,M010,1,0
1,0,0,-1.4,0,0,WP1742,TP53 network,M100,1,0
0,0,1,0,0,-1.2,GO:0031016,pancreas development,M001,1,0
0,1,0,0,-2.2,0,GO:0090630,activation of GTPase activity,M010,1,0
1,0,0,-1.3,0,0,GO:0007584,response to nutrient,M100,1,0
0,1,0,0,-1.5,0,WP313,Hepatocyte growth factor receptor signaling,M010,1,0
0,1,0,0,-1.6,0,R-HSA-9683701,Translation of Structural Proteins,M010,1,0
1,0,0,-0.7,0,0,R-HSA-1500931,Cell-Cell communication,M100,1,0
1,0,0,-0.78,0,0,GO:0034103,regulation of tissue remodeling,M100,1,0
1,0,0,-1.8,0,0,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,M100,1,0
0,1,0,0,-1.7,0,GO:0010951,negative regulation of endopeptidase activity,M010,1,0
1,0,0,-1.8,0,0,GO:2001233,regulation of apoptotic signaling pathway,M100,1,0
0,1,0,0,-0.74,0,GO:0001508,action potential,M010,1,0
0,0,1,0,0,-1.8,GO:0019724,B cell mediated immunity,M001,1,0
0,0,1,0,0,-1.9,GO:0034505,tooth mineralization,M001,1,0
0,0,1,0,0,-1.2,GO:0051051,negative regulation of transport,M001,1,0
0,1,0,0,-2,0,R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,M010,1,0
1,0,0,-0.85,0,0,GO:0033627,cell adhesion mediated by integrin,M100,1,0
0,0,1,0,0,-2.7,GO:0021846,cell proliferation in forebrain,M001,1,0
0,1,0,0,-1.6,0,GO:0045017,glycerolipid biosynthetic process,M010,1,0
0,1,0,0,-1.7,0,WP5052,Nephrogenesis,M010,1,0
0,0,1,0,0,-1,GO:0031110,regulation of microtubule polymerization or depolymerization,M001,1,0
0,1,0,0,-1.6,0,GO:0019934,cGMP-mediated signaling,M010,1,0
1,0,0,-1,0,0,GO:0032732,positive regulation of interleukin-1 production,M100,1,0
1,0,0,-1.8,0,0,WP2332,Interleukin 11 signaling pathway,M100,1,0
0,1,0,0,-2.3,0,hsa00562,Inositol phosphate metabolism,M010,1,0
0,1,0,0,-1.8,0,GO:2000117,negative regulation of cysteine-type endopeptidase activity,M010,1,0
0,1,0,0,-1.3,0,R-HSA-195721,Signaling by WNT,M010,1,0
1,0,0,-0.89,0,0,GO:0044774,mitotic DNA integrity checkpoint signaling,M100,1,0
1,0,0,-0.52,0,0,GO:0045670,regulation of osteoclast differentiation,M100,1,0
0,0,1,0,0,-1.5,GO:0006302,double-strand break repair,M001,1,0
1,0,0,-0.78,0,0,GO:0046889,positive regulation of lipid biosynthetic process,M100,1,0
1,0,0,-3.8,0,0,M234,PID IL2 STAT5 PATHWAY,M100,1,0
0,0,1,0,0,-1.3,GO:0060349,bone morphogenesis,M001,1,0
0,0,1,0,0,-1.4,GO:0002053,positive regulation of mesenchymal cell proliferation,M001,1,0
0,0,1,0,0,-1.3,GO:0009896,positive regulation of catabolic process,M001,1,0
0,0,1,0,0,-2.9,GO:0010463,mesenchymal cell proliferation,M001,1,0
1,0,0,-1.4,0,0,GO:0009247,glycolipid biosynthetic process,M100,1,0
1,0,0,-1.1,0,0,WP1530,miRNA regulation of DNA damage response,M100,1,0
0,1,0,0,-0.6,0,GO:0090497,mesenchymal cell migration,M010,1,0
0,1,0,0,-0.88,0,GO:1905475,regulation of protein localization to membrane,M010,1,0
0,0,1,0,0,-1,GO:0050869,negative regulation of B cell activation,M001,1,0
1,0,0,-2.7,0,0,GO:0001542,ovulation from ovarian follicle,M100,1,0
0,1,0,0,-3.1,0,WP3943,Robo4 and VEGF signaling pathways crosstalk,M010,1,0
1,0,0,-3.1,0,0,GO:0033138,positive regulation of peptidyl-serine phosphorylation,M100,1,0
0,1,0,0,-1.6,0,WP4564,Neural crest cell migration during development,M010,1,0
0,1,0,0,-2.7,0,GO:0060487,lung epithelial cell differentiation,M010,1,0
1,0,0,-0.94,0,0,GO:0007338,single fertilization,M100,1,0
1,0,0,-1.7,0,0,GO:1900046,regulation of hemostasis,M100,1,0
0,1,0,0,-1.8,0,GO:0016358,dendrite development,M010,1,0
0,1,0,0,-0.84,0,GO:0010256,endomembrane system organization,M010,1,0
1,0,0,-2.2,0,0,GO:0046641,positive regulation of alpha-beta T cell proliferation,M100,1,0
1,0,0,-0.77,0,0,GO:0035909,aorta morphogenesis,M100,1,0
0,0,1,0,0,-1.5,GO:0042659,regulation of cell fate specification,M001,1,0
0,1,0,0,-1.2,0,GO:1904951,positive regulation of establishment of protein localization,M010,1,0
0,1,0,0,-1.6,0,GO:0032007,negative regulation of TOR signaling,M010,1,0
1,0,0,-3.4,0,0,GO:0090130,tissue migration,M100,1,0
1,0,0,-0.77,0,0,WP1982,Sterol regulatory element binding proteins SREBP signaling,M100,1,0
1,0,0,-0.66,0,0,GO:0042306,regulation of protein import into nucleus,M100,1,0
0,1,0,0,-0.82,0,GO:0003208,cardiac ventricle morphogenesis,M010,1,0
1,0,0,-3,0,0,GO:0010544,negative regulation of platelet activation,M100,1,0
1,0,0,-2,0,0,GO:0010657,muscle cell apoptotic process,M100,1,0
0,0,1,0,0,-0.7,GO:0071384,cellular response to corticosteroid stimulus,M001,1,0
0,1,0,0,-2.9,0,GO:2000269,regulation of fibroblast apoptotic process,M010,1,0
1,0,0,-1.4,0,0,hsa05417,Lipid and atherosclerosis,M100,1,0
0,0,1,0,0,-1.5,GO:2000191,regulation of fatty acid transport,M001,1,0
0,0,1,0,0,-1,WP2525,Trans sulfuration one carbon metabolism and related pathways,M001,1,0
0,1,0,0,-1.1,0,GO:0006730,one-carbon metabolic process,M010,1,0
0,1,0,0,-0.75,0,R-HSA-3247509,Chromatin modifying enzymes,M010,1,0
0,1,0,0,-1.8,0,GO:0021954,central nervous system neuron development,M010,1,0
1,0,0,-0.93,0,0,hsa05022,Pathways of neurodegeneration - multiple diseases,M100,1,0
1,0,0,-1.3,0,0,WP3967,miR 509 3p alteration of YAP1 ECM axis,M100,1,0
0,1,0,0,-1.9,0,GO:0071676,negative regulation of mononuclear cell migration,M010,1,0
0,1,0,0,-1.6,0,GO:0006650,glycerophospholipid metabolic process,M010,1,0
1,0,0,-1.7,0,0,GO:0032774,RNA biosynthetic process,M100,1,0
1,0,0,-1.7,0,0,GO:0070374,positive regulation of ERK1 and ERK2 cascade,M100,1,0
0,0,1,0,0,-0.6,hsa04916,Melanogenesis,M001,1,0
0,1,0,0,-0.84,0,GO:0060047,heart contraction,M010,1,0
0,1,0,0,-1.3,0,GO:0071621,granulocyte chemotaxis,M010,1,0
0,0,1,0,0,-1.3,WP35,G protein signaling pathways,M001,1,0
0,1,0,0,-2.7,0,GO:0014897,striated muscle hypertrophy,M010,1,0
0,1,0,0,-1.2,0,R-HSA-977443,GABA receptor activation,M010,1,0
1,0,0,-0.81,0,0,WP1772,Apoptosis modulation and signaling,M100,1,0
0,1,0,0,-1.4,0,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,M010,1,0
1,0,0,-1.4,0,0,GO:0006909,phagocytosis,M100,1,0
0,1,0,0,-3.4,0,GO:1903670,regulation of sprouting angiogenesis,M010,1,0
0,0,1,0,0,-1.5,GO:0055021,regulation of cardiac muscle tissue growth,M001,1,0
0,0,1,0,0,-1.2,GO:0045912,negative regulation of carbohydrate metabolic process,M001,1,0
1,0,0,-0.5,0,0,R-HSA-69206,G1/S Transition,M100,1,0
1,0,0,-0.57,0,0,R-HSA-8978868,Fatty acid metabolism,M100,1,0
0,0,1,0,0,-0.96,GO:0030308,negative regulation of cell growth,M001,1,0
0,0,1,0,0,-0.81,GO:0110020,regulation of actomyosin structure organization,M001,1,0
0,1,0,0,-1.2,0,GO:0140448,signaling receptor ligand precursor processing,M010,1,0
0,1,0,0,-0.63,0,GO:0015833,peptide transport,M010,1,0
1,0,0,-1.9,0,0,GO:0001946,lymphangiogenesis,M100,1,0
0,1,0,0,-0.75,0,GO:0048565,digestive tract development,M010,1,0
0,0,1,0,0,-1.6,GO:0023019,signal transduction involved in regulation of gene expression,M001,1,0
0,1,0,0,-1.7,0,GO:0001678,intracellular glucose homeostasis,M010,1,0
1,0,0,-1.8,0,0,GO:0097193,intrinsic apoptotic signaling pathway,M100,1,0
1,0,0,-1,0,0,hsa04730,Long-term depression,M100,1,0
1,0,0,-1.1,0,0,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,M100,1,0
0,0,1,0,0,-0.95,GO:0051099,positive regulation of binding,M001,1,0
0,0,1,0,0,-1.9,GO:0016064,immunoglobulin mediated immune response,M001,1,0
1,0,0,-1.2,0,0,GO:0010821,regulation of mitochondrion organization,M100,1,0
0,1,0,0,-2.2,0,WP5153,N glycan biosynthesis,M010,1,0
0,1,0,0,-2.7,0,GO:0060479,lung cell differentiation,M010,1,0
1,0,0,-1.5,0,0,GO:0071222,cellular response to lipopolysaccharide,M100,1,0
0,0,1,0,0,-1.8,WP4223,Ras signaling,M001,1,0
0,0,1,0,0,-2,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,M001,1,0
0,0,1,0,0,-0.94,GO:0140467,integrated stress response signaling,M001,1,0
0,0,1,0,0,-0.66,GO:0018958,phenol-containing compound metabolic process,M001,1,0
0,1,0,0,-0.73,0,M99,PID TXA2PATHWAY,M010,1,0
1,0,0,-2,0,0,M1529,SA G1 AND S PHASES,M100,1,0
1,0,0,-0.77,0,0,R-HSA-69202,Cyclin E associated events during G1/S transition,M100,1,0
0,0,1,0,0,-0.7,WP4549,Fragile X syndrome,M001,1,0
0,0,1,0,0,-1.4,GO:0048872,homeostasis of number of cells,M001,1,0
0,1,0,0,-0.67,0,hsa04350,TGF-beta signaling pathway,M010,1,0
0,0,1,0,0,-0.9,GO:0051648,vesicle localization,M001,1,0
0,1,0,0,-1.7,0,GO:0006487,protein N-linked glycosylation,M010,1,0
1,0,0,-1.1,0,0,GO:0097035,regulation of membrane lipid distribution,M100,1,0
0,0,1,0,0,-1.6,GO:0050890,cognition,M001,1,0
0,1,0,0,-2.1,0,GO:0043303,mast cell degranulation,M010,1,0
0,1,0,0,-2.4,0,GO:0060986,endocrine hormone secretion,M010,1,0
1,0,0,-1.5,0,0,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,M100,1,0
0,1,0,0,-0.7,0,GO:0051260,protein homooligomerization,M010,1,0
0,1,0,0,-2.4,0,GO:0060509,type I pneumocyte differentiation,M010,1,0
1,0,0,-3.1,0,0,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",M100,1,0
0,0,1,0,0,-1.3,GO:0002449,lymphocyte mediated immunity,M001,1,0
1,0,0,-1.4,0,0,GO:0090103,cochlea morphogenesis,M100,1,0
0,1,0,0,-1.2,0,GO:0050919,negative chemotaxis,M010,1,0
0,0,1,0,0,-0.77,WP3896,Dengue 2 interactions with complement and coagulation cascades,M001,1,0
0,0,1,0,0,-2.3,GO:0007159,leukocyte cell-cell adhesion,M001,1,0
1,0,0,-1.5,0,0,GO:0008286,insulin receptor signaling pathway,M100,1,0
1,0,0,-2.4,0,0,WP3972,PDGFR beta pathway,M100,1,0
1,0,0,-1.2,0,0,GO:0048002,antigen processing and presentation of peptide antigen,M100,1,0
1,0,0,-0.99,0,0,GO:0000082,G1/S transition of mitotic cell cycle,M100,1,0
0,1,0,0,-0.63,0,GO:0009746,response to hexose,M010,1,0
0,0,1,0,0,-0.57,GO:0009581,detection of external stimulus,M001,1,0
0,1,0,0,-1.2,0,GO:0019674,NAD metabolic process,M010,1,0
1,0,0,-1.2,0,0,GO:0032496,response to lipopolysaccharide,M100,1,0
0,1,0,0,-0.76,0,GO:0030705,cytoskeleton-dependent intracellular transport,M010,1,0
0,1,0,0,-0.66,0,GO:0007368,determination of left/right symmetry,M010,1,0
1,0,0,-0.89,0,0,WP3959,DNA IR double strand breaks and cellular response via ATM,M100,1,0
0,0,1,0,0,-1.4,GO:0045185,maintenance of protein location,M001,1,0
0,1,0,0,-2.1,0,GO:0030177,positive regulation of Wnt signaling pathway,M010,1,0
1,0,0,-0.65,0,0,GO:0050792,regulation of viral process,M100,1,0
1,0,0,-0.78,0,0,GO:0060042,retina morphogenesis in camera-type eye,M100,1,0
1,0,0,-0.77,0,0,GO:0032731,positive regulation of interleukin-1 beta production,M100,1,0
0,1,0,0,-1.2,0,GO:0086002,cardiac muscle cell action potential involved in contraction,M010,1,0
1,0,0,-1.5,0,0,WP2446,Retinoblastoma gene in cancer,M100,1,0
1,0,0,-1.3,0,0,GO:0036314,response to sterol,M100,1,0
0,1,0,0,-1.3,0,GO:1901137,carbohydrate derivative biosynthetic process,M010,1,0
1,0,0,-1,0,0,WP5380,5q35 copy number variation,M100,1,0
0,0,1,0,0,-1.5,GO:0002440,production of molecular mediator of immune response,M001,1,0
0,0,1,0,0,-0.72,GO:1990830,cellular response to leukemia inhibitory factor,M001,1,0
1,0,0,-1.1,0,0,GO:0010950,positive regulation of endopeptidase activity,M100,1,0
0,1,0,0,-2.7,0,GO:1902170,cellular response to reactive nitrogen species,M010,1,0
1,0,0,-1.7,0,0,WP2380,Brain derived neurotrophic factor BDNF signaling pathway,M100,1,0
1,0,0,-2.2,0,0,GO:0070328,triglyceride homeostasis,M100,1,0
0,0,1,0,0,-1.9,WP5072,Modulators of TCR signaling and T cell activation,M001,1,0
1,0,0,-1.5,0,0,GO:0032652,regulation of interleukin-1 production,M100,1,0
1,0,0,-2.2,0,0,M3686,SA REG CASCADE OF CYCLIN EXPR,M100,1,0
0,1,0,0,-0.71,0,GO:0060415,muscle tissue morphogenesis,M010,1,0
0,0,1,0,0,-0.6,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,M001,1,0
0,1,0,0,-1.9,0,GO:0061001,regulation of dendritic spine morphogenesis,M010,1,0
0,0,1,0,0,-1,GO:1902414,protein localization to cell junction,M001,1,0
1,0,0,-1.5,0,0,GO:0010755,regulation of plasminogen activation,M100,1,0
1,0,0,-1.8,0,0,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M100,1,0
1,0,0,-1.1,0,0,GO:0003209,cardiac atrium morphogenesis,M100,1,0
0,1,0,0,-0.89,0,GO:0048260,positive regulation of receptor-mediated endocytosis,M010,1,0
0,1,0,0,-1.5,0,GO:0060828,regulation of canonical Wnt signaling pathway,M010,1,0
1,0,0,-2.2,0,0,GO:0055090,acylglycerol homeostasis,M100,1,0
0,0,1,0,0,-1.2,WP3893,Development and heterogeneity of the ILC family,M001,1,0
0,0,1,0,0,-1.5,GO:0050994,regulation of lipid catabolic process,M001,1,0
0,0,1,0,0,-1.2,M81,PID CDC42 PATHWAY,M001,1,0
0,0,1,0,0,-1.5,GO:0021879,forebrain neuron differentiation,M001,1,0
0,0,1,0,0,-2,GO:0048705,skeletal system morphogenesis,M001,1,0
0,0,1,0,0,-2.9,GO:0045191,regulation of isotype switching,M001,1,0
0,1,0,0,-2.7,0,GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,M010,1,0
0,0,1,0,0,-1.2,GO:0048333,mesodermal cell differentiation,M001,1,0
1,0,0,-0.66,0,0,GO:0032886,regulation of microtubule-based process,M100,1,0
0,1,0,0,-0.99,0,R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,M010,1,0
0,1,0,0,-0.81,0,GO:0071674,mononuclear cell migration,M010,1,0
1,0,0,-0.75,0,0,GO:0072088,nephron epithelium morphogenesis,M100,1,0
1,0,0,-0.65,0,0,M5880,NABA ECM AFFILIATED,M100,1,0
1,0,0,-0.66,0,0,GO:0046822,regulation of nucleocytoplasmic transport,M100,1,0
0,0,1,0,0,-1.3,hsa05030,Cocaine addiction,M001,1,0
1,0,0,-0.84,0,0,GO:0050848,regulation of calcium-mediated signaling,M100,1,0
0,0,1,0,0,-0.86,GO:0010232,vascular transport,M001,1,0
1,0,0,-1.3,0,0,GO:0006140,regulation of nucleotide metabolic process,M100,1,0
1,0,0,-1.4,0,0,GO:0071219,cellular response to molecule of bacterial origin,M100,1,0
0,0,1,0,0,-1.9,GO:0046849,bone remodeling,M001,1,0
1,0,0,-1.7,0,0,GO:0009649,entrainment of circadian clock,M100,1,0
1,0,0,-0.77,0,0,GO:0051055,negative regulation of lipid biosynthetic process,M100,1,0
1,0,0,-1.7,0,0,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,M100,1,0
0,0,1,0,0,-1.2,GO:0048168,regulation of neuronal synaptic plasticity,M001,1,0
0,0,1,0,0,-1.9,GO:1905144,response to acetylcholine,M001,1,0
0,1,0,0,-1.3,0,GO:2001044,regulation of integrin-mediated signaling pathway,M010,1,0
0,1,0,0,-1.6,0,GO:0043616,keratinocyte proliferation,M010,1,0
1,0,0,-0.72,0,0,GO:0051092,positive regulation of NF-kappaB transcription factor activity,M100,1,0
1,0,0,-1.5,0,0,hsa05216,Thyroid cancer,M100,1,0
1,0,0,-2,0,0,M71,PID ILK PATHWAY,M100,1,0
0,1,0,0,-0.89,0,hsa04912,GnRH signaling pathway,M010,1,0
1,0,0,-1.3,0,0,GO:0010574,regulation of vascular endothelial growth factor production,M100,1,0
1,0,0,-2.1,0,0,GO:0006468,protein phosphorylation,M100,1,0
0,1,0,0,-1.5,0,GO:0017157,regulation of exocytosis,M010,1,0
1,0,0,-3.4,0,0,WP22,IL 9 signaling pathway,M100,1,0
0,1,0,0,-1.6,0,WP4565,Neural crest cell migration in cancer,M010,1,0
0,0,1,0,0,-2,GO:0002829,negative regulation of type 2 immune response,M001,1,0
0,0,1,0,0,-3.8,GO:0030218,erythrocyte differentiation,M001,1,0
0,0,1,0,0,-2.4,GO:0042473,outer ear morphogenesis,M001,1,0
0,0,1,0,0,-1.2,GO:0030163,protein catabolic process,M001,1,0
0,1,0,0,-1.3,0,hsa05145,Toxoplasmosis,M010,1,0
0,0,1,0,0,-1.5,GO:0043368,positive T cell selection,M001,1,0
0,0,1,0,0,-2.7,GO:0098712,L-glutamate import across plasma membrane,M001,1,0
0,0,1,0,0,-1.1,R-HSA-8986944,Transcriptional Regulation by MECP2,M001,1,0
1,0,0,-1.6,0,0,GO:0043542,endothelial cell migration,M100,1,0
1,0,0,-2.2,0,0,WP3888,VEGFA VEGFR2 signaling,M100,1,0
1,0,0,-2.7,0,0,WP581,EPO receptor signaling,M100,1,0
1,0,0,-0.87,0,0,GO:0045927,positive regulation of growth,M100,1,0
0,1,0,0,-0.71,0,WP138,Androgen receptor signaling pathway,M010,1,0
0,0,1,0,0,-0.59,GO:0008593,regulation of Notch signaling pathway,M001,1,0
1,0,0,-3.1,0,0,R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",M100,1,0
0,1,0,0,-0.94,0,GO:0008344,adult locomotory behavior,M010,1,0
1,0,0,-2.2,0,0,GO:0032680,regulation of tumor necrosis factor production,M100,1,0
0,0,1,0,0,-2.4,GO:0046321,positive regulation of fatty acid oxidation,M001,1,0
1,0,0,-2.7,0,0,M233,PID EPO PATHWAY,M100,1,0
0,1,0,0,-1.4,0,GO:1901570,fatty acid derivative biosynthetic process,M010,1,0
0,0,1,0,0,-0.66,GO:0014902,myotube differentiation,M001,1,0
0,0,1,0,0,-0.86,GO:0001649,osteoblast differentiation,M001,1,0
1,0,0,-1.5,0,0,GO:2001235,positive regulation of apoptotic signaling pathway,M100,1,0
0,0,1,0,0,-1.6,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,M001,1,0
0,0,1,0,0,-3.1,GO:0060710,chorio-allantoic fusion,M001,1,0
1,0,0,-1.5,0,0,GO:0036303,lymph vessel morphogenesis,M100,1,0
1,0,0,-2.5,0,0,GO:0009595,detection of biotic stimulus,M100,1,0
0,0,1,0,0,-1.3,GO:0050860,negative regulation of T cell receptor signaling pathway,M001,1,0
0,1,0,0,-0.59,0,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,M010,1,0
1,0,0,-2,0,0,GO:0014909,smooth muscle cell migration,M100,1,0
0,1,0,0,-0.8,0,hsa04976,Bile secretion,M010,1,0
0,1,0,0,-0.71,0,GO:0097237,cellular response to toxic substance,M010,1,0
1,0,0,-1.5,0,0,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,M100,1,0
0,0,1,0,0,-2.2,GO:0002357,defense response to tumor cell,M001,1,0
0,1,0,0,-1.6,0,GO:0010466,negative regulation of peptidase activity,M010,1,0
1,0,0,-1.3,0,0,GO:0021766,hippocampus development,M100,1,0
0,1,0,0,-0.8,0,hsa05010,Alzheimer disease,M010,1,0
0,0,1,0,0,-1.4,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),M001,1,0
0,0,1,0,0,-1.5,R-HSA-109704,PI3K Cascade,M001,1,0
0,1,0,0,-1.4,0,GO:0086065,cell communication involved in cardiac conduction,M010,1,0
0,1,0,0,-0.66,0,GO:0048644,muscle organ morphogenesis,M010,1,0
0,1,0,0,-1.3,0,hsa04310,Wnt signaling pathway,M010,1,0
1,0,0,-0.66,0,0,GO:1903578,regulation of ATP metabolic process,M100,1,0
0,0,1,0,0,-0.94,GO:2000144,positive regulation of DNA-templated transcription initiation,M001,1,0
0,0,1,0,0,-1.5,GO:0010885,regulation of cholesterol storage,M001,1,0
0,0,1,0,0,-2.1,GO:0045662,negative regulation of myoblast differentiation,M001,1,0
1,0,0,-2.7,0,0,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,M100,1,0
1,0,0,-1.5,0,0,WP4300,Extracellular vesicles in the crosstalk of cardiac cells,M100,1,0
0,1,0,0,-0.7,0,GO:0009749,response to glucose,M010,1,0
1,0,0,-1.3,0,0,GO:0050830,defense response to Gram-positive bacterium,M100,1,0
1,0,0,-2.4,0,0,GO:0099171,presynaptic modulation of chemical synaptic transmission,M100,1,0
1,0,0,-4.7,0,0,GO:0001914,regulation of T cell mediated cytotoxicity,M100,1,0
0,0,1,0,0,-0.77,WP5039,SARS CoV 2 innate immunity evasion and cell specific immune response,M001,1,0
0,0,1,0,0,-2.1,GO:0031018,endocrine pancreas development,M001,1,0
1,0,0,-3.6,0,0,GO:0001916,positive regulation of T cell mediated cytotoxicity,M100,1,0
0,1,0,0,-1.4,0,GO:0090189,regulation of branching involved in ureteric bud morphogenesis,M010,1,0
1,0,0,-1.1,0,0,hsa04530,Tight junction,M100,1,0
1,0,0,-1.2,0,0,GO:0030100,regulation of endocytosis,M100,1,0
1,0,0,-2.1,0,0,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,M100,1,0
1,0,0,-1.5,0,0,R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,M100,1,0
1,0,0,-1.5,0,0,R-HSA-114452,Activation of BH3-only proteins,M100,1,0
0,0,1,0,0,-2.7,GO:0010614,negative regulation of cardiac muscle hypertrophy,M001,1,0
0,1,0,0,-0.72,0,WP5124,Alzheimer 39 s disease,M010,1,0
1,0,0,-3.8,0,0,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M100,1,0
0,0,1,0,0,-0.86,GO:0007043,cell-cell junction assembly,M001,1,0
0,0,1,0,0,-0.62,GO:0006665,sphingolipid metabolic process,M001,1,0
0,1,0,0,-1.4,0,WP3927,BMP signaling in eyelid development,M010,1,0
1,0,0,-1.6,0,0,GO:0040014,regulation of multicellular organism growth,M100,1,0
1,0,0,-2.4,0,0,GO:0030728,ovulation,M100,1,0
0,1,0,0,-1.3,0,GO:0006753,nucleoside phosphate metabolic process,M010,1,0
0,1,0,0,-1.1,0,GO:0034765,regulation of monoatomic ion transmembrane transport,M010,1,0
0,0,1,0,0,-1.1,GO:0048714,positive regulation of oligodendrocyte differentiation,M001,1,0
0,1,0,0,-1.5,0,hsa04926,Relaxin signaling pathway,M010,1,0
1,0,0,-1.1,0,0,GO:0043270,positive regulation of monoatomic ion transport,M100,1,0
1,0,0,-1.3,0,0,GO:0070372,regulation of ERK1 and ERK2 cascade,M100,1,0
1,0,0,-0.57,0,0,GO:0009411,response to UV,M100,1,0
0,0,1,0,0,-1.6,GO:0001708,cell fate specification,M001,1,0
0,1,0,0,-1.2,0,GO:0046486,glycerolipid metabolic process,M010,1,0
1,0,0,-1.3,0,0,GO:0038084,vascular endothelial growth factor signaling pathway,M100,1,0
0,0,1,0,0,-0.78,GO:0006643,membrane lipid metabolic process,M001,1,0
0,1,0,0,-1.3,0,GO:0032006,regulation of TOR signaling,M010,1,0
0,0,1,0,0,-0.77,R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,M001,1,0
0,1,0,0,-0.61,0,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,M010,1,0
0,1,0,0,-1.2,0,GO:1905207,regulation of cardiocyte differentiation,M010,1,0
1,0,0,-2.2,0,0,GO:0140694,non-membrane-bounded organelle assembly,M100,1,0
1,0,0,-1.1,0,0,GO:0042246,tissue regeneration,M100,1,0
0,1,0,0,-0.81,0,WP5115,Network map of SARS CoV 2 signaling pathway,M010,1,0
1,0,0,-0.94,0,0,R-HSA-4086398,Ca2+ pathway,M100,1,0
0,1,0,0,-0.69,0,GO:0014032,neural crest cell development,M010,1,0
0,1,0,0,-1.1,0,GO:0003012,muscle system process,M010,1,0
0,1,0,0,-2.1,0,WP4559,Interactions between immune cells and microRNAs in tumor microenvironment,M010,1,0
1,0,0,-1.3,0,0,R-HSA-5683057,MAPK family signaling cascades,M100,1,0
1,0,0,-0.89,0,0,GO:0051279,regulation of release of sequestered calcium ion into cytosol,M100,1,0
1,0,0,-1.9,0,0,WP4925,Unfolded protein response,M100,1,0
1,0,0,-3.1,0,0,R-HSA-9645135,STAT5 Activation,M100,1,0
0,1,0,0,-1.4,0,GO:0009152,purine ribonucleotide biosynthetic process,M010,1,0
1,0,0,-3.4,0,0,R-HSA-451927,Interleukin-2 family signaling,M100,1,0
0,1,0,0,-1.5,0,GO:0010633,negative regulation of epithelial cell migration,M010,1,0
0,1,0,0,-1.7,0,GO:0032881,regulation of polysaccharide metabolic process,M010,1,0
1,0,0,-0.69,0,0,GO:0001541,ovarian follicle development,M100,1,0
1,0,0,-1.3,0,0,R-HSA-109606,Intrinsic Pathway for Apoptosis,M100,1,0
0,1,0,0,-1,0,hsa05146,Amoebiasis,M010,1,0
0,0,1,0,0,-1.4,hsa04620,Toll-like receptor signaling pathway,M001,1,0
0,0,1,0,0,-2.3,GO:0071345,cellular response to cytokine stimulus,M001,1,0
1,0,0,-1.7,0,0,hsa05320,Autoimmune thyroid disease,M100,1,0
1,0,0,-2.1,0,0,WP2447,Amyotrophic lateral sclerosis ALS,M100,1,0
1,0,0,-0.61,0,0,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,M100,1,0
0,1,0,0,-1.1,0,GO:1900015,regulation of cytokine production involved in inflammatory response,M010,1,0
0,0,1,0,0,-1.3,R-HSA-8939902,Regulation of RUNX2 expression and activity,M001,1,0
1,0,0,-0.63,0,0,GO:0090090,negative regulation of canonical Wnt signaling pathway,M100,1,0
0,0,1,0,0,-1.2,GO:1905953,negative regulation of lipid localization,M001,1,0
0,1,0,0,-0.66,0,hsa04723,Retrograde endocannabinoid signaling,M010,1,0
0,0,1,0,0,-0.7,GO:0035019,somatic stem cell population maintenance,M001,1,0
0,1,0,0,-0.52,0,GO:0009141,nucleoside triphosphate metabolic process,M010,1,0
0,1,0,0,-1.3,0,GO:1990089,response to nerve growth factor,M010,1,0
0,0,1,0,0,-1.5,GO:0002377,immunoglobulin production,M001,1,0
0,1,0,0,-2.2,0,R-HSA-432722,Golgi Associated Vesicle Biogenesis,M010,1,0
0,1,0,0,-0.57,0,GO:0002886,regulation of myeloid leukocyte mediated immunity,M010,1,0
0,1,0,0,-0.92,0,GO:0051259,protein complex oligomerization,M010,1,0
0,1,0,0,-2.2,0,GO:0021780,glial cell fate specification,M010,1,0
0,1,0,0,-1.4,0,GO:0051302,regulation of cell division,M010,1,0
1,0,0,-2.4,0,0,GO:0035723,interleukin-15-mediated signaling pathway,M100,1,0
0,0,1,0,0,-1,R-HSA-5619507,Activation of HOX genes during differentiation,M001,1,0
0,1,0,0,-2.5,0,GO:0090407,organophosphate biosynthetic process,M010,1,0
0,1,0,0,-1.6,0,WP244,Alpha 6 beta 4 signaling pathway,M010,1,0
0,1,0,0,-1.7,0,WP3876,BMP2 WNT4 FOXO1 pathway in primary endometrial stromal cell differentiation,M010,1,0
1,0,0,-0.63,0,0,R-HSA-5218859,Regulated Necrosis,M100,1,0
1,0,0,-1.8,0,0,GO:0071216,cellular response to biotic stimulus,M100,1,0
1,0,0,-0.81,0,0,M237,PID VEGFR1 2 PATHWAY,M100,1,0
1,0,0,-1.3,0,0,R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,M100,1,0
0,0,1,0,0,-1.6,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",M001,1,0
1,0,0,-1.2,0,0,hsa04612,Antigen processing and presentation,M100,1,0
1,0,0,-1.3,0,0,R-HSA-5625740,RHO GTPases activate PKNs,M100,1,0
1,0,0,-1.8,0,0,GO:0051606,detection of stimulus,M100,1,0
0,0,1,0,0,-0.66,GO:0035296,regulation of tube diameter,M001,1,0
1,0,0,-1.6,0,0,GO:0042149,cellular response to glucose starvation,M100,1,0
0,0,1,0,0,-1.3,GO:0060669,embryonic placenta morphogenesis,M001,1,0
0,0,1,0,0,-1.6,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,M001,1,0
0,0,1,0,0,-1.6,GO:0033365,protein localization to organelle,M001,1,0
0,1,0,0,-1.1,0,GO:0046903,secretion,M010,1,0
0,1,0,0,-0.64,0,hsa05208,Chemical carcinogenesis - reactive oxygen species,M010,1,0
1,0,0,-0.6,0,0,GO:0046530,photoreceptor cell differentiation,M100,1,0
1,0,0,-0.99,0,0,GO:0002478,antigen processing and presentation of exogenous peptide antigen,M100,1,0
0,1,0,0,-1.4,0,GO:0016486,peptide hormone processing,M010,1,0
1,0,0,-1.1,0,0,GO:0060538,skeletal muscle organ development,M100,1,0
0,1,0,0,-3.8,0,hsa04216,Ferroptosis,M010,1,0
0,1,0,0,-0.57,0,R-HSA-975155,MyD88 dependent cascade initiated on endosome,M010,1,0
1,0,0,-2,0,0,GO:0007406,negative regulation of neuroblast proliferation,M100,1,0
0,0,1,0,0,-1.6,GO:0060713,labyrinthine layer morphogenesis,M001,1,0
0,0,1,0,0,-1.1,GO:0008543,fibroblast growth factor receptor signaling pathway,M001,1,0
1,0,0,-1.5,0,0,R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,M100,1,0
0,1,0,0,-0.66,0,GO:0046496,nicotinamide nucleotide metabolic process,M010,1,0
0,1,0,0,-1.3,0,GO:0050770,regulation of axonogenesis,M010,1,0
1,0,0,-3.2,0,0,GO:0032946,positive regulation of mononuclear cell proliferation,M100,1,0
0,1,0,0,-2.7,0,hsa00601,Glycosphingolipid biosynthesis - lacto and neolacto series,M010,1,0
0,0,1,0,0,-1.3,R-HSA-190236,Signaling by FGFR,M001,1,0
1,0,0,-2.7,0,0,GO:1900047,negative regulation of hemostasis,M100,1,0
1,0,0,-2.2,0,0,GO:0009617,response to bacterium,M100,1,0
0,1,0,0,-0.99,0,GO:0086001,cardiac muscle cell action potential,M010,1,0
1,0,0,-1.3,0,0,GO:0033209,tumor necrosis factor-mediated signaling pathway,M100,1,0
0,0,1,0,0,-1.6,GO:2001222,regulation of neuron migration,M001,1,0
1,0,0,-1.4,0,0,GO:2001056,positive regulation of cysteine-type endopeptidase activity,M100,1,0
1,0,0,-2,0,0,GO:0015695,organic cation transport,M100,1,0
0,0,1,0,0,-0.63,GO:0045604,regulation of epidermal cell differentiation,M001,1,0
1,0,0,-2.1,0,0,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,M100,1,0
0,0,1,0,0,-0.96,GO:0045930,negative regulation of mitotic cell cycle,M001,1,0
1,0,0,-1.3,0,0,GO:1900542,regulation of purine nucleotide metabolic process,M100,1,0
1,0,0,-1.3,0,0,GO:0001658,branching involved in ureteric bud morphogenesis,M100,1,0
1,0,0,-0.76,0,0,GO:2000241,regulation of reproductive process,M100,1,0
0,0,1,0,0,-1.5,GO:0046621,negative regulation of organ growth,M001,1,0
0,1,0,0,-1,0,WP3624,Lung fibrosis,M010,1,0
0,0,1,0,0,-1.5,GO:0035855,megakaryocyte development,M001,1,0
0,0,1,0,0,-0.99,GO:0060759,regulation of response to cytokine stimulus,M001,1,0
1,0,0,-0.57,0,0,GO:0042789,mRNA transcription by RNA polymerase II,M100,1,0
1,0,0,-0.99,0,0,GO:1900744,regulation of p38MAPK cascade,M100,1,0
1,0,0,-1.7,0,0,GO:0008585,female gonad development,M100,1,0
1,0,0,-0.89,0,0,hsa04672,Intestinal immune network for IgA production,M100,1,0
0,1,0,0,-0.89,0,R-HSA-5687128,MAPK6/MAPK4 signaling,M010,1,0
0,0,1,0,0,-1.7,GO:0021799,cerebral cortex radially oriented cell migration,M001,1,0
1,0,0,-0.93,0,0,hsa05132,Salmonella infection,M100,1,0
1,0,0,-1.1,0,0,GO:0031647,regulation of protein stability,M100,1,0
1,0,0,-1.4,0,0,GO:0032103,positive regulation of response to external stimulus,M100,1,0
1,0,0,-2.2,0,0,WP3584,MECP2 and associated Rett syndrome,M100,1,0
1,0,0,-0.63,0,0,GO:0007093,mitotic cell cycle checkpoint signaling,M100,1,0
0,1,0,0,-0.73,0,R-HSA-9013406,RHOQ GTPase cycle,M010,1,0
1,0,0,-1.7,0,0,GO:0045840,positive regulation of mitotic nuclear division,M100,1,0
0,1,0,0,-0.8,0,GO:1990266,neutrophil migration,M010,1,0
0,1,0,0,-2.6,0,M185,PID ALK1 PATHWAY,M010,1,0
0,0,1,0,0,-1.3,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,M001,1,0
1,0,0,-2.7,0,0,R-HSA-1266695,Interleukin-7 signaling,M100,1,0
1,0,0,-0.59,0,0,hsa04936,Alcoholic liver disease,M100,1,0
0,1,0,0,-0.99,0,GO:0060563,neuroepithelial cell differentiation,M010,1,0
0,0,1,0,0,-0.66,R-HSA-111885,Opioid Signalling,M001,1,0
0,1,0,0,-1.1,0,GO:0009117,nucleotide metabolic process,M010,1,0
0,1,0,0,-1.2,0,GO:0050709,negative regulation of protein secretion,M010,1,0
1,0,0,-1,0,0,GO:0003230,cardiac atrium development,M100,1,0
0,1,0,0,-0.99,0,GO:0030593,neutrophil chemotaxis,M010,1,0
1,0,0,-0.63,0,0,GO:1903707,negative regulation of hemopoiesis,M100,1,0
0,1,0,0,-2,0,GO:0051223,regulation of protein transport,M010,1,0
1,0,0,-0.63,0,0,GO:0045069,regulation of viral genome replication,M100,1,0
1,0,0,-0.73,0,0,WP176,Folate metabolism,M100,1,0
0,0,1,0,0,-0.58,GO:0042116,macrophage activation,M001,1,0
0,1,0,0,-1.1,0,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M010,1,0
1,0,0,-2.2,0,0,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,M100,1,0
0,0,1,0,0,-0.77,WP558,Complement and coagulation cascades,M001,1,0
0,1,0,0,-1.9,0,GO:1903530,regulation of secretion by cell,M010,1,0
1,0,0,-1.7,0,0,GO:0036119,response to platelet-derived growth factor,M100,1,0
0,1,0,0,-0.67,0,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,M010,1,0
1,0,0,-3.6,0,0,GO:0010631,epithelial cell migration,M100,1,0
0,0,1,0,0,-1.6,GO:0120032,regulation of plasma membrane bounded cell projection assembly,M001,1,0
0,0,1,0,0,-0.9,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",M001,1,0
0,1,0,0,-0.77,0,GO:0030516,regulation of axon extension,M010,1,0
0,0,1,0,0,-1.3,R-HSA-977225,Amyloid fiber formation,M001,1,0
1,0,0,-1.7,0,0,GO:0030193,regulation of blood coagulation,M100,1,0
0,1,0,0,-0.57,0,GO:0050771,negative regulation of axonogenesis,M010,1,0
0,1,0,0,-1.1,0,GO:0051851,modulation by host of symbiont process,M010,1,0
1,0,0,-3.2,0,0,GO:0050778,positive regulation of immune response,M100,1,0
1,0,0,-2.6,0,0,GO:0000278,mitotic cell cycle,M100,1,0
1,0,0,-0.6,0,0,GO:0001756,somitogenesis,M100,1,0
1,0,0,-1.6,0,0,GO:0086004,regulation of cardiac muscle cell contraction,M100,1,0
1,0,0,-1.4,0,0,M22,PID GMCSF PATHWAY,M100,1,0
0,0,1,0,0,-0.97,GO:0098739,import across plasma membrane,M001,1,0
0,1,0,0,-0.6,0,GO:0001755,neural crest cell migration,M010,1,0
1,0,0,-1.2,0,0,GO:0070613,regulation of protein processing,M100,1,0
1,0,0,-1.4,0,0,GO:0090199,regulation of release of cytochrome c from mitochondria,M100,1,0
1,0,0,-1.4,0,0,GO:0070231,T cell apoptotic process,M100,1,0
0,1,0,0,-0.69,0,M7,PID FCER1 PATHWAY,M010,1,0
0,0,1,0,0,-1.2,GO:0051603,proteolysis involved in protein catabolic process,M001,1,0
0,0,1,0,0,-0.75,GO:0006275,regulation of DNA replication,M001,1,0
0,1,0,0,-1.2,0,GO:0021988,olfactory lobe development,M010,1,0
1,0,0,-2,0,0,R-HSA-417957,P2Y receptors,M100,1,0
1,0,0,-2.1,0,0,GO:0050691,regulation of defense response to virus by host,M100,1,0
0,1,0,0,-2.2,0,GO:2000271,positive regulation of fibroblast apoptotic process,M010,1,0
1,0,0,-1.1,0,0,GO:0043269,regulation of monoatomic ion transport,M100,1,0
1,0,0,-1,0,0,GO:0010507,negative regulation of autophagy,M100,1,0
1,0,0,-1.2,0,0,GO:0097028,dendritic cell differentiation,M100,1,0
0,1,0,0,-1.1,0,R-HSA-1989781,PPARA activates gene expression,M010,1,0
0,0,1,0,0,-1.4,GO:0002714,positive regulation of B cell mediated immunity,M001,1,0
0,1,0,0,-2.7,0,GO:0071731,response to nitric oxide,M010,1,0
0,0,1,0,0,-0.76,GO:0045216,cell-cell junction organization,M001,1,0
0,1,0,0,-0.73,0,GO:0071300,cellular response to retinoic acid,M010,1,0
0,0,1,0,0,-1.5,R-HSA-112399,IRS-mediated signalling,M001,1,0
0,1,0,0,-0.94,0,GO:0034446,substrate adhesion-dependent cell spreading,M010,1,0
0,0,1,0,0,-1.2,GO:0071347,cellular response to interleukin-1,M001,1,0
0,1,0,0,-1.2,0,WP5284,Cell interactions of the pancreatic cancer microenvironment,M010,1,0
0,1,0,0,-0.69,0,GO:0009743,response to carbohydrate,M010,1,0
0,0,1,0,0,-0.66,GO:0045727,positive regulation of translation,M001,1,0
0,1,0,0,-0.7,0,R-HSA-9678108,SARS-CoV-1 Infection,M010,1,0
1,0,0,-1.2,0,0,GO:0046324,regulation of glucose import,M100,1,0
1,0,0,-1.3,0,0,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",M100,1,0
1,0,0,-1.1,0,0,GO:0090559,regulation of membrane permeability,M100,1,0
0,0,1,0,0,-0.75,GO:0019217,regulation of fatty acid metabolic process,M001,1,0
1,0,0,-0.89,0,0,R-HSA-2682334,EPH-Ephrin signaling,M100,1,0
1,0,0,-1.7,0,0,WP2839,Hair follicle development organogenesis part 2 of 3,M100,1,0
0,1,0,0,-0.75,0,GO:0009101,glycoprotein biosynthetic process,M010,1,0
1,0,0,-0.7,0,0,GO:0050821,protein stabilization,M100,1,0
1,0,0,-2.2,0,0,WP5180,DYRK1A involvement regarding cell proliferation in brain development,M100,1,0
1,0,0,-2.2,0,0,WP205,IL 7 signaling pathway,M100,1,0
1,0,0,-3.5,0,0,GO:0090132,epithelium migration,M100,1,0
1,0,0,-1.1,0,0,GO:0046330,positive regulation of JNK cascade,M100,1,0
0,0,1,0,0,-0.58,GO:0048713,regulation of oligodendrocyte differentiation,M001,1,0
0,0,1,0,0,-2.4,GO:0043068,positive regulation of programmed cell death,M001,1,0
1,0,0,-1.1,0,0,WP5316,Primary ovarian insufficiency,M100,1,0
0,0,1,0,0,-1,GO:0015849,organic acid transport,M001,1,0
0,0,1,0,0,-1.2,GO:2000677,regulation of transcription regulatory region DNA binding,M001,1,0
1,0,0,-2.1,0,0,GO:0008406,gonad development,M100,1,0
0,1,0,0,-2.4,0,GO:0009756,carbohydrate mediated signaling,M010,1,0
1,0,0,-0.89,0,0,GO:0072080,nephron tubule development,M100,1,0
0,1,0,0,-0.94,0,GO:0007018,microtubule-based movement,M010,1,0
0,0,1,0,0,-0.57,GO:0006282,regulation of DNA repair,M001,1,0
0,1,0,0,-1.2,0,GO:0050772,positive regulation of axonogenesis,M010,1,0
0,0,1,0,0,-2.1,WP5102,Familial partial lipodystrophy,M001,1,0
0,1,0,0,-1,0,GO:0007626,locomotory behavior,M010,1,0
0,1,0,0,-1.2,0,GO:0008610,lipid biosynthetic process,M010,1,0
1,0,0,-1.1,0,0,GO:0032814,regulation of natural killer cell activation,M100,1,0
0,0,1,0,0,-0.63,GO:0045682,regulation of epidermis development,M001,1,0
0,0,1,0,0,-0.58,R-HSA-5693532,DNA Double-Strand Break Repair,M001,1,0
0,1,0,0,-1.7,0,GO:0099504,synaptic vesicle cycle,M010,1,0
0,1,0,0,-0.99,0,GO:0086003,cardiac muscle cell contraction,M010,1,0
0,1,0,0,-0.66,0,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,M010,1,0
0,0,1,0,0,-1.9,WP2267,Synaptic vesicle pathway,M001,1,0
0,1,0,0,-2.1,0,WP363,Wnt signaling pathway,M010,1,0
1,0,0,-0.63,0,0,GO:0000280,nuclear division,M100,1,0
0,1,0,0,-1.9,0,GO:0043114,regulation of vascular permeability,M010,1,0
1,0,0,-1.4,0,0,GO:2001057,reactive nitrogen species metabolic process,M100,1,0
0,1,0,0,-1.4,0,GO:1902003,regulation of amyloid-beta formation,M010,1,0
0,1,0,0,-0.92,0,hsa04360,Axon guidance,M010,1,0
1,0,0,-2,0,0,GO:0045137,development of primary sexual characteristics,M100,1,0
1,0,0,-0.89,0,0,GO:0019884,antigen processing and presentation of exogenous antigen,M100,1,0
1,0,0,-3,0,0,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,M100,1,0
1,0,0,-1.7,0,0,R-HSA-4420097,VEGFA-VEGFR2 Pathway,M100,1,0
1,0,0,-0.84,0,0,GO:0072331,signal transduction by p53 class mediator,M100,1,0
1,0,0,-2.8,0,0,M254,PID MYC REPRESS PATHWAY,M100,1,0
0,0,1,0,0,-0.6,GO:0051492,regulation of stress fiber assembly,M001,1,0
1,0,0,-2.1,0,0,GO:0043029,T cell homeostasis,M100,1,0
0,1,0,0,-0.69,0,M5493,WNT SIGNALING,M010,1,0
0,1,0,0,-0.81,0,hsa05142,Chagas disease,M010,1,0
0,0,1,0,0,-1.2,GO:0051058,negative regulation of small GTPase mediated signal transduction,M001,1,0
1,0,0,-1.4,0,0,GO:0010823,negative regulation of mitochondrion organization,M100,1,0
0,0,1,0,0,-2.4,GO:0007213,G protein-coupled acetylcholine receptor signaling pathway,M001,1,0
0,0,1,0,0,-1.9,GO:0050905,neuromuscular process,M001,1,0
0,0,1,0,0,-2.7,GO:0060337,type I interferon-mediated signaling pathway,M001,1,0
1,0,0,-1,0,0,GO:0010332,response to gamma radiation,M100,1,0
0,1,0,0,-1.8,0,GO:1904407,positive regulation of nitric oxide metabolic process,M010,1,0
0,1,0,0,-1.1,0,GO:0010498,proteasomal protein catabolic process,M010,1,0
0,0,1,0,0,-1.4,R-HSA-8878166,Transcriptional regulation by RUNX2,M001,1,0
0,0,1,0,0,-2.3,hsa04024,cAMP signaling pathway,M001,1,0
0,0,1,0,0,-1.1,GO:2000142,regulation of DNA-templated transcription initiation,M001,1,0
1,0,0,-0.61,0,0,R-HSA-453279,Mitotic G1 phase and G1/S transition,M100,1,0
0,0,1,0,0,-3.7,GO:0045321,leukocyte activation,M001,1,0
1,0,0,-0.99,0,0,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",M100,1,0
0,1,0,0,-1.9,0,GO:1903671,negative regulation of sprouting angiogenesis,M010,1,0
1,0,0,-2.4,0,0,GO:0060397,growth hormone receptor signaling pathway via JAK-STAT,M100,1,0
1,0,0,-2,0,0,GO:0032107,regulation of response to nutrient levels,M100,1,0
0,0,1,0,0,-2.7,M235,PID TCR CALCIUM PATHWAY,M001,1,0
0,1,0,0,-1.2,0,hsa05415,Diabetic cardiomyopathy,M010,1,0
0,1,0,0,-0.94,0,GO:0042311,vasodilation,M010,1,0
0,0,1,0,0,-2,GO:0035235,ionotropic glutamate receptor signaling pathway,M001,1,0
0,1,0,0,-1.3,0,GO:0051222,positive regulation of protein transport,M010,1,0
1,0,0,-1.5,0,0,GO:0032689,negative regulation of type II interferon production,M100,1,0
1,0,0,-2,0,0,GO:0043408,regulation of MAPK cascade,M100,1,0
0,1,0,0,-0.98,0,GO:1903829,positive regulation of protein localization,M010,1,0
0,0,1,0,0,-0.81,GO:0007224,smoothened signaling pathway,M001,1,0
1,0,0,-1.1,0,0,GO:0042752,regulation of circadian rhythm,M100,1,0
1,0,0,-0.89,0,0,GO:0051150,regulation of smooth muscle cell differentiation,M100,1,0
1,0,0,-1,0,0,GO:0098900,regulation of action potential,M100,1,0
0,1,0,0,-0.97,0,GO:0050900,leukocyte migration,M010,1,0
0,0,1,0,0,-2.2,GO:0015813,L-glutamate transmembrane transport,M001,1,0
0,1,0,0,-0.6,0,GO:0072524,pyridine-containing compound metabolic process,M010,1,0
1,0,0,-2.7,0,0,GO:0042492,gamma-delta T cell differentiation,M100,1,0
1,0,0,-0.99,0,0,WP2828,Bladder cancer,M100,1,0
0,1,0,0,-1.5,0,GO:0021781,glial cell fate commitment,M010,1,0
1,0,0,-2.4,0,0,M135,PID IL5 PATHWAY,M100,1,0
0,0,1,0,0,-0.9,GO:0060711,labyrinthine layer development,M001,1,0
0,0,1,0,0,-0.82,WP2877,Vitamin D receptor pathway,M001,1,0
0,1,0,0,-1.2,0,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,M010,1,0
0,0,1,0,0,-1.1,GO:0006417,regulation of translation,M001,1,0
0,1,0,0,-1.8,0,GO:0051781,positive regulation of cell division,M010,1,0
1,0,0,-4.5,0,0,R-HSA-186763,Downstream signal transduction,M100,1,0
0,1,0,0,-0.72,0,WP2059,Alzheimer 39 s disease and miRNA effects,M010,1,0
1,0,0,-0.72,0,0,GO:0072028,nephron morphogenesis,M100,1,0
0,0,1,0,0,-1.3,GO:0032922,circadian regulation of gene expression,M001,1,0
1,0,0,-1.8,0,0,hsa04935,"Growth hormone synthesis, secretion and action",M100,1,0
0,0,1,0,0,-0.89,GO:0045834,positive regulation of lipid metabolic process,M001,1,0
0,1,0,0,-0.81,0,GO:0030048,actin filament-based movement,M010,1,0
0,1,0,0,-1.7,0,GO:0036465,synaptic vesicle recycling,M010,1,0
0,0,1,0,0,-1.7,WP4767,FGFR3 signaling in chondrocyte proliferation and terminal differentiation,M001,1,0
1,0,0,-1.4,0,0,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,M100,1,0
0,0,1,0,0,-1.5,GO:0001819,positive regulation of cytokine production,M001,1,0
1,0,0,-0.96,0,0,GO:0010810,regulation of cell-substrate adhesion,M100,1,0
0,1,0,0,-0.63,0,GO:0045778,positive regulation of ossification,M010,1,0
1,0,0,-2.6,0,0,R-HSA-9607240,FLT3 Signaling,M100,1,0
0,0,1,0,0,-1.1,GO:0008154,actin polymerization or depolymerization,M001,1,0
0,0,1,0,0,-1.7,GO:2001053,regulation of mesenchymal cell apoptotic process,M001,1,0
1,0,0,-2.5,0,0,GO:0019883,antigen processing and presentation of endogenous antigen,M100,1,0
1,0,0,-1.6,0,0,GO:0002501,peptide antigen assembly with MHC protein complex,M100,1,0
0,0,1,0,0,-0.81,R-HSA-9013408,RHOG GTPase cycle,M001,1,0
0,1,0,0,-1,0,WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,M010,1,0
1,0,0,-1.1,0,0,GO:0000077,DNA damage checkpoint signaling,M100,1,0
0,0,1,0,0,-0.81,GO:0048193,Golgi vesicle transport,M001,1,0
0,1,0,0,-1.9,0,GO:0045429,positive regulation of nitric oxide biosynthetic process,M010,1,0
1,0,0,-1.7,0,0,GO:0031623,receptor internalization,M100,1,0
0,0,1,0,0,-2.1,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,M001,1,0
1,0,0,-2,0,0,GO:0060396,growth hormone receptor signaling pathway,M100,1,0
1,0,0,-1.6,0,0,GO:0001822,kidney development,M100,1,0
1,0,0,-1,0,0,GO:0001909,leukocyte mediated cytotoxicity,M100,1,0
1,0,0,-1.8,0,0,hsa04520,Adherens junction,M100,1,0
1,0,0,-2.7,0,0,GO:0050671,positive regulation of lymphocyte proliferation,M100,1,0
1,0,0,-0.6,0,0,GO:0051057,positive regulation of small GTPase mediated signal transduction,M100,1,0
1,0,0,-1.1,0,0,hsa04710,Circadian rhythm,M100,1,0
1,0,0,-1.1,0,0,GO:0045088,regulation of innate immune response,M100,1,0
1,0,0,-2.4,0,0,GO:0050817,coagulation,M100,1,0
1,0,0,-0.66,0,0,GO:0032648,regulation of interferon-beta production,M100,1,0
1,0,0,-1.7,0,0,GO:0040018,positive regulation of multicellular organism growth,M100,1,0
1,0,0,-1,0,0,GO:0001906,cell killing,M100,1,0
0,0,1,0,0,-0.99,GO:0016032,viral process,M001,1,0
0,1,0,0,-1.9,0,GO:0140238,presynaptic endocytosis,M010,1,0
0,1,0,0,-1.5,0,GO:0045428,regulation of nitric oxide biosynthetic process,M010,1,0
0,1,0,0,-1.9,0,GO:2000725,regulation of cardiac muscle cell differentiation,M010,1,0
1,0,0,-0.94,0,0,GO:0042461,photoreceptor cell development,M100,1,0
1,0,0,-1.8,0,0,R-HSA-2990846,SUMOylation,M100,1,0
1,0,0,-2.4,0,0,GO:0010757,negative regulation of plasminogen activation,M100,1,0
1,0,0,-1.4,0,0,GO:0019218,regulation of steroid metabolic process,M100,1,0
1,0,0,-1.2,0,0,GO:0050764,regulation of phagocytosis,M100,1,0
1,0,0,-1.3,0,0,GO:0046546,development of primary male sexual characteristics,M100,1,0
1,0,0,-2.2,0,0,M13,PID ERBB4 PATHWAY,M100,1,0
1,0,0,-1.5,0,0,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,M100,1,0
0,1,0,0,-1,0,GO:0055123,digestive system development,M010,1,0
1,0,0,-0.8,0,0,GO:0061326,renal tubule development,M100,1,0
0,1,0,0,-1.2,0,GO:0071277,cellular response to calcium ion,M010,1,0
0,0,1,0,0,-1.6,R-HSA-9834899,Specification of the neural plate border,M001,1,0
1,0,0,-3,0,0,GO:0030239,myofibril assembly,M100,1,0
0,1,0,0,-0.87,0,GO:0051702,biological process involved in interaction with symbiont,M010,1,0
0,1,0,0,-2.7,0,GO:0003300,cardiac muscle hypertrophy,M010,1,0
1,0,0,-2.1,0,0,GO:0072001,renal system development,M100,1,0
0,1,0,0,-3.1,0,GO:0071732,cellular response to nitric oxide,M010,1,0
0,1,0,0,-1,0,GO:0050796,regulation of insulin secretion,M010,1,0
0,0,1,0,0,-2.4,GO:0098976,excitatory chemical synaptic transmission,M001,1,0
0,1,0,0,-0.74,0,hsa04668,TNF signaling pathway,M010,1,0
0,1,0,0,-0.82,0,GO:0032755,positive regulation of interleukin-6 production,M010,1,0
0,0,1,0,0,-1.5,GO:0022406,membrane docking,M001,1,0
0,0,1,0,0,-0.81,R-HSA-5173105,O-linked glycosylation,M001,1,0
0,0,1,0,0,-2,GO:0043031,negative regulation of macrophage activation,M001,1,0
0,0,1,0,0,-0.92,GO:0097191,extrinsic apoptotic signaling pathway,M001,1,0
1,0,0,-1.8,0,0,M153,PID P75 NTR PATHWAY,M100,1,0
1,0,0,-1.5,0,0,GO:0042634,regulation of hair cycle,M100,1,0
0,0,1,0,0,-1.3,GO:0021801,cerebral cortex radial glia-guided migration,M001,1,0
1,0,0,-0.72,0,0,GO:0019882,antigen processing and presentation,M100,1,0
1,0,0,-1.2,0,0,GO:0045981,positive regulation of nucleotide metabolic process,M100,1,0
0,1,0,0,-0.8,0,WP3937,Microglia pathogen phagocytosis pathway,M010,1,0
0,1,0,0,-1.1,0,GO:0009064,glutamine family amino acid metabolic process,M010,1,0
1,0,0,-1.4,0,0,GO:1903725,regulation of phospholipid metabolic process,M100,1,0
1,0,0,-2,0,0,R-HSA-4085001,Sialic acid metabolism,M100,1,0
1,0,0,-1.3,0,0,GO:0060603,mammary gland duct morphogenesis,M100,1,0
0,0,1,0,0,-0.86,GO:0030278,regulation of ossification,M001,1,0
1,0,0,-1.4,0,0,R-HSA-9674555,Signaling by CSF3 (G-CSF),M100,1,0
0,0,1,0,0,-1.7,GO:0010996,response to auditory stimulus,M001,1,0
0,1,0,0,-2.5,0,WP4971,Phosphoinositides metabolism,M010,1,0
0,1,0,0,-1.4,0,hsa04060,Cytokine-cytokine receptor interaction,M010,1,0
1,0,0,-2.4,0,0,GO:0016045,detection of bacterium,M100,1,0
1,0,0,-1.5,0,0,GO:0060907,positive regulation of macrophage cytokine production,M100,1,0
0,1,0,0,-1,0,GO:0048841,regulation of axon extension involved in axon guidance,M010,1,0
1,0,0,-1,0,0,GO:0042063,gliogenesis,M100,1,0
0,0,1,0,0,-1.4,hsa04922,Glucagon signaling pathway,M001,1,0
0,1,0,0,-1.2,0,GO:0060326,cell chemotaxis,M010,1,0
0,1,0,0,-1.7,0,GO:0021955,central nervous system neuron axonogenesis,M010,1,0
0,0,1,0,0,-1.6,R-HSA-9022699,MECP2 regulates neuronal receptors and channels,M001,1,0
1,0,0,-0.57,0,0,R-HSA-9759194,Nuclear events mediated by NFE2L2,M100,1,0
0,0,1,0,0,-0.96,GO:0120031,plasma membrane bounded cell projection assembly,M001,1,0
0,1,0,0,-1.3,0,R-HSA-9634815,Transcriptional Regulation by NPAS4,M010,1,0
1,0,0,-0.95,0,0,GO:0009408,response to heat,M100,1,0
1,0,0,-0.89,0,0,hsa04931,Insulin resistance,M100,1,0
0,0,1,0,0,-1.4,GO:0001666,response to hypoxia,M001,1,0
1,0,0,-3.6,0,0,WP49,IL 2 signaling pathway,M100,1,0
1,0,0,-1.1,0,0,GO:0002237,response to molecule of bacterial origin,M100,1,0
0,1,0,0,-1,0,GO:0050768,negative regulation of neurogenesis,M010,1,0
0,0,1,0,0,-1.6,GO:0098815,modulation of excitatory postsynaptic potential,M001,1,0
0,1,0,0,-0.81,0,GO:0009791,post-embryonic development,M010,1,0
0,0,1,0,0,-0.88,GO:0021915,neural tube development,M001,1,0
0,0,1,0,0,-1.3,GO:0006865,amino acid transport,M001,1,0
0,0,1,0,0,-2.2,GO:0002320,lymphoid progenitor cell differentiation,M001,1,0
0,0,1,0,0,-1,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",M001,1,0
0,1,0,0,-0.74,0,GO:2000179,positive regulation of neural precursor cell proliferation,M010,1,0
1,0,0,-1,0,0,GO:0003177,pulmonary valve development,M100,1,0
1,0,0,-0.69,0,0,R-HSA-1592230,Mitochondrial biogenesis,M100,1,0
0,0,1,0,0,-1.2,GO:0007601,visual perception,M001,1,0
1,0,0,-1.8,0,0,hsa04152,AMPK signaling pathway,M100,1,0
1,0,0,-1.3,0,0,GO:0007005,mitochondrion organization,M100,1,0
0,0,1,0,0,-0.87,WP3594,Circadian rhythm genes,M001,1,0
0,1,0,0,-1.8,0,GO:0023061,signal release,M010,1,0
1,0,0,-1.2,0,0,GO:0007519,skeletal muscle tissue development,M100,1,0
0,0,1,0,0,-1.3,GO:0060420,regulation of heart growth,M001,1,0
1,0,0,-1.5,0,0,R-HSA-9675126,Diseases of mitotic cell cycle,M100,1,0
1,0,0,-1.4,0,0,GO:0030178,negative regulation of Wnt signaling pathway,M100,1,0
0,0,1,0,0,-1.8,GO:0060998,regulation of dendritic spine development,M001,1,0
0,1,0,0,-2,0,R-HSA-196807,Nicotinate metabolism,M010,1,0
0,0,1,0,0,-1.6,GO:0016445,somatic diversification of immunoglobulins,M001,1,0
1,0,0,-1.7,0,0,GO:0002230,positive regulation of defense response to virus by host,M100,1,0
0,1,0,0,-0.89,0,R-HSA-5689603,UCH proteinases,M010,1,0
1,0,0,-1.7,0,0,GO:0010506,regulation of autophagy,M100,1,0
0,1,0,0,-0.89,0,M176,PID FOXM1 PATHWAY,M010,1,0
1,0,0,-0.71,0,0,R-HSA-397014,Muscle contraction,M100,1,0
0,0,1,0,0,-1,GO:0006940,regulation of smooth muscle contraction,M001,1,0
1,0,0,-3.1,0,0,R-HSA-9020558,Interleukin-2 signaling,M100,1,0
1,0,0,-1.9,0,0,R-HSA-3232118,SUMOylation of transcription factors,M100,1,0
0,0,1,0,0,-3.1,GO:0032763,regulation of mast cell cytokine production,M001,1,0
0,1,0,0,-0.84,0,hsa04970,Salivary secretion,M010,1,0
1,0,0,-1.2,0,0,GO:0002861,regulation of inflammatory response to antigenic stimulus,M100,1,0
0,1,0,0,-1.4,0,M164,PID ERBB1 DOWNSTREAM PATHWAY,M010,1,0
0,1,0,0,-0.77,0,GO:0030534,adult behavior,M010,1,0
0,0,1,0,0,-1,GO:0000226,microtubule cytoskeleton organization,M001,1,0
1,0,0,-1.4,0,0,GO:0032649,regulation of type II interferon production,M100,1,0
0,0,1,0,0,-2.4,GO:0045830,positive regulation of isotype switching,M001,1,0
0,1,0,0,-1.4,0,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,M010,1,0
0,0,1,0,0,-3.8,GO:0046649,lymphocyte activation,M001,1,0
0,1,0,0,-1.7,0,GO:0030336,negative regulation of cell migration,M010,1,0
0,0,1,0,0,-2.1,hsa04721,Synaptic vesicle cycle,M001,1,0
0,1,0,0,-1,0,M5887,NABA BASEMENT MEMBRANES,M010,1,0
0,0,1,0,0,-2.3,GO:0010611,regulation of cardiac muscle hypertrophy,M001,1,0
1,0,0,-1.7,0,0,GO:0061024,membrane organization,M100,1,0
0,1,0,0,-2.5,0,GO:1901293,nucleoside phosphate biosynthetic process,M010,1,0
0,0,1,0,0,-1.7,GO:0045600,positive regulation of fat cell differentiation,M001,1,0
1,0,0,-1.4,0,0,GO:0010575,positive regulation of vascular endothelial growth factor production,M100,1,0
1,0,0,-2.2,0,0,WP4585,Cancer immunotherapy by PD 1 blockade,M100,1,0
0,1,0,0,-1.5,0,WP4871,Kisspeptin kisspeptin receptor system in the ovary,M010,1,0
0,1,0,0,-1.7,0,GO:0070936,protein K48-linked ubiquitination,M010,1,0
1,0,0,-0.94,0,0,hsa01524,Platinum drug resistance,M100,1,0
1,0,0,-1.7,0,0,R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",M100,1,0
0,0,1,0,0,-0.63,GO:0035967,cellular response to topologically incorrect protein,M001,1,0
0,0,1,0,0,-1.5,GO:0002712,regulation of B cell mediated immunity,M001,1,0
0,0,1,0,0,-0.67,WP2806,Complement system,M001,1,0
0,1,0,0,-0.66,0,GO:0009308,amine metabolic process,M010,1,0
1,0,0,-1.3,0,0,R-HSA-9645723,Diseases of programmed cell death,M100,1,0
1,0,0,-2,0,0,GO:0010658,striated muscle cell apoptotic process,M100,1,0
0,0,1,0,0,-2.7,GO:0071357,cellular response to type I interferon,M001,1,0
0,1,0,0,-0.99,0,M19,PID P73PATHWAY,M010,1,0
0,0,1,0,0,-1.2,GO:0010464,regulation of mesenchymal cell proliferation,M001,1,0
1,0,0,-1.3,0,0,GO:0001954,positive regulation of cell-matrix adhesion,M100,1,0
0,1,0,0,-0.97,0,GO:0051961,negative regulation of nervous system development,M010,1,0
1,0,0,-1.6,0,0,GO:0031579,membrane raft organization,M100,1,0
1,0,0,-1.8,0,0,hsa05416,Viral myocarditis,M100,1,0
0,0,1,0,0,-1,WP2018,RANKL RANK signaling pathway,M001,1,0
0,0,1,0,0,-1.4,GO:0003309,type B pancreatic cell differentiation,M001,1,0
0,1,0,0,-1.2,0,GO:0009913,epidermal cell differentiation,M010,1,0
1,0,0,-1.6,0,0,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,M100,1,0
0,1,0,0,-0.63,0,GO:0009205,purine ribonucleoside triphosphate metabolic process,M010,1,0
1,0,0,-1.3,0,0,GO:0010955,negative regulation of protein processing,M100,1,0
0,1,0,0,-0.99,0,GO:0032091,negative regulation of protein binding,M010,1,0
0,1,0,0,-1.7,0,hsa00513,Various types of N-glycan biosynthesis,M010,1,0
1,0,0,-2.3,0,0,GO:0031667,response to nutrient levels,M100,1,0
0,0,1,0,0,-2,GO:1900006,positive regulation of dendrite development,M001,1,0
0,1,0,0,-1.2,0,WP4312,Rett syndrome,M010,1,0
0,1,0,0,-2.5,0,GO:0060395,SMAD protein signal transduction,M010,1,0
0,0,1,0,0,-0.77,GO:0002066,columnar/cuboidal epithelial cell development,M001,1,0
0,0,1,0,0,-1.6,WP3892,Development of pulmonary dendritic cells and macrophage subsets,M001,1,0
0,1,0,0,-1.5,0,hsa04070,Phosphatidylinositol signaling system,M010,1,0
1,0,0,-2.4,0,0,R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,M100,1,0
0,1,0,0,-0.82,0,GO:0002791,regulation of peptide secretion,M010,1,0
0,0,1,0,0,-1.9,GO:0044344,cellular response to fibroblast growth factor stimulus,M001,1,0
0,1,0,0,-1,0,GO:0048483,autonomic nervous system development,M010,1,0
1,0,0,-1.2,0,0,GO:0051924,regulation of calcium ion transport,M100,1,0
0,1,0,0,-0.99,0,GO:0060425,lung morphogenesis,M010,1,0
1,0,0,-1.5,0,0,GO:0045589,regulation of regulatory T cell differentiation,M100,1,0
1,0,0,-1.9,0,0,GO:1903018,regulation of glycoprotein metabolic process,M100,1,0
1,0,0,-0.85,0,0,GO:0042220,response to cocaine,M100,1,0
0,1,0,0,-1.3,0,GO:0021772,olfactory bulb development,M010,1,0
0,1,0,0,-1.8,0,GO:0006644,phospholipid metabolic process,M010,1,0
0,1,0,0,-2.8,0,GO:0007179,transforming growth factor beta receptor signaling pathway,M010,1,0
0,1,0,0,-1.5,0,GO:0009395,phospholipid catabolic process,M010,1,0
0,0,1,0,0,-1.6,GO:0045655,regulation of monocyte differentiation,M001,1,0
0,0,1,0,0,-1.1,R-HSA-9664323,FCGR3A-mediated IL10 synthesis,M001,1,0
0,1,0,0,-0.5,0,GO:0000041,transition metal ion transport,M010,1,0
1,0,0,-1,0,0,GO:0003181,atrioventricular valve morphogenesis,M100,1,0
1,0,0,-2.3,0,0,GO:0016311,dephosphorylation,M100,1,0
0,1,0,0,-1,0,hsa04932,Non-alcoholic fatty liver disease,M010,1,0
0,0,1,0,0,-0.94,WP2637,Interleukin 1 IL 1 structural pathway,M001,1,0
0,1,0,0,-0.66,0,GO:0090277,positive regulation of peptide hormone secretion,M010,1,0
0,0,1,0,0,-0.57,GO:0006575,cellular modified amino acid metabolic process,M001,1,0
1,0,0,-2.4,0,0,R-HSA-1912408,Pre-NOTCH Transcription and Translation,M100,1,0
1,0,0,-2.7,0,0,GO:0030195,negative regulation of blood coagulation,M100,1,0
0,1,0,0,-0.69,0,GO:0009259,ribonucleotide metabolic process,M010,1,0
0,1,0,0,-2,0,GO:0110011,regulation of basement membrane organization,M010,1,0
0,0,1,0,0,-0.81,GO:0050982,detection of mechanical stimulus,M001,1,0
1,0,0,-0.66,0,0,WP5356,Affected pathways in Duchenne muscular dystrophy,M100,1,0
0,1,0,0,-0.71,0,GO:0009150,purine ribonucleotide metabolic process,M010,1,0
1,0,0,-1.1,0,0,hsa04210,Apoptosis,M100,1,0
1,0,0,-3.7,0,0,GO:0006470,protein dephosphorylation,M100,1,0
1,0,0,-1.9,0,0,GO:0031638,zymogen activation,M100,1,0
1,0,0,-0.83,0,0,GO:0006790,sulfur compound metabolic process,M100,1,0
1,0,0,-1.8,0,0,GO:0034113,heterotypic cell-cell adhesion,M100,1,0
0,1,0,0,-0.84,0,WP5095,Overview of proinflammatory and profibrotic mediators,M010,1,0
0,1,0,0,-0.5,0,R-HSA-5689880,Ub-specific processing proteases,M010,1,0
1,0,0,-0.81,0,0,GO:0045581,negative regulation of T cell differentiation,M100,1,0
1,0,0,-2.2,0,0,M180,PID HIF1A PATHWAY,M100,1,0
0,0,1,0,0,-2.2,GO:0095500,acetylcholine receptor signaling pathway,M001,1,0
0,0,1,0,0,-0.69,GO:0001841,neural tube formation,M001,1,0
1,0,0,-0.94,0,0,WP4747,Netrin UNC5B signaling pathway,M100,1,0
0,1,0,0,-0.82,0,GO:0050729,positive regulation of inflammatory response,M010,1,0
0,0,1,0,0,-1.1,GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,M001,1,0
0,1,0,0,-0.73,0,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,M010,1,0
1,0,0,-1.3,0,0,R-HSA-3928663,EPHA-mediated growth cone collapse,M100,1,0
0,1,0,0,-1.2,0,GO:0002064,epithelial cell development,M010,1,0
0,1,0,0,-1.8,0,GO:0072521,purine-containing compound metabolic process,M010,1,0
1,0,0,-3.4,0,0,GO:0070672,response to interleukin-15,M100,1,0
1,0,0,-2,0,0,GO:0071361,cellular response to ethanol,M100,1,0
1,0,0,-1.3,0,0,GO:0010665,regulation of cardiac muscle cell apoptotic process,M100,1,0
1,0,0,-3.1,0,0,GO:0072103,glomerulus vasculature morphogenesis,M100,1,0
1,0,0,-1.3,0,0,GO:0006366,transcription by RNA polymerase II,M100,1,0
1,0,0,-1,0,0,R-HSA-5673001,RAF/MAP kinase cascade,M100,1,0
1,0,0,-2.2,0,0,R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,M100,1,0
0,0,1,0,0,-0.68,GO:1990778,protein localization to cell periphery,M001,1,0
0,1,0,0,-1.1,0,GO:0022600,digestive system process,M010,1,0
0,0,1,0,0,-2.7,GO:0042474,middle ear morphogenesis,M001,1,0
1,0,0,-1.7,0,0,GO:0002821,positive regulation of adaptive immune response,M100,1,0
1,0,0,-0.6,0,0,R-HSA-418346,Platelet homeostasis,M100,1,0
1,0,0,-3.1,0,0,hsa05218,Melanoma,M100,1,0
0,1,0,0,-0.69,0,hsa04061,Viral protein interaction with cytokine and cytokine receptor,M010,1,0
1,0,0,-1.5,0,0,R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,M100,1,0
1,0,0,-2.2,0,0,R-HSA-109582,Hemostasis,M100,1,0
0,0,1,0,0,-1.7,GO:0032507,maintenance of protein location in cell,M001,1,0
0,1,0,0,-0.74,0,GO:1900180,regulation of protein localization to nucleus,M010,1,0
1,0,0,-2.4,0,0,GO:0050819,negative regulation of coagulation,M100,1,0
1,0,0,-1.5,0,0,R-HSA-1227986,Signaling by ERBB2,M100,1,0
1,0,0,-1.3,0,0,GO:0010827,regulation of glucose transmembrane transport,M100,1,0
0,1,0,0,-3.4,0,WP5411,Phosphatidyl inositol phosphate pathway,M010,1,0
0,1,0,0,-0.85,0,GO:0048709,oligodendrocyte differentiation,M010,1,0
0,1,0,0,-1.4,0,GO:0048857,neural nucleus development,M010,1,0
0,0,1,0,0,-1.4,GO:0070482,response to oxygen levels,M001,1,0
0,0,1,0,0,-2.2,GO:0019233,sensory perception of pain,M001,1,0
0,1,0,0,-1.5,0,GO:0042832,defense response to protozoan,M010,1,0
1,0,0,-0.72,0,0,GO:1903169,regulation of calcium ion transmembrane transport,M100,1,0
1,0,0,-0.88,0,0,GO:0018193,peptidyl-amino acid modification,M100,1,0
1,0,0,-2.2,0,0,R-HSA-1236394,Signaling by ERBB4,M100,1,0
0,1,0,0,-1.3,0,hsa04929,GnRH secretion,M010,1,0
1,0,0,-0.55,0,0,GO:0016197,endosomal transport,M100,1,0
0,0,1,0,0,-1.5,GO:0006310,DNA recombination,M001,1,0
0,1,0,0,-2.2,0,WP5216,Warburg effect modulated by deubiquitinating enzymes and their substrates,M010,1,0
1,0,0,-1.2,0,0,GO:0003184,pulmonary valve morphogenesis,M100,1,0
1,0,0,-0.93,0,0,GO:0046890,regulation of lipid biosynthetic process,M100,1,0
0,1,0,0,-1.5,0,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,M010,1,0
0,0,1,0,0,-1.6,GO:0060491,regulation of cell projection assembly,M001,1,0
1,0,0,-1.9,0,0,M182,PID IL3 PATHWAY,M100,1,0
1,0,0,-3.4,0,0,WP3981,miRNA regulation of prostate cancer signaling pathways,M100,1,0
0,1,0,0,-0.63,0,hsa04911,Insulin secretion,M010,1,0
0,1,0,0,-1.7,0,GO:0002090,regulation of receptor internalization,M010,1,0
1,0,0,-1.6,0,0,hsa04940,Type I diabetes mellitus,M100,1,0
1,0,0,-2.2,0,0,GO:1903047,mitotic cell cycle process,M100,1,0
1,0,0,-1.4,0,0,GO:0055117,regulation of cardiac muscle contraction,M100,1,0
0,1,0,0,-0.52,0,GO:0061005,cell differentiation involved in kidney development,M010,1,0
0,1,0,0,-1.2,0,GO:0048485,sympathetic nervous system development,M010,1,0
0,1,0,0,-1.9,0,hsa00510,N-Glycan biosynthesis,M010,1,0
1,0,0,-0.6,0,0,GO:0097553,calcium ion transmembrane import into cytosol,M100,1,0
1,0,0,-0.86,0,0,hsa04110,Cell cycle,M100,1,0
1,0,0,-2.5,0,0,GO:0006914,autophagy,M100,1,0
0,1,0,0,-0.81,0,R-HSA-5621481,C-type lectin receptors (CLRs),M010,1,0
1,0,0,-1.1,0,0,GO:0006959,humoral immune response,M100,1,0
0,1,0,0,-3.5,0,GO:0045576,mast cell activation,M010,1,0
0,0,1,0,0,-2,GO:0002200,somatic diversification of immune receptors,M001,1,0
0,0,1,0,0,-1.6,GO:0031529,ruffle organization,M001,1,0
0,1,0,0,-0.61,0,R-HSA-975871,MyD88 cascade initiated on plasma membrane,M010,1,0
0,0,1,0,0,-0.75,GO:0051384,response to glucocorticoid,M001,1,0
0,1,0,0,-0.66,0,GO:0019362,pyridine nucleotide metabolic process,M010,1,0
1,0,0,-1.3,0,0,GO:1903115,regulation of actin filament-based movement,M100,1,0
0,1,0,0,-1.1,0,GO:0045123,cellular extravasation,M010,1,0
0,1,0,0,-1.7,0,GO:0010596,negative regulation of endothelial cell migration,M010,1,0
0,1,0,0,-0.66,0,GO:0030316,osteoclast differentiation,M010,1,0
0,0,1,0,0,-0.85,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",M001,1,0
0,0,1,0,0,-1.3,GO:0022030,telencephalon glial cell migration,M001,1,0
0,0,1,0,0,-2.2,GO:1905145,cellular response to acetylcholine,M001,1,0
0,1,0,0,-1.9,0,GO:0032885,regulation of polysaccharide biosynthetic process,M010,1,0
0,1,0,0,-1.4,0,GO:0071542,dopaminergic neuron differentiation,M010,1,0
0,1,0,0,-1,0,GO:0021517,ventral spinal cord development,M010,1,0
1,0,0,-1.1,0,0,GO:0050673,epithelial cell proliferation,M100,1,0
1,0,0,-1.1,0,0,M113,PID NFAT 3PATHWAY,M100,1,0
1,0,0,-0.63,0,0,GO:0001754,eye photoreceptor cell differentiation,M100,1,0
0,1,0,0,-1.3,0,GO:0060560,developmental growth involved in morphogenesis,M010,1,0
0,1,0,0,-1.8,0,GO:0040013,negative regulation of locomotion,M010,1,0
0,1,0,0,-1.7,0,GO:0099003,vesicle-mediated transport in synapse,M010,1,0
1,0,0,-1.1,0,0,GO:0052548,regulation of endopeptidase activity,M100,1,0
0,1,0,0,-0.84,0,M223,PID BETA CATENIN NUC PATHWAY,M010,1,0
1,0,0,-1.7,0,0,R-HSA-9725554,Differentiation of keratinocytes in interfollicular epidermis in mammalian skin,M100,1,0
1,0,0,-0.89,0,0,GO:0007566,embryo implantation,M100,1,0
0,0,1,0,0,-0.78,GO:0048640,negative regulation of developmental growth,M001,1,0
0,0,1,0,0,-0.85,GO:0032231,regulation of actin filament bundle assembly,M001,1,0
0,0,1,0,0,-1.7,GO:0042542,response to hydrogen peroxide,M001,1,0
0,0,1,0,0,-1.4,R-HSA-2428924,IGF1R signaling cascade,M001,1,0
0,1,0,0,-1.1,0,WP4830,GDNF RET signaling axis,M010,1,0
0,0,1,0,0,-1.1,GO:0043388,positive regulation of DNA binding,M001,1,0
0,0,1,0,0,-0.5,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,M001,1,0
1,0,0,-1.8,0,0,GO:0006351,DNA-templated transcription,M100,1,0
0,0,1,0,0,-0.68,GO:0043409,negative regulation of MAPK cascade,M001,1,0
0,0,1,0,0,-1.2,GO:0046320,regulation of fatty acid oxidation,M001,1,0
0,0,1,0,0,-2,GO:0097094,craniofacial suture morphogenesis,M001,1,0
1,0,0,-1.2,0,0,GO:0002825,regulation of T-helper 1 type immune response,M100,1,0
1,0,0,-1.3,0,0,hsa05213,Endometrial cancer,M100,1,0
0,0,1,0,0,-1,GO:0010171,body morphogenesis,M001,1,0
0,1,0,0,-2.4,0,GO:0003301,physiological cardiac muscle hypertrophy,M010,1,0
0,1,0,0,-2,0,GO:0048015,phosphatidylinositol-mediated signaling,M010,1,0
0,0,1,0,0,-0.66,GO:0035150,regulation of tube size,M001,1,0
0,1,0,0,-2.7,0,GO:0021529,spinal cord oligodendrocyte cell differentiation,M010,1,0
0,1,0,0,-0.89,0,GO:0002686,negative regulation of leukocyte migration,M010,1,0
1,0,0,-0.8,0,0,R-HSA-8878159,Transcriptional regulation by RUNX3,M100,1,0
0,0,1,0,0,-1.3,hsa05031,Amphetamine addiction,M001,1,0
1,0,0,-1.2,0,0,GO:0051282,regulation of sequestering of calcium ion,M100,1,0
0,1,0,0,-1.8,0,GO:0021953,central nervous system neuron differentiation,M010,1,0
0,1,0,0,-2.9,0,GO:0002448,mast cell mediated immunity,M010,1,0
1,0,0,-1.1,0,0,R-HSA-1852241,Organelle biogenesis and maintenance,M100,1,0
1,0,0,-2.4,0,0,GO:0032516,positive regulation of phosphoprotein phosphatase activity,M100,1,0
1,0,0,-2.2,0,0,GO:0007599,hemostasis,M100,1,0
0,0,1,0,0,-0.81,GO:0061384,heart trabecula morphogenesis,M001,1,0
1,0,0,-2,0,0,GO:0042698,ovulation cycle,M100,1,0
0,1,0,0,-1,0,GO:0048259,regulation of receptor-mediated endocytosis,M010,1,0
0,0,1,0,0,-1.9,GO:0051938,L-glutamate import,M001,1,0
0,1,0,0,-2.1,0,GO:0070201,regulation of establishment of protein localization,M010,1,0
1,0,0,-1.1,0,0,WP4155,Endometrial cancer,M100,1,0
0,0,1,0,0,-0.86,GO:0031960,response to corticosteroid,M001,1,0
1,0,0,-1.2,0,0,GO:0070227,lymphocyte apoptotic process,M100,1,0
0,1,0,0,-1.4,0,GO:0046488,phosphatidylinositol metabolic process,M010,1,0
0,1,0,0,-3.1,0,WP3655,Hypothetical craniofacial development pathway,M010,1,0
0,1,0,0,-1.3,0,WP4787,Osteoblast differentiation and related diseases,M010,1,0
1,0,0,-1.1,0,0,GO:0032660,regulation of interleukin-17 production,M100,1,0
0,0,1,0,0,-0.5,GO:0032677,regulation of interleukin-8 production,M001,1,0
0,0,1,0,0,-1.6,R-HSA-6798695,Neutrophil degranulation,M001,1,0
1,0,0,-1.8,0,0,GO:0031663,lipopolysaccharide-mediated signaling pathway,M100,1,0
1,0,0,-0.75,0,0,GO:0030307,positive regulation of cell growth,M100,1,0
1,0,0,-1.8,0,0,GO:0008202,steroid metabolic process,M100,1,0
0,1,0,0,-0.73,0,GO:0140962,multicellular organismal-level chemical homeostasis,M010,1,0
0,1,0,0,-0.63,0,GO:0031047,regulatory ncRNA-mediated gene silencing,M010,1,0
0,1,0,0,-1.4,0,R-HSA-114604,GPVI-mediated activation cascade,M010,1,0
1,0,0,-1,0,0,GO:0030325,adrenal gland development,M100,1,0
1,0,0,-1,0,0,GO:0006304,DNA modification,M100,1,0
0,1,0,0,-0.94,0,GO:0009948,anterior/posterior axis specification,M010,1,0
1,0,0,-0.91,0,0,hsa04141,Protein processing in endoplasmic reticulum,M100,1,0
0,1,0,0,-0.85,0,GO:0090276,regulation of peptide hormone secretion,M010,1,0
0,1,0,0,-2.1,0,GO:1903053,regulation of extracellular matrix organization,M010,1,0
1,0,0,-1.9,0,0,GO:0036120,cellular response to platelet-derived growth factor stimulus,M100,1,0
0,0,1,0,0,-1,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,M001,1,0
0,0,1,0,0,-3.5,GO:0034101,erythrocyte homeostasis,M001,1,0
1,0,0,-1.9,0,0,hsa05332,Graft-versus-host disease,M100,1,0
1,0,0,-1.6,0,0,GO:0035307,positive regulation of protein dephosphorylation,M100,1,0
0,0,1,0,0,-1.6,GO:0061117,negative regulation of heart growth,M001,1,0
0,0,1,0,0,-1.7,GO:0071774,response to fibroblast growth factor,M001,1,0
1,0,0,-0.69,0,0,R-HSA-202424,Downstream TCR signaling,M100,1,0
0,1,0,0,-1.2,0,GO:0010975,regulation of neuron projection development,M010,1,0
1,0,0,-2.5,0,0,GO:0061919,process utilizing autophagic mechanism,M100,1,0
1,0,0,-5.1,0,0,M143,PID IL2 PI3K PATHWAY,M100,1,0
0,1,0,0,-0.77,0,GO:0003158,endothelium development,M010,1,0
1,0,0,-1.5,0,0,GO:0046328,regulation of JNK cascade,M100,1,0
1,0,0,-3.1,0,0,GO:0001787,natural killer cell proliferation,M100,1,0
1,0,0,-3.2,0,0,R-HSA-186797,Signaling by PDGF,M100,1,0
1,0,0,-1.3,0,0,hsa04145,Phagosome,M100,1,0
1,0,0,-1.5,0,0,GO:0000086,G2/M transition of mitotic cell cycle,M100,1,0
1,0,0,-0.77,0,0,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,M100,1,0
1,0,0,-0.64,0,0,GO:0061333,renal tubule morphogenesis,M100,1,0
1,0,0,-0.9,0,0,R-HSA-69278,"Cell Cycle, Mitotic",M100,1,0
0,1,0,0,-1.4,0,GO:0009260,ribonucleotide biosynthetic process,M010,1,0
0,1,0,0,-1.2,0,GO:0008654,phospholipid biosynthetic process,M010,1,0
0,1,0,0,-1.9,0,GO:0021952,central nervous system projection neuron axonogenesis,M010,1,0
0,1,0,0,-1.5,0,R-HSA-445717,Aquaporin-mediated transport,M010,1,0
0,0,1,0,0,-2,GO:0034114,regulation of heterotypic cell-cell adhesion,M001,1,0
0,0,1,0,0,-2.4,GO:0003416,endochondral bone growth,M001,1,0
0,1,0,0,-3.1,0,GO:0090263,positive regulation of canonical Wnt signaling pathway,M010,1,0
0,0,1,0,0,-1.4,R-HSA-2029485,Role of phospholipids in phagocytosis,M001,1,0
1,0,0,-2,0,0,GO:0070365,hepatocyte differentiation,M100,1,0
1,0,0,-1.8,0,0,GO:0048608,reproductive structure development,M100,1,0
0,1,0,0,-2.2,0,GO:0060428,lung epithelium development,M010,1,0
0,1,0,0,-0.99,0,R-HSA-5607764,CLEC7A (Dectin-1) signaling,M010,1,0
0,1,0,0,-2.1,0,GO:2000736,regulation of stem cell differentiation,M010,1,0
1,0,0,-1.5,0,0,WP3651,Pathways affected in adenoid cystic carcinoma,M100,1,0
0,0,1,0,0,-0.63,GO:0060324,face development,M001,1,0
0,1,0,0,-0.73,0,GO:0045747,positive regulation of Notch signaling pathway,M010,1,0
1,0,0,-1.9,0,0,WP4320,Effect of progerin on genes involved in progeria,M100,1,0
0,1,0,0,-0.76,0,R-HSA-373080,Class B/2 (Secretin family receptors),M010,1,0
0,0,1,0,0,-0.8,GO:0046632,alpha-beta T cell differentiation,M001,1,0
0,1,0,0,-2.4,0,GO:0051046,regulation of secretion,M010,1,0
0,0,1,0,0,-1.1,GO:0060317,cardiac epithelial to mesenchymal transition,M001,1,0
1,0,0,-1.7,0,0,R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,M100,1,0
1,0,0,-1,0,0,GO:0010952,positive regulation of peptidase activity,M100,1,0
0,1,0,0,-1.1,0,GO:0097530,granulocyte migration,M010,1,0
0,1,0,0,-1.1,0,R-HSA-400206,Regulation of lipid metabolism by PPARalpha,M010,1,0
0,1,0,0,-2.2,0,GO:0097475,motor neuron migration,M010,1,0
0,0,1,0,0,-1.2,R-HSA-9856649,Transcriptional and post-translational regulation of MITF-M expression and activity,M001,1,0
1,0,0,-1.3,0,0,GO:0016126,sterol biosynthetic process,M100,1,0
0,0,1,0,0,-0.66,GO:0034620,cellular response to unfolded protein,M001,1,0
1,0,0,-0.69,0,0,GO:0032411,positive regulation of transporter activity,M100,1,0
0,1,0,0,-0.59,0,GO:0062207,regulation of pattern recognition receptor signaling pathway,M010,1,0
0,0,1,0,0,-1.2,M121,PID MTOR 4PATHWAY,M001,1,0
0,1,0,0,-2.4,0,GO:0061140,lung secretory cell differentiation,M010,1,0
0,1,0,0,-2.7,0,WP2895,Differentiation of white and brown adipocyte,M010,1,0
1,0,0,-0.95,0,0,GO:0060675,ureteric bud morphogenesis,M100,1,0
1,0,0,-1.9,0,0,GO:0043153,entrainment of circadian clock by photoperiod,M100,1,0
0,0,1,0,0,-0.72,GO:0051235,maintenance of location,M001,1,0
1,0,0,-1.9,0,0,WP4861,Endoplasmic reticulum stress response in coronavirus infection,M100,1,0
1,0,0,-2.4,0,0,GO:0072102,glomerulus morphogenesis,M100,1,0
0,0,1,0,0,-1,GO:0045911,positive regulation of DNA recombination,M001,1,0
0,0,1,0,0,-1.2,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,M001,1,0
0,0,1,0,0,-2.2,GO:0051154,negative regulation of striated muscle cell differentiation,M001,1,0
1,0,0,-1.8,0,0,R-HSA-453274,Mitotic G2-G2/M phases,M100,1,0
0,1,0,0,-0.76,0,WP5348,11p11 2 copy number variation syndrome,M010,1,0
0,0,1,0,0,-1.9,GO:0060037,pharyngeal system development,M001,1,0
0,1,0,0,-2.3,0,WP4659,Gastrin signaling pathway,M010,1,0
1,0,0,-3.1,0,0,GO:0043380,regulation of memory T cell differentiation,M100,1,0
1,0,0,-0.75,0,0,hsa04270,Vascular smooth muscle contraction,M100,1,0
1,0,0,-1.4,0,0,GO:0044839,cell cycle G2/M phase transition,M100,1,0
1,0,0,-0.84,0,0,GO:0042632,cholesterol homeostasis,M100,1,0
0,0,1,0,0,-1,M67,PID ARF6 TRAFFICKING PATHWAY,M001,1,0
0,1,0,0,-2.1,0,R-HSA-1660499,Synthesis of PIPs at the plasma membrane,M010,1,0
1,0,0,-2,0,0,R-HSA-9020958,Interleukin-21 signaling,M100,1,0
1,0,0,-1.6,0,0,WP2328,Allograft rejection,M100,1,0
0,0,1,0,0,-0.66,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,M001,1,0
0,1,0,0,-1.6,0,M55,PID S1P S1P3 PATHWAY,M010,1,0
1,0,0,-0.72,0,0,GO:0001776,leukocyte homeostasis,M100,1,0
1,0,0,-1.5,0,0,GO:2001259,positive regulation of cation channel activity,M100,1,0
0,1,0,0,-0.52,0,GO:0014014,negative regulation of gliogenesis,M010,1,0
0,1,0,0,-1.2,0,GO:1902991,regulation of amyloid precursor protein catabolic process,M010,1,0
1,0,0,-3.4,0,0,GO:0042102,positive regulation of T cell proliferation,M100,1,0
0,1,0,0,-1.3,0,hsa05135,Yersinia infection,M010,1,0
0,1,0,0,-0.95,0,GO:0030216,keratinocyte differentiation,M010,1,0
0,0,1,0,0,-1.7,GO:0042475,odontogenesis of dentin-containing tooth,M001,1,0
0,0,1,0,0,-0.66,GO:0097746,blood vessel diameter maintenance,M001,1,0
0,1,0,0,-1.3,0,M86,PID ARF6 PATHWAY,M010,1,0
1,0,0,-1.9,0,0,WP1545,miRNAs involved in DNA damage response,M100,1,0
1,0,0,-1.4,0,0,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,M100,1,0
0,0,1,0,0,-1.6,GO:0021872,forebrain generation of neurons,M001,1,0
0,1,0,0,-1.9,0,GO:0050767,regulation of neurogenesis,M010,1,0
0,0,1,0,0,-0.85,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,M001,1,0
1,0,0,-2.5,0,0,GO:2000278,regulation of DNA biosynthetic process,M100,1,0
1,0,0,-2.5,0,0,GO:0031348,negative regulation of defense response,M100,1,0
1,0,0,-0.88,0,0,GO:0072593,reactive oxygen species metabolic process,M100,1,0
0,0,1,0,0,-1.2,R-HSA-74752,Signaling by Insulin receptor,M001,1,0
1,0,0,-1.3,0,0,GO:0031099,regeneration,M100,1,0
1,0,0,-0.94,0,0,GO:0009954,proximal/distal pattern formation,M100,1,0
1,0,0,-2,0,0,hsa05330,Allograft rejection,M100,1,0
0,0,1,0,0,-0.83,hsa05130,Pathogenic Escherichia coli infection,M001,1,0
0,1,0,0,-0.99,0,GO:0043537,negative regulation of blood vessel endothelial cell migration,M010,1,0
1,0,0,-2.1,0,0,GO:1903035,negative regulation of response to wounding,M100,1,0
1,0,0,-0.88,0,0,GO:0006898,receptor-mediated endocytosis,M100,1,0
1,0,0,-1.2,0,0,GO:0045332,phospholipid translocation,M100,1,0
0,0,1,0,0,-0.77,GO:0033002,muscle cell proliferation,M001,1,0
0,0,1,0,0,-0.91,GO:0060840,artery development,M001,1,0
1,0,0,-1.4,0,0,GO:0009994,oocyte differentiation,M100,1,0
1,0,0,-1.1,0,0,GO:1903317,regulation of protein maturation,M100,1,0
0,0,1,0,0,-1.1,GO:0051385,response to mineralocorticoid,M001,1,0
1,0,0,-2.4,0,0,GO:0007596,blood coagulation,M100,1,0
0,0,1,0,0,-1.1,GO:0043648,dicarboxylic acid metabolic process,M001,1,0
1,0,0,-0.75,0,0,GO:0051928,positive regulation of calcium ion transport,M100,1,0
1,0,0,-0.99,0,0,GO:0006839,mitochondrial transport,M100,1,0
1,0,0,-2.9,0,0,GO:0043666,regulation of phosphoprotein phosphatase activity,M100,1,0
0,1,0,0,-1.2,0,GO:0001895,retina homeostasis,M010,1,0
0,0,1,0,0,-1,GO:0051098,regulation of binding,M001,1,0
0,1,0,0,-2,0,GO:0002467,germinal center formation,M010,1,0
1,0,0,-0.92,0,0,hsa05012,Parkinson disease,M100,1,0
1,0,0,-0.89,0,0,GO:0032414,positive regulation of ion transmembrane transporter activity,M100,1,0
1,0,0,-1.2,0,0,GO:0002832,negative regulation of response to biotic stimulus,M100,1,0
1,0,0,-1.2,0,0,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,M100,1,0
0,0,1,0,0,-1.7,GO:0080135,regulation of cellular response to stress,M001,1,0
0,0,1,0,0,-1.3,GO:1904646,cellular response to amyloid-beta,M001,1,0
1,0,0,-1.4,0,0,M187,PID TRKR PATHWAY,M100,1,0
1,0,0,-1.4,0,0,GO:0061298,retina vasculature development in camera-type eye,M100,1,0
0,0,1,0,0,-1.6,GO:0055022,negative regulation of cardiac muscle tissue growth,M001,1,0
0,0,1,0,0,-1,GO:0061383,trabecula morphogenesis,M001,1,0
0,0,1,0,0,-1.3,GO:0003333,amino acid transmembrane transport,M001,1,0
1,0,0,-1.5,0,0,R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",M100,1,0
1,0,0,-1.7,0,0,R-HSA-8854691,Interleukin-20 family signaling,M100,1,0
1,0,0,-2.2,0,0,R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,M100,1,0
1,0,0,-1.1,0,0,WP5426,HDAC6 interactions in the central nervous system,M100,1,0
0,0,1,0,0,-0.6,GO:0045739,positive regulation of DNA repair,M001,1,0
0,0,1,0,0,-1.3,WP4868,Type I interferon induction and signaling during SARS CoV 2 infection,M001,1,0
1,0,0,-2.7,0,0,GO:0031343,positive regulation of cell killing,M100,1,0
0,0,1,0,0,-0.6,GO:0010812,negative regulation of cell-substrate adhesion,M001,1,0
1,0,0,-0.89,0,0,GO:0090102,cochlea development,M100,1,0
0,0,1,0,0,-0.81,GO:0048167,regulation of synaptic plasticity,M001,1,0
1,0,0,-0.99,0,0,WP2864,Apoptosis related network due to altered Notch3 in ovarian cancer,M100,1,0
0,1,0,0,-0.8,0,GO:0099111,microtubule-based transport,M010,1,0
0,1,0,0,-1.1,0,GO:1990138,neuron projection extension,M010,1,0
1,0,0,-1.2,0,0,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,M100,1,0
0,1,0,0,-0.94,0,GO:0045446,endothelial cell differentiation,M010,1,0
1,0,0,-2.2,0,0,R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,M100,1,0
1,0,0,-3.1,0,0,GO:0048009,insulin-like growth factor receptor signaling pathway,M100,1,0
0,0,1,0,0,-1.1,GO:0071312,cellular response to alkaloid,M001,1,0
1,0,0,-0.91,0,0,M166,PID ATF2 PATHWAY,M100,1,0
0,0,1,0,0,-1,GO:0046942,carboxylic acid transport,M001,1,0
1,0,0,-2.2,0,0,GO:0022602,ovulation cycle process,M100,1,0
1,0,0,-1.4,0,0,GO:0021696,cerebellar cortex morphogenesis,M100,1,0
0,1,0,0,-2.2,0,GO:0045602,negative regulation of endothelial cell differentiation,M010,1,0
0,0,1,0,0,-1.2,GO:0140056,organelle localization by membrane tethering,M001,1,0
1,0,0,-1.2,0,0,GO:0007292,female gamete generation,M100,1,0
0,1,0,0,-0.61,0,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,M010,1,0
0,0,1,0,0,-0.57,GO:0007613,memory,M001,1,0
1,0,0,-0.94,0,0,GO:0008589,regulation of smoothened signaling pathway,M100,1,0
0,1,0,0,-1,0,GO:0008038,neuron recognition,M010,1,0
1,0,0,-0.77,0,0,WP3929,Chemokine signaling pathway,M100,1,0
1,0,0,-1.2,0,0,GO:0034204,lipid translocation,M100,1,0
1,0,0,-1.7,0,0,WP2203,Thymic stromal lymphopoietin TSLP signaling pathway,M100,1,0
1,0,0,-0.89,0,0,hsa04657,IL-17 signaling pathway,M100,1,0
0,1,0,0,-1.4,0,GO:0045601,regulation of endothelial cell differentiation,M010,1,0
0,0,1,0,0,-1.9,GO:0003310,pancreatic A cell differentiation,M001,1,0
1,0,0,-2.3,0,0,GO:0001667,ameboidal-type cell migration,M100,1,0
0,0,1,0,0,-1,GO:0000018,regulation of DNA recombination,M001,1,0
0,1,0,0,-0.84,0,GO:0050922,negative regulation of chemotaxis,M010,1,0
0,1,0,0,-1.4,0,hsa04923,Regulation of lipolysis in adipocytes,M010,1,0
0,1,0,0,-0.8,0,M229,PID P38 ALPHA BETA DOWNSTREAM PATHWAY,M010,1,0
0,0,1,0,0,-1.8,GO:0007610,behavior,M001,1,0
0,1,0,0,-1,0,WP4298,Acute viral myocarditis,M010,1,0
1,0,0,-1.7,0,0,GO:0048008,platelet-derived growth factor receptor signaling pathway,M100,1,0
1,0,0,-1.9,0,0,GO:0002711,positive regulation of T cell mediated immunity,M100,1,0
1,0,0,-0.86,0,0,GO:1903900,regulation of viral life cycle,M100,1,0
1,0,0,-2.7,0,0,GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,M100,1,0
1,0,0,-1.7,0,0,R-HSA-9734767,Developmental Cell Lineages,M100,1,0
0,0,1,0,0,-2.9,GO:0001818,negative regulation of cytokine production,M001,1,0
1,0,0,-0.88,0,0,GO:0052547,regulation of peptidase activity,M100,1,0
1,0,0,-3.1,0,0,hsa04114,Oocyte meiosis,M100,1,0
